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1. INTRODUCTION
“Life love the liver of it.”
-Maya Angelou.
Siddha system of medicine is one of the ancient system of medicine in India.
The term siddha is derived from the word ‘Siddhi’. Siddhi means attainment of
perfection, accomplished or achievement. The unique nature of this system is its
continuous service to humanity[1].
In Siddha system, there were eight supernatural powers are called
“Attamasiddhi”. Those who attained the supernatural powers are called Siddhars.
Siddhars gained the supreme wisdom and overall immortality. Through this spiritual
knowledge, they wrote scriptures on all aspect of life, from arts to science and truth of
life to miracle cure for diseases[2].
Siddhars have the concept that a healthy soul can only be developed by a
healthy body. Saint Thirumoolar said that,
 MingL  MingL  ngngL  MinL
 iMinM  7a7g7i  ′n⸳i 7g0MgL
 Mi⸵n nGL i  ngni  LiX  
 Mi⸵n nGL0  0  ngL nGL   7 
  it7X ini.[3]
The art of bestowing immortality is a unique feature of Siddha medicine which
is termed as “Kayakalpa”.
Kaya means body, Kalpa means stone like, together meaning keeping the
body as strong as a stone. Kayakalpa therapy is based on prevention of diseases. It
also promote the health of the body and prevent aging process[1a].
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According to Siddha system, the physiological components of the human
beings are classified as Vaatham (air), Pitham (fire) and Kabam (earth and water).
When the normal equilibrium of this three humors were disturbed, disease is caused[4].
The treatment in Siddha medicine is aimed at keeping the three humors in
equilibrium and maintenance of seven elements such as saaram (plasma),
cheneer (blood), oon (muscle), kozhuppu (fatty tissue), enbu (bone), moolai (bone
marrow), sukkilam (semen) or suronitham (ovum)[1b].
Proper diet, medicine and a disciplined regimen of life are advised for a
healthy living and to restore equilibrium of humors in diseased condition. Saint
Thiruvalluvar said that,
  Ln0  VLHng0 7tX ⸵M䁞  ′Lng 70
LHn7g     L 7tX  
  it Li 
He explains four requisites of successful treatment. These are the patient, the
attendant, physician and medicine. When the physician is well-qualified and the other
agents possess the necessary qualities, even severe diseases can be cured easily,
according to these concepts[1c].
Hepatoprotection or Anti-Hepatotoxicity means the ability to prevent damage
to the liver[5].
Fig 1.1
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Fig 1.2
Liver is the largest internal organ weighing about 1400grams in adults. It
constitute 2.5% of total body weight. Liver plays an important role in carbohydrate,
protein and lipid metabolism. In carbohydrate metabolism maintaining blood glucose
level is the important function of liver. In lipid metabolism it regulates the circulating
blood lipids.
Liver also involved in the synthesis of fatty acids, lipoproteins, amino acids
and plasma proteins which is known as albumin, fibrinogen and prothrombin. Liver
also plays an important role in storage and metabolism of fat soluble vitamins and
irons. In water soluble vitamins, Vitamin B12 are also stored in liver[6].
The liver is a metabolically active organ responsible for many vital life
functions. The liver is thought to be responsible for up to 500 separate
functions,usually in combination with other systems and organs[7]. It interacts with
cardiovascular and immune system and it also serves as an excretory organ.
Behind the liver there is a small organ called the gallbladder, which function is
to store bile produced by the liver and empty it into the small intestine to aid digestion
and absorption[7a]. Bile pigment, cholesterol and drugs are excreted by liver. Liver
also regulate endocrine functions of hormones. Various hormones like insulin,
glucagon, growth hormone and GI hormones are degraded by liver.
Kuffer cells are most important phagocytic cells which is present in liver.
These kuffer cells plays an important role in removing unwanted materials from the
circulation. Endocytosis is the mechanism by which these materials are removed.
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Liver cells are called Hepatocytes. Heaptocyte plays an important role in the
metabolism of drugs and xenobiotics. For effective elimination, the drug and the
metabolite must be made hydrophilic. Reabsorption of these metabolite by renal
tubules is dependent on its hydrophobicity. Many drugs and metabolites are
hydrophobic. The more hydrophobic a substance is, the more likely it will be
reabsorbed. The liver converts them into hydrophilic compounds so the metabolite
will easily removed from the body[6a].
The liver is the vital organ and supports almost every other organ in the body.
Because of its strategic location and multidimensional function, the liver is also prone
to many diseases[8].
Liver diseases caused by variety of factors. Such as viruses, alcohol, drugs
particularly paracetamol and drugs used to treat cancer. Fast food, environmental
pollutants and sedentary life style also caused liver diseases. If the liver become
diseased it results loss of vital functions like depression of immune system, sluggish
digestive system, obesity, fatigue which can cause significant damage to the body.
The most common liver diseases are Hepatitis, Cirrhosis, Alcohol and drug related
liver diseases, Liver tumour, Rey’s syndrome[9].
In recent years, people widely suffered from liver diseases. In India, liver
disease is the tenth most common cause of death.
According to the latest WHO data published in may 2014, Liver disease
deaths in India reached 2,16,865 or 2.44% of total deaths. The age adjusted death rate
is 21.96 per 1,00,000 of populations. Population ranks India #61 in the world[10].
According to WHO, about 46% of global disease and 59% of the mortality is
because of chronic diseases and almost 35millon people in the world die of chronic
liver diseases. Liver diseases rate steadily increasing over the years[11].
The major sign of liver disease is Jaundice (Hyperbilirubinemia) which is
known as yellowish discolourisation of skin and mucous membrane[12]. In Siddha
system of medicine, “Jaundice” is correlated with “Pitha Kamaalai” or “Manjal
Kamaalai”. As per the text ManjalKamaalai is of 13 types.[13] Clinically Jaundice is
divided into three types. They are Pre hepatic, Hepatic and Post hepatic. Many of liver
diseases are accompanied by Jaundice[12a].
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A healthy liver is essential for the healthy life. So it is important to take care
of liver in a healthy way. One of the natural and healthy way to take care of liver is
Siddha system of medicine. In this medicine various polyherbal preparations are
available to treat liver diseases.
Herbal drugs are significant source of hepatoprotective drugs. Mono and poly-
herbal preparations have been used in various liver disorders. According to one
estimate, more than 700 mono and poly-herbal preparations in the form of decoction,
tincture, tablets and capsules from more than 100 plants are in clinical use[7b].
In the modern scenario, diseases are becoming drug-resistant and scientists are
studying possible roles of plant based drugs for screening life saving drugs. Treatment
options for common liver diseases such as cirrhosis, fatty liver, and chronic hepatitis
are problematic. The effectiveness of treatments such as interferon, colchicine,
penicillamine, and corticosteroids are inconsistent at best and the incidence of side-
effects profound. it may also cause various other diseases. So there is a need for safe
and potent hepatoprotective drug to treat various liver disease.
In recent years synthetic drugs are showing more adverse effect, to overcome
this problem researchers are trying to avoid this risk of those drugs. Whenever a drug
is prescribed to a patient they are facing risk of side effect, so long term use of these
drugs patient should be careful. But in herbal medicine the toxicity of herbal drugs is
less when compared with the synthetic medicines[7c].
Due to known side effect, patient preferred to take alternative medicine which
is natural and healthy way[14]. The process of healing and regeneration of liver cells
are support and promote by herbal preparations with less side effects.
Several hundred plants have been examined for use in a wide variety of liver
disorders. Just a handful has been fairly well researched. The latter category of plants
include: Silybum marianum (milk thistle), Picrorhiza kurroa (kutkin), Curcuma longa
(turmeric), Camellia sinensis (green tea), Chelidonium majus (greater celandine),
Glycyrrhiza glabra (licorice), and Allium sativa (garlic).
The World Health Organization (WHO) estimates that 80% of the world
health populations presently use herbal medicines for some aspect of primary health
care[7d].
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Although various drugs are flooding in the market used as hepatoprotective
agent. In that many of them having adverse effects. Siddha system is a treasure which
contains enormous herbal preparations. They are highly effective and devoid of
adverse effects. For this reason Siddha system of medicine has been drawing global
attention in recent times.
Liver disorders are increasing day by day. So there is a need and demand for
effective, safe and accurate treatment of liver diseases.
Therefore it is not surprising that a considerable interest has been developed in
search of potent hepatoprotective drug from herbal origin.
Based on above facts, One of the polyherbal preparation mentioned in Siddha
literature is Maavilingapattai Chooranam. I hope this Siddha medicine
Maavilingapattai Chooranam will be effective drug for the cure of liver disease. So, I
interested to validate the Maavilingapattai Chooranam, a unique herbal preparation
for its hepato-protective activity.
This Siddha drug “Maavilingapattai Chooranam” is yet remained unexplored
for its exact chemical, pharmacological, toxicological profile in terms of scientific
research. To fill these scientific lacunae, the present work will be undertaken to
evaluate the chemical, toxicity profile and pharmacological potentials of
Maavilingapattai Chooranam in various hepatotoxicity models.
AIM AND OBJECTIVES
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2.AIM AND OBJECTIVES
AIM:
The present study was focused to validate the hepatoprotective potentials of
Maavilingapattai Chooranam in experimental animals with CCL4, Paracetamol and
Ethanol induced hepato toxicity.
OBJECTIVE:
The scientific study on Maavilingapattai Chooranam was carried out in the
following stages.
 Collection of various Siddha and modern literature relevant to this study.
 Description of pharmacognostic features of the plant in this formulation
including the taxonomic identification, collection, purification of the plant etc.
 Preparation of Maavilingapattai Chooranam as per classical Siddha text.
 Standardisation of the trial drug Maavilingapattai chooranam by means of
physio chemical analysis, phyto chemical analysis.
 Evaluate bio chemical analysis of the test drug to derive acidic and basic
radicals.
 To estimate the presence of elements, functional groups and particle size
through instrumental analysis of the trial drug.
 Evaluation of the acute and 28 days repeated oral toxicity study of the test
drug according to OECD guidelines.
 Evaluation of pharmacological study of the drug through the following
activities:
1) Hepatoprotective activity of CCL4 induced hepatotoxicity.
2) Hepatoprotective activity of Paracetamol induced hepatotoxicity.
3) Hepatoprotective activity of Ethanol induced hepatotoxicity.
REVIEW OF LITERATURE
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3. REVIEW OF LITERATURE
INGREDIENTS OF MAAVILINGAPATTAI CHOORANAM:
1. Iruveli - Vetiveria zizanioides
2. Vilamichu - Plectranthus vetttiveroides
3. Chiru kurinchan - Gymnema sylvestre
4. Poonai vanangi - Acalypha indica
5. Kozhunji - Tephrosia purpurea
6. Koovilam - Aegle marmelos
7. Pathiri - Stereospermum colais
8. Thulasi - Ocimum sanctum
9. Musumuskkai - Mukia maderaspatana
10. Musuttai - Rivea ornata
11. Vila - Limonia acidissima
12. Nannari - Hemidesmus indicus
13. Kurundhotti - Sida rhombifolia
14. Ashwagandhi - Withania somnifera
15. Parangichakkai - Smilax china
16. Maavilingapattai - Crateva magna
17. Seeni sarkarai - Saccharam officinaram
DRUG REVIEW
3.1.GUNAPADAM ASPECT OF THE DRUGS:
1. Iruveli
Scientific name: Vetiveria zizanioides
Synonyms: Vettiver, Vizhal ver, Viranam, Guruver.
Vernacular names:
Tam : Vettiver
Eng : Cuscus grass
Tel : Avvuuru-goddi-veru
REVIEW OF LITERATURE
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Mal : Vetti-veru
Kan : Lavancha
Sansk : Usheera, veeranam
Hindi : Balah
Parts used : Roots
Properties and action:
 Suvai (Taste) : Inippu (sweet)
 Thanmai (Potency) : Thatpam (cold potency)
 Pirivu (Bio transformation) : Inippu (sweet)
 Seigai (Actions) : Tonic, Antispasmodic, Diuretic,
Emmenagogue.
General characters:
              㐠    㐠Ȁሀ ை̀       ti
̀  㐠   凘ޏ   㐠             凘ޏ
     tiޏ  ޏt ޏ  ̀  凘ޏை   곀  䗉㐠    
           㐠̀  凘⸶         凘   곀    
      㐠~凘  Y   ޏ  
Indications:
Vettiver cures jaundice, hypertension, fever, impotence, abscess or ulcer in the
breast and venereal abscess.
Medicinal uses:
1) Decoction of vetiver 30-60ml use to treat intestinal related diseases.
2) Root extract is used for headache and toothache[15].
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2. Vilamichu- ver
Scientific name: Plectranthus vettiveroides
Vernacular names:
Tam : Vilamichu-ver
Eng : white cuscus grass
Mal : Iruveli
Sans : Hroeberam
Parts used : Roots
Properties and action:
 Suvai (Taste) : Kaippu (Bitter)
 Thanmai (Potency) : Thatpam (Cold potency)
 Pirivu (Bio transformation) : Inippu (Sweet)
 Seigai (Actions) : Refrigerant, Anti pittha.
General charactrs:
       䗉㐠 ~곀ޏ y  ǹ㐠            
       凘ޏை     곀  ̀ ~         
 㐠       ை  ~      ~  Ȁ   㐠ޏ⸳ 
  곀⸳     yைȀ  ை  
-    㐠~凘  Y   ޏ  
Indications:
Vilamichu cures diabetes mellitus, hypertension, dropsy, head ache, bilious
fever, burning sensation in the eyes and mental delusion.
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Medicinal uses:
1) While taking vilamichu oil bath everyweek it cures head ache, burning
sensation in the eyes, bilious fever, mental delusion[15a].
3. Chiru-kurinchan
Scientific name: Gymnema sylvestre
Synonyms: Kurinchan
Vernacular names:
Tam : Chiru-kurinchan
Eng : Periploca of the woods
Tel : Poda-patra, Putla-podra
Mal : Cheru kurinja
Sans : Sarpadarushtrik, Meshasri
Parts used : Leaves, Root.
Properties and action:
 Suvai (Taste) : Kaippu(Bitter)
 Thanmai (Potency) : Hot potency
 Pirivu (Bio transformation) : Kaarppu(Pungent)
 Seigai (Actions) : Stomachic, Astringent, Emetic.
General characters:
 㐠a ̀㐠   ̀   凘  ޏ ை    n凘     t䙍Ȁ 
 a⸳ ሀ t       䗉㐠  곀     ̀㐠  Y 
  Y     G y  i    ⸳    곀 Y    
   Y  ޏG  㐠 ைt   t 
-    㐠~凘  Y   ޏ  
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Indications:
Gymnema sylvestre root cures poisonous bites, vatha fever, cough and
bronchial asthma.
Medicinal uses:
1) Decoction of Chiru kurinchan leaves cures cough and fever.
2) Chewing of the leaves depressed the taste of the tongue. So the tongue
doesn’t know the sweet and bitter taste.
3) Root of this plant used both internally and externally. Externally root powder
dusted over the area of snake bite or decoction of this root gives internally
cures snake bite[15b].
4. Kuppai-meni
Scientific name: Acalypha indica
Synonyms: Arimangchari, Poonaivanangi, Meni
Vernacular names:
Tam : Kuppai meni
Eng : Indian acalypha, Cat’s struggle
Tel : Kuppi-chettu
Mal : Kuppigida
Sans : Arittamanjarie
Hindi : Kuppi
Parts used :Whole plant
Properties and action:
 Suvai (Taste) : Kaippu(Bitter), Kaarppu(Pungent)
 Thanmai (Potency) : Hot potency
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 Pirivu (bio transformation) : Kaarppu(Pungent)
 Seigai (Action) : Anodyne, Emmenogogue, Diuretic,Cathartic,
Emetic.
General characters:
 곀   Ȁ   Y  n   곀 㐠 ޏ   凘   ޏ 
 곀  ̀          㐠    Ȁ곀 㐠t㌳
 Ȁ ⸳         ޏ凘    ሀ       
  Ȁሀ   t   t䙍~  t y 
-    ̀  Y   ޏ  
Indications:
Acalypha indica leaves are used to cure gum related diseases, burns, stomach
ache, piles, itching, bronchial asthma and sinusitis.
Medicinal uses:
1) Leaves ground along with salt applied over the skin cures scabies.
2) Leaf juice cures head ache. Leaf powder cures bed sore.
3) Decoction of the leaves drink with salt cures constipation.
4) Paste of acalypha root along with water cures rat poisoning[15c].
5. Kozhunji
Scientific name: Tephrosia purpurea
Synonyms: Kollukkaivelai, Kaai velai
Vernacular names:
Tam : Kollukkaivelai
Eng : Purple tephrosia or Wild indigo
Tel : Vempali, Pampara chettu
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Mal : Kozhinnila
Kan : Kaggi
Sans : Puleehashtree
Hindi : Sarphaoka
Parts used : Leaves, Roots, Seeds, Root bark.
Properties and action:
 Suvai (Taste) : Kaarppu (Pungent)
 Thanmai (Potency) : Hot potency
 Pirivu (Biotransformation) : Kaarppu (Pungent)
 Seigai (Actions) : Nutritive, Expectorant, Diuretic, Deobstruent,
Anthelmintic.
General properties:
    㐠     ̀  凘        ̀凘 㐠  ~̀     
 O  곀   Ȁ     ~̀  凘        ì
   t               ì㐠~  ̀   凘     G
   t        ை ைt  a 
-    㐠~凘  Y   ޏ  
Indications:
Tephrosia purpurea cures dryness of the tongue, drooling of salaiva and dental
diseases.
Medicinal uses:
1) Tephrosia purpurea root ground with turmeric and cow’s milk applied
externally cures lymphadenopathy.
2) Take 1part of this plant root, 2part of pepper- make it as a decoction cures
fever, hepatomegaly and splenomegaly[15d].
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6. Vilvam
Scientific name: Aegle marmelos
Synonyms: Kusaabhi, Koovilam, Koovilai, Sivaththurumam, Ninmali, Maathuram.
Vernacular names:
Tam : Vilvam
Eng : Bael tree, Holy fruit tree
Te : Bilvamu
Mal : Kuvalam
Kan : Beta
Sans : Bilva
Hindi : Bel
Parts used : Leaves, Flower, Fruit, Root, Resin, Root bark.
Properties and action:
 Suvai (Taste) : Thuvarppu(Astringent), Kaippu (Bitter)
 Thanmai (Potency) : Cold potency
 Pirivu (Bio transformation) : Kaarppu(Pungent)
 Seigai (Actions) : Diaphoretic, Digestive, Stomachic, Laxative.
General characters:
  y   㐠̀   G    na ̀    ⸶   
   y   Y      곀    ޏ凘   ை    Ȁ  
   ⸳    n  ì   곀 㐠 ~       Ȁ㐠⸶ 
         nሀ    
-    㐠~凘  Y   ޏ  
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Indications:
Aegle marmelos cures tastelessness, loss of appetite, hiccup, vomiting,
diarrhoea, dysentry.
Medicinal uses:
1) Root of Aegle marmelos, Pavonia zeylanica, Zingiber officinalae make it as a
decoction and mixed it with honey which cures vomiting and balances vatha,
pitha, kabha.
2) Leaf juice mixed with pepper powder cures dropsy and jaundice.
3) Leaf juice mixed with honey cures rhinitis and fever[15e].
7. Pathiri
Scientific name: Stereospermum colais
Synonyms: Kanni, Paadalimaram, Paadalam, Punkaali.
Vernacular names:
Tam : Pathiri
Eng : Trumpet flower, Yellow snake flower
Tel : Kaligottu
Mal : Pathiri
Sans : Patala
Hindi : Peader
Parts used : Leaves, Flower, Bark, Root.
Properties and action:
 Suvai (Taste) : Thuvarppu(Astringent)
 Thanmai (Potency) : Cold potency
 Pirivu (Biotransformation) : Inippu(Sweet)
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 Seigai (Action) : Diuretic, Febrifuge
Gereral characters:
   㐠곀~ ̀   凘 Y곀  ̀   凘  㐠y       
  ⸳     䗉ைȀ  ~              t 
   Ỳ㐠㌳     곀㌳ ை  ~곀㌳    Ȁ곀㌳ 
 㐠 Y~            㐠   
-    㐠~凘  Y   ޏ  
Indications:
Stereospermum colais cures diabetes mellitus, eczema, peripheral neuritis,
abscess, haemorrhoides, scabies, indigestion.
Medicinal uses:
1) Flower decoction cures venereal diseases and fever. While taking it with
honey it cures hiccup.
2) 1 part of root bark soaked with 10 part of water about 15-30ml cures stomach
ache, cough and dropsy.
3) Root decoction or root powder used to treat diabetes mellitus, eczema,
peripheral neuritis, abscess, haemorrhoides, scabies and indigestion[15f].
8. Thulasi
Scientific name: Ocimum sanctum
Synonyms: Ari, Ramathulasi, Krishnathulasi, Thiruthulaai, Thulavu, Kullai, Vanam,
Viruntham, Thuzhasi, Maalalangal.
Vernacular names:
Tam : Thulasi
Eng : Holy basil, Sacred basil
Tel : Thulasi
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Mal : Thulasi
Sans : Thulasi
Hindi : Thulasi
Parts used : Leaves. Seeds, Root.
Properties and action:
 Suvai (Taste) : Kaarppu (Pungent)
 Thanmai (Potency) : Hot potency
 Pirivu (biotransformation) : Kaarppu (Pungent)
 Seigai (Actions) : Stimulant, Expectorant, Diaphoretic,
Dimulcent.
General characters:
   Ȁ 凘      㐠   ޏ   t䙍     Y ை~
  Ȁ 凘        ሀ        Ȁ
 G곀   ޏi    ޏ         Ȁ 凘  
  G곀 ை    ~   㐠~ ை       
-    ̀ ~         
Indications:
Ocimum sanctum cures sinusities and fever. It also reduces body heat.
Medicinal uses:
1) Leaves ground with water and then applied on bad boils.
2) Leaf juice powderd into the ear is a first rate remedy for earache. It also cures
chronic fever, haemorrhage, dysentry and dyspepsia.
3) Leaf juice is mixed with small amount of ginger is given for colic in children
and one thola is mixed with quarter thola of black pepper is given in catarrhal
fever and in the cold stages of intermittent fever[15g].
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9. Musumuskkai
Scientific name: Mukia maderaspatana
Synonyms: Ayileyam, Irukurangin kai, Mosumosukkai.
Vernacular names:
Tam :Musumusukkai
Eng : Rough bryony
Tel :Musumusukaya
Hindi : Bilavi
Mal : Chitrati
Parts used : Leaves, Root.
Properties and action:
 Suvai (Taste) : Thuvarppu (Astringent)
 Thanmai (Potency) : Hot potency
 Pirivu (Biotransformation) : Kaarppu (Pungent)
 Seigai (Actions) : Expectorant, Astringent.
General characters:
 곀     ㌳  䙍ޏ 䙍⸶  ޏ̀  ޏ 
 곀     G  ޏ     곀 㐠      곀  
  G  ሀ    㐠ޏ          㐠 G   
 㐠G  ሀ   ை   G     
-    㐠~凘  Y   ޏ  
Indications:
Mukia maderaspatana cures impotence, indigestion, vomiting, ulcer and
cardiac diseases.
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Medicinal uses:
1) Leaf juice mixed with purified ox gall or ox bile cures impotence, indigestion,
vomiting, ulcer and cardiac diseases.
2) Leaf decoction or powder cures cardiac diseases and vomiting[15h].
10. Musuttai
Scientific name: Rivea ornata
Synonyms: Panjchi
Vernacular name:
Tam :Musuttai
Parts used :Whole plant
Properties and action:
 Suvai (Taste) : Kaippu (Bitter), Kaarppu (Pungent)
 Thanmai (Potency) : Hot potency
 Pirivu (Biotransformation) : Kaarppu (Pungent)
 Seigai (Action) : Germicide, Anti-vatha, Laxative.
General characters:
       ⸳凘ைޏ~           ~ ை  
 n   ޏ곀 nை    n凘  ሀ         ைt   
 ̀ Ȁ ை    t    ̀凘 㐠    ̀㐠 㐠 ሀை ޏ
 ̀  ̀       㐠       ia 
-    㐠~凘  Y   ޏ  
Indications:
Rivea ornata cures leucorrhoea, scabies, eczema and constipation. It also
balance vatha and kabha.
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Medicinal uses:
1) Its root ground and mixed with gingely oil used to treat scabies and skin
diseases.
2) Leaf decoction or powder cures leucorrhoea, scabies, eczema and burning
micturation[15i].
11. Vila
Scientific name: Limonia acidissima
Synonyms: Kadippagai, Kapiththam, vilavu. Vellil
Vernacular names:
Tam : Vila
Eng : Wood-apple tree, Elephant apple, Curd fruit, Monkey fruit.
Tel : Velaga
Mal : Vilav
Kan : Baelada
Sans : Kapitha
Hindi : Kavitha, Dharkahth-kaveet
Parts used : Leaves, Fruit, Bark, Resin.
Properties and action:
 Suvai (Taste) : Thuvarppu (Astringent)
 Thanmai (potency) : Hot potency
 Pirivu (biotransformation) : Inippu (Sweet)
 Seigai (Action) : Aromatic, Demulcent, Carminative, Astringent,
Refrigerant,.
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General characters:
 ̀t̀   y  凘   a   yȀ  
 ̀t  㐠ைt     ㌳ Ȁ i    ̀t䙍ޏ
       ㌳ޏȀ  ை    凘    㐠ޏȀ ޏi
        r    i     
-    ̀       
Indications:
Limonia acidissima balance vatha, pitha and kaba. It also strengthen’s our
body.
Medicinal uses:
1) Leaves are purgative and sudorific and are used in snake bite.
2) The bark and leaves of Limonia acidissima are used for vitiated conditions of
vatha and pitha.
3) Leaves are astringent and carminative, good for vomiting, indigestion, hiccup
and dysentry. The leaves have hepatoprotective activity.
4) The gum is demulcent and constipating, and is useful in diarrhoea, dysentery,
gastropathy, haemorrhoids and diabetes[15j].
12. Nannari
Scientific name: Hemidesmus indicus
Synonyms: Angarimooli, Narunetti, Paathaalamooli, Kopaagu, Saaribam, Paarkodi,
Neerundi, Kaananuchaari, Krishnavalli, Chaariyam.
Vernacular names:
Tam : Nannari
Eng : Indian sarasaparilla
Mal : Nannari
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Kan : Sugandha-palada
Sans : Sariba
Hindi :Magrabu
Parts used : Root
Properties and action:
 Suvai (Taste) : Inippu (Sweet)
 Thanmai (Potency) : Cold potency
 Pirivu (Biotransformation) : Inippu (Sweet)
 Seigai (Action) : Alternative, Tonic, Demulcent, Diuretic,
Diaphoretic.
General characters:
 Ȁ   ޏ        㐠       䗉ைȀ
 Ȁ  a  R  㐠̀t 凘      Ȁ   㐠i
   ̀t        ޏ  ⸳  㐠ை  ~ Ȁ    䗉㐠   
  ̀     ̀t 곀   凘 
-   ̀  Y   ޏ  
Indications:
Hemidesmus indicus cures pitha diseases, insect bite, thirst, sinusitis, diabetes
melitus, syphilis.
Medicinal uses:
1) The root is soaked with 30ml of warm water and give it thrice a day cures
indigestion and impotence.
2) Root powder mixed with cow’s milk cures oliguria. It also gives along with
cumin seeds[15k].
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13. Kurunthotti
Scientific name: Sida rhombifolia
Synonyms: Cittamutti, Kurunthotti, Yanaikkuruntotti, Mayirmanikkam, Velaippacai.
Vernacular names:
Tam : Kurunthotti
Eng : Arrow leaf sida, Indian hemp
Mal : Vankurunthotti
Sans : Athibala
Hindi : Barela, Lalbarela
Ben : Svetabrela, Svetabala, Pitaberela, Pitabala
Parts used :Whole plant
Properties and action:
 Suvai (Taste) : Thuvarppu (Astringent)
 Thanmai (Potency) : Cold potency
 Pirivu (Biotransformation) : Inippu (Sweet)
 Seigai (Action) : Emollient
Medicinal uses:
1) The pounded leaves are used to relieve swelling. The fruits are used to
relieve head ache.
2) Stem’s mucilage is useful in calculous troubles and as a febrifuge with
pepper.
3) Mucilage are also used in scorpion sting.
4) Root of this plant are used in the treatment of rheumatism[16].
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14. Ashwagandhi
Scientific name: Withania somnifera
Synonyms: Amukkrak-kizhangu, Amukkiri, Amukkuravi, Amukkuravu,
Amukkinanagizhangu, Ashwagandham, Ashwaganthi, Ashuvam, Irulichchevi,
Kidichchevi, Varahakarni.
Vernacular names:
Tam : Amukkurak-kizhangu
Eng : Winter cherry
Mal : Amukkuram
Kan : Sogade-beru
Urdu : Asgandh
Tel : Penneru-gadda
Sans : Aswagandha
Arb : Habdul kaknaje-hindi
Pers : Tukhma kaknaje-hindi
Parts used : Leaves, Seeds, Root.
Properties and action:
 Suvai (Taste) : Kaippu (Bitter)
 Thanmai (Potency) : Hot potency
 Pirivu (Biotransformation) : Kaarppu (Pungent)
 Seigai (Action) : Febrifuge, Diuretic, Alternative, Aphrodisiac,
Deobstruent, Tonic, Sedative.
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General characters:
     곀   凘   ሀ    ~ ~   ைȀ~곀
 㐠 ⸳      ̀           ޏ       㐠
 ⸳㌳a    ޏ            t   ޏ  
 ⸳  곀  㐠   ̀ ̀̀㐠 
-    㐠~凘  Y   ޏ  
Indications:
Root cures eczema, anemia, dropsy and also kabha diseases. It also cures loss
of appetite.
Medicinal uses:
1) Root powder mixed with ghee and honey in equal parts is recommened for
impotence or senile debility.
2) For leucorrhoea, ashwagandha powder 45grams and sugar candy 1 thola is
given in cow’s milk, morning and evening till cure is obtained.
3) The fresh green root of ashwagandha is mixed with cow’s urine or with water
used to treat scrofulous and other glandular swelling[15l].
15. Parangichakkai
Scientific name: Smilax china
Synonyms: Parankippattai, Mathusmikam, Mathusmigi, Chinappattai.
Vernacular names:
Tam : Parankippattai
Eng : China root
Tel : Pirangi-chekka
Mal : Pavu
Sans :Madushuhi
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Hindi : Chobchini
Parts used : Root
Properties and action:
 Seigai (Taste) : Inippu (Sweet)
 Thanmai (Potency) : Cold potency
 Pirivu (Biotransformation) : Inippu (Sweet)
 Seigai (Action) : Alternative, Antisyphilitic, Aphrodisiac,
Depurative.
General characters:
      Ȁ   곀     凘ޏ  ޏ   ை 
   ሀ   㐠 곀 㐠  nr Ȁ곀     ޏ̀
 凘ைޏ   곀   i    t  t       ̀ሀ 㐠 
 凘ைޏ~ ைt ⸶ޏ 곀      凘 
-  ை ~凘  Y   ޏ  
Indications:
Root cures thirst, vatha related diseases, diabetes mellitus, scabies,
haemorrhoide, rheumatoid arthritis, syphilitic ulcer and also cures impotence.
Medicinal uses:
1) Root improves agni, cleans urine and stools.
2) Root cures flatulence, epilepsy, insanity, syphilis, colic, pain in the body and
skin diseases[15m].
16. Maavilingappattai
Scientific name: Crataeva magna
Synonyms:Maavilangu, Kumaaragam, Varani
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Vernacular name:
Tam :Maavilangu
Eng : Three leaved caper
Tel : Urumathi
Mal : Nirvala
Hindi : Banah
Sans : Pashungandha, Asmarighna
Kan : Narumbele
Parts used : Leaves, Bark, Root.
Properties and action:
 Suvai (Taste) : Kaippu (Bitter)
 Thanmai (Potency) : Hot potency
 Pirivu (Biotransformation) : Kaarppu (Pungent)
 Seigai (Action) : Stomachic, Febrifuge, Tonic, Rubefacient,
Laxative, Lithontriptic.
General characters:
⸳ ሀ ~ ̀  ̀ ޏ곀    ைȀ~       
     a   ޏሀ    䗉㐠⸶    ⸳  ሀ
 G      ~  ሀ   ޏ ⸳ሀ   Y  
 G     Ȁ㐠ሀ    ை  
-    㐠~凘  Y  ޏ  
    Ȁሀ    凘ைޏ~ t y          ̀t䙍   
  ㌳ 㐠̀̀  yȀைޏ ޏ    a   
-    㐠~凘  Y  ޏ  
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Indictions:
Crateva magna is used to treat fever, insect bite, snake bite and vatha diseases.
Bark cures vatha diseases, renal stones(urolithiasis) and it also balance vatha,
pitha, kaba.
Medicinal uses:
1) Leaf juice cures fever and indigestion.
2) The extracts of bark or root bark is used to cure vatha diseases.
3) The leaf of Crataeva magna is applied externally for the treatment of piles
and the juice is taken internally cures bleeding piles[15n].
17. Seeni sarkarai
Scientific name: Saccharum officinaram
Synonyms: Punarpoosam, Ikku, vaei.
Vernacular name:
Tam : Karumbu
Eng : Sugarcane, Noble cane.
Tel : Cheruku
Mal : Karinpa
Kan : Khabbu
Sans : Ikshu, Rasalah
Arab : Qasabus-sakar
Pers : Nai-shakar
Hindi : Ukh-ganna
Parts used : Juice, Sugar, Root.
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Properties and action:
 Suvai (Taste) : Inippu (Sweet)
 Thanmai (Potency) : Cold potency
 Pirivu (Biotransformation) : Inippu (Sweet)
 Seigai (Action) : Antiseptic, Demulcent.
General characters:
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   곀 㐠ை ை~   凘   ޏ    
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Indictions:
Seeni sarkarai cures vata fever, vata related diseases, vomiting and hiccup.
Medicinal uses:
1) Sugar syrup can be used as preservative and also it cures Sinusitis and
Rhinitis[15o].
3.2.BOTANICAL ASPECT OF THE DRUGS:
1. Vetiveria zizanioides
Common name: Vettiver
Scientific classification:
 Kingdom : Plantae
 Division : Magnoliophyta
 Class : Liliopsida
 Order : Cyperales
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 Family : Poaceae
 Genus : Vetiveria
 Species : zizanioides
The plant description
 Description:
Perennial grass that can grow upto 1 or 2 meters high with wide clumps. These
tillers are known as stem produced by grass plants. The clumps or tillers arise from
rhizomes. The root system of the plant is somewhat massive but compact, structured
and very strong. The leaves are narrow, keel and erect with rough margins. The
inflorescence panicles are long whorl branches. These are purple brown in colour. The
spikelet are of grey, green or purple in colour.
 Distribution:
This plant grows in the tropical areas of Asia, Africa, Australia, India, China,
Brazil, Haiti, Indonesia and Guatemala. In India it grows in the regions of Punjab,
Utter pradesh, Rajasthan, Kerala, Karnataka, Madhya predesh and Assam.
 Parts used: Root, oil.
 Chemical constituents:
Allokhusiol, benzoic acid, cyclocapacamphene, epikhusinol, epizizanal, 2-
epizizanone, B-eduesmol, eugenol, iskhusimol, isokhusinoloxide, isovalencenol,
isovalenic, khusimylacetate, khusinodiol, khusinol, khusitoneol, laevojujenol,
levojuneol, vanillin, vertiselinenol, B- & J vetivene, vetivenic acid, vetiverol, zizaene,
zizanol[17].
 Properties and uses:
1) The plant is used as anthelmintic for children. It is also used for boils, burns,
epilepsy, fever, scorpion sting, snakebite and sores in the mouth. The paste of
fresh roots used for burn, snakebite and scorpion sting.
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2) Decoction of the roots as a tonic for weakness; the Lodhas of West Bengal
use the root paste for headache, rheumatism and sprain, and a stem decoction
for urinary tract infection; the Mandla and Bastar tribes of Madhya Pradesh
use the leaf juice as anthelmintic; the tribes of the Varanasi district inhale the
root vapour for malarial fever. The root ash is given for acidity by the Oraon
tribe[18].
2. Plectranthus vettiveroides
Common name: Vilamicham ver
Scientific classification:
 Kingdom : Plantae
 Division : Eudicots
 Class : Magnoliosida
 Order : Lamiales
 Family : Lamiaceae
 Genus : Plectranthus
 Species : vettiveroides
The plant description
 Description:
Perennial plant , branched , aromatic herb, about 30 to 62 cm height with thick
root . Stem stout , villous or hispid. Flowers born in racemes, stout. Upper calyx, lip
rounded – ovate, corolla pale blue; fruits nut lets.
 Distribution:
Found wild in dry and Barren hills of sub tropical Himalayas including
Kumaon and Nepal ascending to 2700m, in the Deccan, Peninsula, Gujarat and Bihar;
cultivated in Baroda and Maharashtra.
 Parts used: Arial part of root
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 Chemical constituents:
Allylroyleanone, barbatusin, 3β-hydroxy-3-deoxy-barbatusin, coleons E and F,
cyclobutatusin, plectrin, plectrinonA, plectrinon B, brbatusol, 20-deoxocarnosol,
coleonol D, coleonol E, coleonone, coleosol, deoxycoleonol,β-bisabolene,
bornylacetate, camphene,α-copaene, β-cymene, 3-decanone, β-clemene, cariocal, 6α-
hydroxycarnosol.
 Properties and uses:
1) Aril: Spasmolytic, root: hypertensive, spasmolytic and given to children in
constipation: decoction as tonic and in the treatment of worms, parts to allay. Burning
festering boils: mixed with mustard oil, grounded root externally applied to eczema
and skin disease.
2) Forskolin, isolated from roots, is a bronchodilatator, cardiac tonic in the
treatment of congestive heart failure, glaucomotherapy, anti-hypertensive, remedy for
metastatic condition and thrombosis[19].
3. Gymnema sylvestre
Common name: Chiru-kurinjan
Scientific classification:
 Kingdom : Plantae
 Division : Magnoliophyta
 Class : Magnoliopsida
 Order : Gentianales
 Family : Apocynaceae
 Genus : Gymnema
 Species : sylvestre
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The plant description
 Description:
A large stout, woody, climber with demely appressed hairy branchlets.
Leaves- elliptic or obovate, acute, rarely pubescent above. Flower small, crowded,
umbelliform cymes. Fruits slender, follicles, glabrous. Seeds narrowly ovoid-oblong,
flat with a broad, thing wing, pale brown.
 Distribution:
Gymnema sylvestre grows in tropical areas of India, Africa and Australia, Sri
lanka, Southern China and Japan.
 Parts used: whole plant, leaves, seeds and root.
 Chemical constituents:
Alanine, gamma-aminobutyric acid, isoleucine, valin, adenine, alkaloid, cyclic
alcohol, inositol, d-quercitol, alpha and beta chlorophylls, lupeol, stigmasterol,
gymnamo saponins, gymanamagenin, gymnestrogenin[20].
 Properties and uses:
1) Sushrutha describes Gymnema sylvestre as a destroyer of madhumegha
(glycosuria) and other urinary disorders. On account of its property of
absorbing the taste of sugar it has been given the name of ‘Gurmar’ meaning
sugar destroyer. Therefore that it might neutralized the excess of sugar
present in the body in Diabetes melitus.
2) Root powder has long been reputed as a remedy for snake bite[16a].
4. Acalypha indica
Common name: Kuppaimeni
Scientific classification:
 Kingdom : Plantae
 Division : Tracheophyta
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 Class : Equisetopsida
 Order : Malpighiales
 Family : Euphorbiaceae
 Genus : Acalypha
 Species : indica
The plant description
 Description:
Annual herb to 60cm tall. Stem striate, pubescent; Leaves broadly ovate, base
rounded to shortly attenuate; spikes axillary, monoecious, rachis endind in a triradiate
hood at the tip. Male flowers above, ebracteate, minuate clustered, anthers
vermicuniform. Female flowers below subtended by foliaceous. Ovary hisbid, 3 lobed,
styles 3. Capsules 3 valved, concealed by bract, hispid.
 Distribution:
Acalypha indica widely throughout tropical Africa and the Indian ocean
islands. It also occurs in the south east Asia , Yemen and Oceania.
 Parts used:
Leaves, stalk (young shoots), flowers and root.
 Chemical constituents:
Alkaloids acalypus and acalyphene. The arial parts contain a cyanogenic
glycoside called acalyphin (a 3-cyanopyridone derivative) as well as flavanoids. Such
as kaempferol glycosides mauritianin, clitorin, nicotiflorin and biorobin. Tannins β-
sitosterol, acalyptamide, aurantiamide, succinimide and flindersin (a
pyranoquinollinone alkaloid) have also isolated. The chemicals that attracts cats are
the iridoid compounds isodihydronepetalactone and isoiridomyrmecin.
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 Properties and uses:
1) The leaves are used in the form of powder or decoction. While it mixing with
garlic they are used as anthelmintic. Mixing it with common salt they are
used to treat scabies.
2) By instilling the decoction in the ear it cures earache and also used
fomentation around the aching ear[16b].
5. Tephrosia purpurea
Common name: Kozhunji
Scientific classification:
 Kingdom : Plantae
 Division : Magnoliophyta
 Class : Magnoliopsida
 Order : Fabales
 Family : Fabaceae
 Genus : Tephrosia
 Species : purpurea
The plant description
 Description:
A suberect, much branched, polymorphis, perennial herb, 30-60cm in height.
Leaves imparripinnate, perennial herb, 5-15cm long. Leaflets 9-21, glabrous above,
obscurely silky beneath, narrow, oblanceolate. Flowers borne in leaf opposed racemes,
blue or purple in colour. Pods linear, slightly curved, glabrescent. Seeds 5-10, smooth,
greenish grey colour.
 Distribution:
It is found throughout India and Srilanka in poor soils.
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 Parts used:Whole plant, seeds, root-bark, root.
 Chemical constituents:
Betasitosterol, lupeol, retin, delphinidinchloride, cyaniding chloride,
isolonchocarpin, lanceolatins A&B, pongamol, karangin, kangone, 5,7-dimethoxy-8,
flavanone, 2-methoxy-3-9-dihydroxycoumestone, flevichapparins B and C, methyl
karanjic acid and purpurin[21].
 Properties and uses:
1) Leaves are used in dyspepsia, pectrol disease, syphilitis, gonorrhoea and
bruritis.
2) A decoction of herb when administered in Bright's diseases with dropsy,
showed mild diuretic effect causing reversed oedema. The herb was also
tested for ascites and was found to be responsible for improving the function
of liver.
3) Seeds are used to treat skin diseases and rat poisoning. Seeds are used against
worm infestations in children[22].
6. Aegle marmelos
Common name: Vilvam
Scientific classification:
 Kingdom : Plantae
 Division : Magnoliophyta
 Class : Magnoliopsida
 Order : Sapindales
 Family : Rutaceae
 Genus : Aegle
 Species : marmelos
REVIEW OF LITERATURE
HEPATOPROTECTIVE ACTIVITY OFMAAVILINGAPATTAI CHOORANAM 38
The plant description
 Description:
A spinous, deciduous, aromatic tree, spines, straight, strong, axillary. It grows
upto 18meters tail and bears long throns. Leaves usually 3or 5 foliate. Leaflets ovate,
lanceolate, lateral sessile, terminal long petioled. Flowers borne in few flowered,
axillary panicles, greenish white, sweet scented. Fruit large upto 15cm diameter,
globose, ovoid or pyriform, grey or greenish yellow woody, pulp orange sweet. Seeds
numerous, aromatic pulp and mucilaginous.
 Distribution:
Aegle marmelos is native across the Indian subcontinent and southern Asia
and it is also present in Srilanka, Thailand and Malesia.
 Parts used: Leaves, flower, fruit, seed, bark, root.
 Chemical constituents:
Beta sitosterol, amino acids, dictamnine, marmesin, marmin, umbelliferone,
skimmianine, carbohydrate, carotene, tannins an vitamins, imperatorin(marmelosin)
and its isomers, alloimperatorin and marmelide, psorallen and tannic acids, alpha-d-
phellandrene[23].
 Properties and uses:
1) Unripe or half ripe fruit pulp, owiry to the pressence of tannins or
mucilagenous substances which act as a demulcent. These fruit pulp dried and made
into powder is prescribed in chronic diarrhoea and dysentry.
2) Rind of the beal fruit 5, coculus corditobus 4, mix and make it as a decoction
used to treat vomiting[16c].
7. Stereospermum colais
Common name: Pathiri
Scientific classification:
 Kingdom : Plantae
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 Division : Eudicots
 Class : Asterids
 Order : Lamiales
 Family : Bignoniaceae
 Genus : Stereospermum
 Species : Colais
The plant description
 Description:
It is large deciduous tree, about 10-20m tall with velvet-hairy branches.
Leaves are compound with 3-4 pairs of leaflets. Leaflets broadly elliptic, long pointed.
Flower are borne in large lax panicles. Flowers brownish white in colour.
Inflorescence terminal panicles. Sepal cup is bell shaped. Stamens are 4, remaining
inside the flower tube. Seed pod is long, cylindric, ribbed, rough.
 Distribution:
It is distributed throughout the moist parts of India and widely distributed in
the deciduous forests of kerala. It is also found in tropical Himalayas, Assam and
Meghalaya.
 Parts used: Leaves, flower, bark and root.
 Chemical constituents:
n-Triacontanol, β-sitosterol, lapachol, dehydro-α-lapachone, dehydrotectol, 6-
0glucosylscutellarein and stereolensin. Leaves contain a flavone named stereolensin
and has been characterised as 5,7,3,4- tetrahydroxy 6-0-β-D glucopyranosyl
flavones[24].
 Properties and uses:
1) Root bark is one of the constituents of “Dashmula” which is the preparation
used as tonic and diuretic.
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2) Root has anti inflammatory, anti asthmatic, anti emetic and febrifuge
properties.
3) It has biliary stimulant and cardio tonic activity. The root is also used in piles
and nervous disorders[16d].
8. Ocimum sanctum
Common name: Thulasi
Scientific classification:
 Kingdom : Plantae
 Division : Magnoliophyta
 Class : Magnoliopsida
 Order : Lamiales
 Family : Lamiaceae
 Genus : Ocimum
 Species : sanctum
The plant description
 Description:
Ocimum sanctum is an erect, many branched subshrub. 30-60cm tall with
hairy stems. Leaves are green or purple in colour. They are simple, petioled with an
ovate upto 5cm long blade which usually has a slightly toothed margin. They are
strongly scented and have a decussate phyllotaxy. The purplish flowers are placed in
close whorls on elongate racemes.
 Distribution:
Ocimum sanctum is considered indigenous to the Indian subcontinent
including the Himalayas, Malesia and other tropical and subtropical parts of Asia and
now widely cultivated and naturalized in places around the world.
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 Parts used: Leaves, seeds.
 Chemical constituents:
Oleanolic acid, ursolic acid, rosmarinic acid, eugenol, carvacrol, linalool, β-
caryophyllene. Tulasi essential oil consists mostly of eugenol(70%), β-
elemene(11.0%), β-caryophyllene(8%) &germacrene(2%) with the balance being
made up of various trace compounds mostly terpenes.
 Properties and uses:
1) Infusion of the leaves is given in malaria and used to treat gastric diseases of
children and hepatic infections.
2) Dried plant decoction is a domestic remedy for cough, catarrh, bronchitis and
diarrhoea[16e].
9. Mukia maderaspatana
Common name: Musumuskkai
Scientific classification:
 Kingdom : Planate
 Division : Tracheophyta
 Class : Magnoliopsida
 Order : Cucurbitales
 Family : Cucurbitaceae
 Genus : Mukia
 Species : maderaspatana
The plant description
 Description:
Climbing scabrid herbs, tendrils simple. Leaves ovate, deltoid, angular or
shallowly 3-5 lobed, base cordate, margin denticulate, apex accuminate. Flowers in
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axillary, sessile clusters. Calyx tube 2mm, villous, lobes subulate, erect. Petals 5,
ovate-oblong, obtuse, yellow. Stamens 3 free, inserted at base of calyx tube, anthers
oblong, ciliate. Female flowers solitary or cluster. Ovary villous. Berry-globose, red.
Seeds lenticular, rugose.
 Distribution:
Mukia maderaspatana is globally distributed in the paleotropic. Within India,
it is said to be found throughout Andaman and Nicobar Islands.
 Parts used: Leaves, root.
 Chemical constituents:
Leaves contains mainly dichloroacetic acid, 4-methylpentyl ester, 2-butyn-1-
0-1, 4-methoxy and also showed the pressence of other constituents like flavanoids,
saponins, carbohydrates, steroids, tannins and phenolic compounds.
 Properties and uses:
1) The leaves and tender shoots are useful as aperient, diuretic, stomachic,
antipyretic, antiflatulent, anti asthmatic, anti histaminic and expectorant.
2) The leaf tea is administered for the alleviation of jaundice.
3) The leaf tea is also claimed to possess hypotensive properties in human
subjects with concomitant beneficial effects on serum anti oxidant potential,
plasma lipid profile, fibrinogen, serum bilirubin and body mass index[25].
10. Rivea ornata
Common name: Musuttai
Scientific classification:
 Kingdom : Plantae
 Division : Magnoliophyta
 Class : Magnoliatae
 Order : Polemoniales
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 Family : Convolvulaceae
 Genus : Rivea
 Species : ornata
The plant description
 Description:
Rivea ornata is a woody climber, branchless stout, white tomentose. Leaves
ovate, cordate, 3-5 in diameter often broader than long, glabrous above, white silky
tomentose beneath while young. Petiole 1-2 in. Flowers large, white, short, mostly 3-
fid. Peduncles bracts 1/2 inch. Fruit 2/3 in diameter, indeniscent, globose, shining,
yellow brown nearly dries.
 Distribution:
It is distributed throughout southern part of India.
 Parts used:Whole plant
 Chemical constituents:
Rivea ornata seed oil was found to contain 12,13-epoxy-octadec-cis-9-enoic
acid (vernolic acid 22.0%) along with the other normal fatty acids like palmitic acids
(24.2%), stearic acid (8.9%), oleic acid (17.1%) and linoleic acid (27.8%).
 Properties and uses:
1) Rivea ornata is a potential medicinal plant used topically in haemorrhagic
diseases and piles.
2) Leaf juice is mixed with butter and made into oinment used to treat
pityeriasis[16f].
11. Limonia acidissima
Common name: Vila
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Scientific classification:
 Kingdom : Plantae
 Division : Tracheophyta
 Class : Magnoliopsida
 Order : Sapindales
 Family : Rutaceae
 Genus : Limonia
 Species : Acidissima
The plant description
 Description:
Moderate sized desiduous tree. The leaves are alternate, dark greeen, leathery,
3-5inch long. It dotted with oil glands and slightly lemon scented when crushed.
Flowers small, numerous, dull red greenish colour. Fruits is berry, rounded to oval,
2.5 inch wide, greyish white in colour.
 Distribution:
Limonia acidissima is native to India so it is distributed throughout India and
also cultivated in Bangladesh, Pakistan and Srilanka.
 Parts used: Leaves, fruit, bark, resin and root.
 Chemical constituents:
Fruit of this plant contains stigmasterol. Pericarp contains umbelliferone,
dictamine, xanthotoxol, scoparone, torin, xanthotoxin, isopimpinelin, isoimperatorin
and marmerin. Leaves contains stigmasterol, psorallen, bergapten, orientin, vitedin,
saponin, tannins and an essential oil. Marmesin, feronone have been isolated from
bark. Seeds contains fixed oil, carbohydrates, proteins and amino acids. Root contain
feronia lactone, geranylum, belliferone, bargaapten, osthol, isopimpinellin, marmesin
and marmin.
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 Properties and uses:
1) Limonia Fruits are refrigerant, stomachic, stimulant, astringent, aphrodisiac,
diuretic, cardiotonic, tonic to liver and lungs.
2) It cures cough, hiccup and good for asthma, tumours, opthalmia and
leucorrhoea.
3) It’s seeds are used in heart diseases.
4) The fruits are used as a substitute for bael (Aegle marmelos) in diarrhea and
dysentery[26].
12. Hemidesmus indicus
Common name: Nannari
Scientific classification:
 Kingdom : Plantae
 Division : Magnoliophyta
 Class : Magnoliopsida
 Order : Gentianales
 Family : Apocyanaceae
 Genus : Hemidesmus
 Species : indicus
The plant description
 Description:
It is semi erect and sometimes prostrate shrub with woody aromatic roots. The
slender, numerous stem is terrate with thick nodes. The leaves are variable, opposite
and short petioled. They are oblong, elliptic to linear lanceolate. The flowers are green
on the outside and purplish inside. The stem and branches of the plant twine anti
clockwise and the roots have a camphor like smell. Flowers may be greenish yellow
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to greenish purple on the outside and yellow to light purple on the inside. It has fused
corolla that numbers twice that of the calyx. Pistil is bicarpellary with free ovaries
many ovuled and having distrint styles.
 Distribution:
The species is distributed throughout the tropical and subtropical parts of India,
especially in upper Gangetic plains, Bengal, Madhya pradesh and South India.
 Parts used: Roots.
 Chemical constituents:
The root contains hexatriacontane, lupeol, octacosanoate, α-amyrin, β-amyrin,
acetate, sitosterol, coumarino-lignoid-hemidesminine, hemidesmin 1 and hemidesmin
2, six pentacyclic triterpenes including two oleaneces and three ursenes.
 Properties and uses:
1) Root bark of this plant known as “Indian sarsaparilla” are prescribed in
dyspepsia, loss of appetite, nutritional disorders, fever, skin diseases and
ulceration especially those of syphilitic origin, constitutional syphilitis,
chronic rheumatism and leucorrhoea.
2) Hot infusion of root bark with milk and sugar is used as tonic especially for
children in chronic cough and diarrhoea[16g].
13. Sida rhombifolia
Common name: Kurunthotti
Scientific classification:
 Kingdom : Plantae
 Division : Angiosperms
 Class : Eudicots
 Order : Malvales
 Family : Malvaceae
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 Genus : Sida
 Species : rhombifolia
The plant description
 Description:
A summer annual with yellow flowers and very small spines at the base of
each leaf and branch. Leaves arranged alternately along the stem approximately 3/4
inches long with petioles that are less than 1/3 the length of the leaves. The upper 1/2
of the leaves have toothed or serrated margins while the remaining of the leaves are
untoothed. Flowers occur singly on flower stalks that arise from the area between the
stems and leaf petioles. Flowers consist of 5 yellow petals that are 4 to 8mm long.
Seeds 2, heart shaped cotyledons. The small spines that occur at the base of each leaf
petiole and the rhombic leaves are characteristic that help in the idetification of jelly
leaf.
 Distribution:
This is a weed very common in India and Srilanka in the dry country. The
species is usually confined and rocky areas.
 Parts used:Whole plant
 Chemical constituents:
Sitosterol Іa, stigmasterol Іb, sinosterol-3-0-β-D glucopyranoside 2a,
phaeophysin A, 173-ethoxypheophorbide A, 132-hydroxyphaephyrin B, 173-
ethoxypheophorbide B, 5,7- dihydroxy-4’-methoxyflavone, cryptolepinone, salt of
cryptolepine[27].
 Properties and uses:
1) Root of these weeds is held in great repute in treatment of rheumatism.
2) Mucilage is used by chemists in oxidizing mercury. It also used to treat
scorpion sting[16h].
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14.Withania somnifera
Common name: Amukkura-kizhangu
Scientific classification:
 Kingdom : Plantae
 Division : Magnoliophyta
 Class : Magnoliopsida
 Order : Solanales
 Family : Solanaceae
 Genus : Withania
 Species : somnifera
The plant description
 Description:
An erect, evergreen, tentose shrub about 0.5 to 2 cm high. Leaves simple,
ovate, glabrous. Flower inconspicuous, greenish or lurid yellow, inaxillary, umbellete
cymes. Fruits- the berries are glabose, orange red when mature, enclosed in the
persistent calyx. Seed- yellow, reniform. Flowers and fruits during november,
february.
 Distribution:
Withania somnifera grows abundantly in India(especially Madhya pradesh),
Pakistan, Bangla desh, Srilanka and parts of Northern Africa.
 Parts used: Leaves, fruit, seeds, root.
 Chemical constituents:
Withanolides- withaferin A, withanone, withanolides I, II, III, III A, C, D, E,
F, G, H, I, J, K, L, M, WS-I, P and S, withasomidienone, cuscohygrine, anahygrine,
tropine, pseudotropine, anaferine, isopellatierine, 3- tropyltigloate.
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All arial parts contains proteins and amino acids. Leaves contains erggostane
which include withanone, alkaloides, fatty acids, beta sitosterol, polyphenols,
phytosterols, withaferia, withanolide C,D,E[28].
 Properties and uses:
1) Root and bitter leaves are used to treat alcoholism and emphysematous
dyspnoea.
2) Leaves are used as anthelmintic and as an application to carbuncles.
3) Root is used to treat senile debility, rheumatism, in all cases of general
debility, nervous exhaustion, brain fog, loss of memory, loss of muscular
energy and spermatorrhoea[16i].
15. Smilax china
Common name: Parangippattai
Scientific classification:
 Kingdom : Planate
 Division : Tracheophyta
 Class : Magnoliopsida
 Order : Liliales
 Family : Liliaceae
 Genus : Smilax
 Species : china
The plant description
 Description:
It is a bushy spiny plant, grew about 3 feet high. The leaves are thin,
membranous, ovate to ovate-oblong, five nerved, acute or obtuse at both ends. Root or
rhizome are stipules distinct obtuse and hard, large, blackish outer, pale and whitish
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internally. Flowers are small found in umbels greenish yellow. Fruits are red and
small.
 Distribution:
It is found in tropical and subtropical regions. It is native to China, Korea,
Taiwan, Japan, Philippines, Vietnam, Thailand, Myanmar and Assam.
 Parts used: Roots.
 Chemical constituents:
Kaemperol-7-0-beta-D-glucopyranoside, engeletin, isoengeletin, kaempferol,
dihydrokaempferol, dihydrokaempferol-5-0-P-D glucopyranoside, rutin, kaempferol-
5-0-beta-D-glucopyranoside, 3,5,4’-trihydroxystibene, vanillic acid, 3,5-dimthoxy 4-
0-beta-D-glucopyranosylcinnamic acid, beta sitosterol, beta daucosterol[29].
 Properties and uses:
1) Root used to treat rheumatism, gout, chronic nervous diseases, cachexia and
constitutional syphilis.
2) Inhalation of root used in asthma[16j].
16. Crataeva magna
Common name: Maavilangapattai
Scientific classification:
 Kingdom : Plantae
 Division : Angiosperms
 Class : Dicotyledons
 Order : Parietales
 Family : Capparaceae
 Genus : Crateva
 Species : magna
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The plant description
 Description:
A small much branched deciduous tree. Leaves 3 foliate. Leaflets 5-15cm long,
ovate, lanceolate or obovate. Flowers many, in dense terminal corymbs, petals nearly
2.5cm long, greenish white, stamens longer than the petals. Fruit ovoid, woody berry.
 Distribution:
The plant is distributed along the riparian vegetation of India, Burma,
Malaysia, China, Nepal, Myanmar, Srilanka and Indonesia. In India it is found in
peninsular, western gangetic plains and eastern India upto Tripura and Manipura. It is
mostly found along the banks of rivers and streams and near to temple side.
 Parts used: Leaves, bark, root.
 Chemical constituents:
Cadabacine, cadabacine diacetate, (-) -catechin, (-) - epicatechin-5- glucoside,
(-)epiafzelechin, isothicyanate glucoside, glucocapparin, taraxasterol, lupeol, 3-
epilupeol, lupeol acetate, diosgenin, friedelin, betulinic acid, ceryl alcohol and
spinasterol acetate.
Stem bark contains ceryl alcohol, friedelin,cadabicine, diacetate, lupeol,
betulinic acid and diosgenin. Fruits contains glycocaparin, β-sitosterol, triacontane,
triacontanol. Cetyl and ceryl alcohols. Leaves contain І-stachydrine. Root bark
contains rutin, quercetin, lupeol, varunol and β-sitosterol.
 Properties and uses:
1) The leaf paste of Crataeva magna is applied externally on piles and the juice
is drunk to get relief from bleeding piles.
2) Decoction along with the plant of Boerhaavia diffusa is given orally during
inflammation.
3) Bark and roots are used for urinary disorder, fever, vomiting and gastric
problems.
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4) Stem bark paste mixed with powdered black pepper is taken twice daily with
honey to cure infantile diarrhoea[30].
Saccharum officinarum
Common name: Seeni-sarkkarai
Scientific classification:
 Kingdom : Plantae
 Division : Angiosperms
 Class : Monocotyledons
 Order : Poales
 Family : Poaceae
 Genus : Saccharum
 Species : officinarum
The plant description
 Description:
It is a tropical, perennial grass that forms lateral shoots at the base to produce
multiple stems, typically three or four meters high and about 5 cm diameter. The
leaves grows from the nodes of the stem, arranged in two rows on either side of the
stem. The leaves are tubular and blades like, thicker in the centres than at the margins
and encircle than the stem. The inflorescence of sugar cane is a terminal panicle
which possesses two spikelet and seeds protected by husks covered in silky hair.
 Distribution:
Sugar cane is indigenous to tropical south and Southeast Asia.
 Parts used: Juice, sugar, root.
 Properties and uses:
1) Sugar syrup can be used as preservative and also it cures Sinusitis and Rhinitis[31].
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DISEASE REVIEW
3.3.SIDDHA ASPECT DISEASE REVIEW:
JAUNDICE (KAMALAI)
Other names: In Siddha literature Kamalai also known as Manjal kamalai, Piththa
kamalai, Kamala, Kamila.
Kamalai is one among those diseases which occur due to derangement of pitha
uyir thathu. In this disease eyes, tongue, urine and the whole body will get yellowish
discolouration.
Aetiology:
Yugi vaidhya chinthamani states that jaundice will occur when one consumes
more food which stimulates pitha thathu, drinking unhygienic and impure water,
seasonal changes and also indulges in excessive sexual activity under the conditions
of severe anaemia are the causes of this disease.
Premonitory symptoms:
In this disease, excessive salivation, nausea, bitterness of tongue, anorexia,
indigestion, dryness of the body and shrinking of skin like a frog. After that, eyes, nail
beds, face and skin and also urine become yellow in colour.
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Again, in this disease, palm, sole, face, eyes and the body will become pale;
there would be severe fatigue in the extremities, shivering of the body, frequent
dyspnoea, constipated and hardened feces, and yellowish discolouration of face,
oedema, lassitude, deafness and heaviness of head[32].
Classification of the disease:
In Siddha literatures, it is classified in to 13 varieties. They are as follows;
1. Vatha kamalai
2. Pittha kamalai
3. Kaba kamalai
4. Vatha kaba kamalai
5. Pittha kaba kamalai
6. Mukkutra kamalai
7. Manjal kamalai
8. Uthu kamalai
9. Varal kamalai
10. Azhagu kamalai
11. Sengamala kamalai
12. Kumba kamalai
13. Gunma kamalai
Curable and Incurable:
Among the 13 varieties of jaundice, seven types are curable and eight types
are incurable. Curable types include 1.Udhu kamalai, 2.Varal kamalai, 3.Manjal
kamalai, 4.Pitha kamalai, 5.Kabha kamalai, 6.Vatha kabha kamalai, 7.Pitha kabha
kamalai. The other varieties are not easily curable.
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Treatment:
Intake of variable food and other deeds stimulates pittha thathu, pitha
increases in its strength, joins kaba and becomes pitha kaba factor. This factor spoils
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the spreading vayu (paravu kal- Vyanan) and prevents it from doing its normal work
and thus it spoils the strength of blood. Because of this, liver gets affected and also the
bile unable to flow in its normal route as there is an obstruction.
Hence the bile mixes with the blood and jaundice occurs. The vatha factor gets
affected and the disease occurs due to pitha vatha factor. Apart from this, the other
vayu (gases) also get spoiled.
Hence the duty of the doctor is to set right the altered pitha kabam and pitha
vatham, in order to make the bile flow in its normal route and to increase the strength
of blood by suitable treatment. The altered spreading vayu (gas) and other vayu (gases)
should be brought to normal and made to do the normal regular work. Then medicines
for the disease should be given.
To induce vomiting:
Since vomiting is a symptom in this disease, it should not be induced though it
is advocated in Siddha literatures.
To induce diarrhoea:
To stimulate normal and easy bowel movements, the following substances
which have laxative action can be given:
 Phyllanthus emblica ( Indian gooseberry )
 Terminalia chebula ( Kadukkai )
 Anthemides flower ( Simai samanthi flower )
 Buds of rose ( Roja )
 Grapes ( Kodi munthrigai )
 Picorrhiza kurroa ( Kadukurohini )
 Bark, leaves and flower of purging cassia ( Sarakkondrai)
 Root of Indian jalap ( Sivathai )
 Flower of neem ( Veppam pu)
 Tinospora cordifolia ( Sinthil )
A decoction of the above substances may be made and given for jaundice for laxative
purpose[32a].
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Other medicines for vomiting and diarrhoea:
1.Malakudara oil
The medicinal malakkudara oil in a dose of one teaspoonful with a small
quantity of milk can be given at bed time. The next day morning faeces will be
passed out easily.
2.Malakudara mezhugu
Malalakudara wax (mezhugu) of the size of a fever nut (kazhal kay-Caelpinia
bonduc) can be given at bet time. Easy motion will occur in the morning
3.Thithippu bedi mezhugu or legiyam
Sweet diarrhoea wax (thithippu bedhi mezhugu) or sweet diarrhoea leghiyam
(thithippu bedhi leghiyam) should be taken at bed time as a size of Indian gooseberry.
Easy to motion will occur in the morning. It may be given in suitable doses in the
morning and evening.
4.Sanjivi tablets
If the motion is not passed out properly by the above methods, 2 Sanjivi
tablets given along with hot water can be given for children. Motion will be passed
easily.
For adults, one among the following may be given in a dose of 2 tablets with
hot water in the morning alone. Faeces will be passed easily. The medicines are
vajjirakandi tablet, attabairava tablet, suka viresana tablet, jivarathina tablet,
virechana bhupathy and lavangathy tablet. When sanjivi tablet along with leaf juice
of Euphorbia nivula (ilaikkalli) is given, vomiting and diarrhoea will be induced.
Vomiting for two or three times will occur. Diarrohoea will also occur. Along with
vomit or faeces, the bile fluid will also come out.
5.Marukkarai kaai
The unripened fruit of Randia dumetorum (marukkarai kaai) in its tender
reddish form may be taken. It may be soaked in lime juice and leaf juice of
Euphorbia nivula(ilaikkalli) for two days in each. Then it can be taken out and dried.
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This can be ground and made into powder. ½ pinches can be given in the morning
alone. Diarrhoea and vomiting will occur[34].
Medicines for Jaundice (Siddha Aspect):
1.Karisalai chooranam (Powder of Eclipta alba):
 Powder of dry leaves of Eclipta alba (Karisalai) 35 gm
 Powder of epicarp of Terminalia chebula (Kadukkay) 15gm
 Powder of pepper (Milagu) 10 gm
 Powder of the root of Lowsonia alba – henna plant (Maruthonri) 10
gm
Mix the all the above ingredients and ground it in the mortar to make it as a
fine powder. Take 2gm of the above, add 200mg of rusted iron Chenduram and take 2
times a day with buttermilk. Within 5 to 10 days, jaundice will get cured.
2.Karisalai matthirai (Tablet of Eclipta alba):
 Eclipta alba - one hand full
 Black cumin
 Long pepper
 Pepper (Piper nigrum)
 Garlic (Allium sativam)
Take each ingredient ¼ palam(8.5 gm) , Ground them all in the mortar and
make tablets in the size of Solanum torvum (Sundai), dry them in shade and put them
in a wide-mouthed bottle; pour good quality gingily oil and close it with a lid and put
it in sunlight. Take each tablet twice a day. Jaundice along with oedema will get
cured. Tamarind and salt should be avoided [35].
3.Jaundice powder (another process):
 Charred turmeric – one part
 Cubeb – fried, pounded and powdered – one part
 Cumin seeds – fried, pounded and powdered – one part
 Cane sugar powder – 4 parts
 Calx of gypsum – 1 part
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Mix all the above five ingredients and make it as a powder. Jaundice will be cured
when this powder is taken in doses of 10 to 15 Kundri two to three times a day when
with cow’s milk or goat’s milk or honey or in orange juice. It can also used as
adjuvant to any other calyx or Chenduram or any other medicines prescribed for
jaundice. By this, anaemia, oedema and liver diseases will get cured [36].
4.Kizha nelli ney (Ghee of Phyllanthus amarus):
 Juice of Phyllanthus amarus 1.35 liter (one measure)
 Cow’s ghee1.35 liter (one measure)
 Cubeb (Valmilagu)
 Nutmeg (Myristica fragrances) (Jathikkay)
 Cardamom (Eletaria cardamom) (Elam)
Each 17.5 gm (1/2 palam) is taken. All of them may be ground in a mortar
with milk. Then this may be heated and processed for oil (Thylam) and filtered. 16 ml
(the standard volume of a small spoon (Uchikarandi) may be consumed in the
morning and evening. Jaundice will be cured. Salt-free diet is essential[36a].
5.Karisalai ney (Ghee of Eclipta alba):
 Juice of Eclipta 1.35 litre (one measure),
 Cow’s ghee 1.35 litre (one measure),
 Thirikaduku (dry ginger, pepper, long pepper) 35 gm (one palam),
 Hyoscyamus niger(Kurosani omam) 8.5 gm (1/4 palam),
 Cubeb (Valmilagu) 17.5 gm (½ palam)
Ghee may be prepared as per the literature. Mix the above two and take in
doses of ¼ to ½ teaspoon two or three times a day with cow’s milk or its buttermilk or
goat’s milk or its buttermilk.
It can be given with honey also or it can be taken separately. It can be used as
an adjuvant for any other Calx or Chenduram. It will give an excellent cure for
spleen and liver enlargement also[36b].
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6.Ponnangani (Ghee of Alternanthera sessilis for jaundice):
The root of Alternanthera sessilis may be collected and macerated on a stone
slab. It is taken in elumichai alavu and be soaked into 4 liters of cow’s milk and is
allowed to mix with it. The next day, the butter from it may be taken out and
consumed. Jaundice will be cured.
7.Arunelli (Phyllanthus distichus for jaundice):
Phyllanthus distiches in the size of the fruit of Alexandrian laurel (punnai kay)
may be taken and macerated on a stone slab. This may be given along with ¼ of a
measure of sour buttermilk for 3 days in the morning. Jaundice will be cured. Rice
with goat’s milk can be taken. Salt should be avoided.
8.Nandiyavattai (Powder of East Indian rose for jaundice):
Pericarp of the root of multiple-layered East Indian rose, pericarp of the root
of Indian jalap which is cooked in milk, the outer part of Terminalia chebula – equal
quantities of these 3 things may be dried and pounded in a stone mortar and the
powder may be filtered by a muslin cloth. If this powder in a three finger pinch is
consumed with hot water, jaundice, predominant Pittha condition, and oedema can be
cured.
9.Kaiyanthakarai karkam (Green paste of Eclipta alba):
Tender leaves of Eclipta alba, tender leaves of Coldenia procumbens
(Seruppadai), turmeric and pepper- equal quantities of the above 4 substances may be
taken and macerated on a stone slab.
A lime- sized paste may be consumed along with goat’s urine. Jaundice and
oedematous jaundice will be cured.
10.Pirandai (Cissus quadrangularismedicine for jaundice):
Tender leaves of Cissus quandrangularis, Pepper,Acorus calamus, dry
ginger – equal quantities of these ingredients may be taken and macerated on a stone
slab. An areca nut sized ball of this paste may be covered in rice bran and consumed.
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11.Aridradhi churnam parpam (Medicine of turmeric, etc. and calx for jaundice):
Turmeric (Manjal), pericarp of Terminalia chebula (Kadukkay thol), pericarp
of Terminalia belerica (Thandrikay thol) and pericarp of Indian gooseberry (Nelli
mullai), Pircorzhiazha kurroa (Kadugurohini), rock salt (Induppu) equal quatities of
the above substances may be taken, dried and pounded in a stone mortar. One
Verukadi (cat’s foot print) quantity mixed with water may be consumed. Jaundice will
be cured.
Leaves of Pavonia zeylanica (Chitramutti), bark of Cassia fistula (Konrai),
Syzygium cumini (Naval), coriander leaves, purified iron powder, leaves of Indigofera
tinctoria(Avuri) – equal quantities of the above substances may be taken and Calx of
the above may be prepared. The Calx may be put in a mortar and ground with lime
juice. The paste in the size of the Solanum torvum(Sundaikkay) may be consumed.
Jaundice will be cured.
12.Amanakkilai marundhu (Leaves of castor plant for jaundice):
Tender leaves of castor plant (Aamanakku kozhundhu), tender leaves of
Trianthema protulacasturm (Saranai kozhundhu), dry ginger and white onion- equal
quantities of the above things may be taken and macerated on a stone slab. The paste
may be mixed with buffalo curd and consumed. Jaundice will be cured.
13.Arappodi marunthu (Medicine of iron filings for jaundice):
Iron filings may be put soaked in the bark juice of Terminalia arjuna (maruthu)
and allowed to absorb the juice. Then the iron filings may be takenout and dried in
the sun. Then it is powdered. Take 40 Terminalia chebula fruits. Remove the seeds.
Fry the epicarp portion in a vessel and make it charred, and then it is powdered. Equal
quantities of this powder along with the iron powder may be consumed. Ascitis,
anaemia and jaundice will be cured.
14.Puvarasu kozhundhu ilai kudinir (Decoction of tender leaves of Thespesia
populnea for jaundice):
Put the iron pot on a stove. 8 gm of pepper may be put into the pot and fried.
Make a powder of it keeping it in the pot itself. Then pour ½ measures of tender
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coconut water into the pot over the pepper. Let it be boiled in the pot. One handful of
tender leaves of Thespesia populnea may be taken and squeezed to get juice.
The juice may be poured into the pot when it starts boiling and the squeezed
leaves may also be put in to the pot itself. Within a few minutes, the water portion in
the pot will be reduced to 1/8 of a measure.
Take the pot away from the stove and make it cool. Filter the decoction. The
decoction is to be consumed when it is slightly hot. If it is prepared and consumed for
three times, jaundice will get cured immediately.
Saltiest and pungent diet should not be taken at the time of drinking this
decoction for the whole day. Sweet substances are also to be reduced. Before
consuming this medicine, the required food can be eaten[37].
The procedure for consuming this medicine
If the first dose of medicine is taken at 6pm of the day. The second dose is to
be taken at 6 am of the next day. The third dose is to be taken at 6pm on the second
day. For the whole day, salt-free rice porridge alone should be taken.
The next day morning a little of cow’s butter may be put on the head and after
half an hour, bath should be taken in cold water.
Then the needed food can be taken. Those who suffer from this disease for a
longer duration can consume 3 doses of this medicine with a break of one day. For
children, dosage should be adjusted suitably according to their age, body type and
strength [38].
15.Decoction for jaundice:
1) Flower of Madhuca longifolia (Iluppai), Tinospera cordifolia (Sinthil), neem
petioles, petioles of Adathoda vasica, clearing nut, Vettiver ziznaioides- take
equal quantities of the above and prepare a decoction. The decoction may be
taken along with sugar, ghee and honey. Jaundice will get cured.
2) 70 gm of Sivanatha powder along with cold water or honey or with the three fruit
(three myrobalans-kadu, tanri and nelli) decoction may be consumed. Jaundice
will get cured.
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Diet for jaundice:
i. Salt should be restricted according to the strength of the patient. Porridge without
salt and tamarind is good. Twice boiled rice can be given.
ii. As stated in above, when the bile flow is obstructed in the bile duct, fat will not
be digested as bile is not available for digestion. Ghee, butter, oil and all other
fatty substances should be avoided until the disease is cured completely.
iii. Tender vegetables which are not fried with mustard and gingelly oil, green, fruits,
butter milk and goat’s milk can be taken in. Ginger paste can be added to diet to
induce appetite. To the diet, cane juice, lime juice and ginger can be added.
iv. Smoking, tobacco chewing, and alcohol–like substances should be fully avoided.
Rest is essential until the disease is completely cured[39].
Liver diseases and medicinal plants:
 Foeniculum vulgare:
Hepatoprotective activity of Foeniculum vulgare (Family of Umbelliferae)
essential oil was studied using a carbon tetrachloride induced liver fibrosis model in
rats. The hepatotoxicity produced by chronic carbon tetrachloride administration was
found to be inhibited by Foeniculum vulgare essential oil with evidence of decreased
levels of serum aspartate aminotransferase, alanine aminotransferase, alkaline
phosphatase and bilirubin.
 Indigofera tinctoria:
A bioactive fraction, indigtone (12.5100mg/kg p.o) characterized as trans-
tetracos-15enoic acid (TCA), obtained by fractionation of a petroleum ether extract of
the aerial parts of Indigofera tinctoria (Family of Fabaceae), showed significant dose
dependent hepatoprotective activity against paracetamol (200mg/kg i.p) and CCl4
(0.5ml/kg p.o mixed with liquid paraffin 1:1) induced liver injury in rats and mice.
Pretreatment reduced Hexobarbitone induced sleep time, and zoxazolamine induced
paralysis time. Pre and post treatment reduced levels of transaminases, bilirubin, TG,
LPO and restored the depleted GSH in serum.
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 Rubia cordifolia:
Rubiadin isolated from Rubia cordifolia Linn, (Family of Rubiaceae) at a dose
of 50, 100 and 200 mg/kg was administered orally once daily for 14 days in rats. The
substantially elevated serum enzymatic activities of serum GOT, GPT, ALP and GGT;
decreased activities of glutathione Stransferase and glutathione reductase were
restored towards normalization in dose dependent manner which were induce by CCl4
treatment in rats. It also significantly prevents the elevation of hepatic MDA
formation and depletion of reduced GSH content in the liver.
 Solanum nigrum:
The effects of Solanum nigrum (Family of Solanaceae) extract (SNE) was
evaluated on thioacetamide (TAA) induced liver fibrosis in mice. Mice in the three
TAA groups were treated daily with distilled water and SNE (0.2 or 1.0 g/kg) via
gastrogavage throughout the experimental period. SNE reduced the hepatic
hydroxyproline and αsmooth muscle actin protein levels in TAA treated mice. SNE
inhibited TAA induced collagen (α1) (I), transforming growth factor-β1 (TGF-β1)
and mRNA levels in the liver. Histological examination also confirmed that SNE
reduced the degree of fibrosis caused by TAA treatment. Oral administration of SNE
significantly reduces TAA induced hepatic fibrosis in mice, probably through the
reduction of TGF-β1 secretion.
 Terminalia catappa:
Punicalagin and Punicalin isolated from the leaves of Terminalia catappa L.
(Family of Combretaceae) reduced hepatitis by reducing levels of AST and ALT
which increased by APAP administration in rats[40].
3.4.MODERN ASPECT OF DISEASE REVIEW:
Liver Diseases:
Liver diseases is any disturbances of liver functions that causes illness. The
liver is responsible for many critical functions within the body and should it become
diseased or injured, the loss of those functions can cause significant damage to the
body.
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Liver diseases also refered to as hepatic disease. Liver diseases are a broad
term re-counting any number of diseases affecting the liver. Many are escorted by
jaundice caused by increased levels of bilirubin in the system. Liver disease may be
classified as:-
1) Hepatitis, inflammation of the liver, instigated mainly by various viruses but also
by some poisons, autoimmunity or hereditary conditions.
2) Cirrhosis is the foundation of fibrous tissue in the liver, replacing dead liver cells.
The death of the liver cells can be affected by viral hepatitis, alcoholism or
contact with other liver-toxic chemicals.
3) Haemochromatosis, a hereditary disease causing the accretion of iron in the body,
eventually leading to liver damage[41].
4) Cancer of the liver (Primary hepatocellular carcinoma or Cholangio carcinoma
and metastatic cancers, usually from other Parts of the gastrointestinal tract).
5) Wilson's disease, a hereditary disease which reasons the body to retain copper.
6) Primary sclerosing cholangitis, an inflammatory disease of the bile duct, likely
autoimmune in nature.
7) Primary billiary cirrohisis, autoimmune disease of slight bile ducts.
8) Budd-Chiari syndrome, complication of the hepatic vein.
9) Gilbert's syndrome, a genetic syndrome of bilirubin metabolism, found in about
5% of the population.
10) Glycogen storage disease type II, the build-up of glycogen causes liberal muscle
weakness (Myopathy) throughout the body and touches various body tissues,
particularly the heart, skeletal muscles, liver and nervous system[42].
Causes for Liver diseases:
Liver disease can be caused by a variety of factors. Causes include:
i. Congenital birth defects, or abnormalities of the liver present at birth
ii. Metabolic disorders, or defects in basic body processes
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iii. Viral or bacterial infections
iv. Alcohol or poisoning by toxins
v. Certain medications that is toxic to the liver
vi. Nutritional deficiencies
vii. Trauma, or injury[7e]
Symptom of liver diseases includes:
Symptoms may begin slowly and slowly get worse. They may also begin suddenly
and be severe from the start.
Early symptoms may be mild and include:
Breath with a musty or sweet odor, Change in sleep patterns, Changes in
thinking, Confusion that is mild, Forgetfulness, Mental fogginess, Personality or
mood changes, Poor concentration, Poor judgment, Worsening of handwriting or loss
of other small hand movements.
More severe symptoms may include:
Abnormal movements or shaking of hands or arms, Agitation, excitement, or
seizures (occur rarely), Disorientation, Drowsiness or confusion, Strange behavior or
severe personality changes, Slurred speech, Slowed or sluggish movement, People
with hepatic encephalopathy can become unconscious, unresponsive, and possibly
enter a coma.
A rare but severe form of the liver infection called acute fulminant hepatitis causes
liver failure. Symptoms of liver failure include:
An enlarged and tender liver, Enlarged spleen, Susceptibility to bleeding,
Encephalopathy which is a disorder that affects how the brain functions, Changes in
mental status or level of consciousness, Ascites which is an accumulation of fluid
inside the abdomen, Edema or swelling under the skin, Aplastic anemia a condition in
which the bone marrow cannot make blood cells[7f].
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Hepatitis:
It is the infection and damage of liver particularly involving the hepatocytes. It
is usually due to various infective and toxic substances. The condition can be self
limiting, healing on its own, or can progress to scarring of the liver. A group of
viruses had known as the hepatitis viruses’ origin most cases of liver damage
worldwide. Hepatitis can also be due to toxins (notably alcohol), other infections or
from autoimmune process[42a].
Viral Hepatitis:
Viral hepatitis is the cause of most cases of acute hepatitis. Types include
Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis B with D, Hepatitis E, Hepatitis F
virus (existence unknown), and Hepatitis G or GBV-C.
 Hepatitis A or infectious jaundice is affected by a picornavirus transmitted by the
fecaloral route. It causes an acute form of hepatitis and does not have a chronic
stage.
 Hepatitis B is caused by a hepadnavirus, which can cause 500,000 to 1,200,000
deaths per year worldwide due to the complications of chronic hepatitis, cirrhosis,
and hepatocellular carcinoma. Hepatitis C (originally "non-A non-B hepatitis") is
caused by a virus with an RNA genome that is a member of the Flaviviridae
family.
 Hepatitis C may lead to a chronic form of hepatitis, culminating in cirrhosis.
 Hepatitis D is caused by hepatitis delta agent, which is alike to a viroid as it can
only propagate in the presence of the Hepatitis B virus.
 Hepatitis E produces symptoms similar to hepatitis A.
 Hepatitis F virus is a hypothetical virus linked to hepatitis. Several hepatitis F
virus candidates emerged in the 1990s; none of these reports have been
substantiated.
 Another potential viral cause of hepatitis, initially identified as hepatitis G virus is
probably spread by blood and sexual contact[43]. There is very little evidence that
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this virus causes hepatitis, as it does not appear to replicate primarily in the liver.
It is now classified as GB virus C.
 In addition to the hepatitis viruses, other viruses can also cause hepatitis,
including cytomegalovirus, Epstein-Barr virus, yellow fever, etc. Non viral
infection like Toxoplasma, Leptospira and Q fever also causes hepatitis[44].
Fatty Liver:
Fatty liver, also known as fatty liver disease (FLD), Steatorrhoeic hepatosis or
Steatosis hepatitis, is a reversible condition where outsized vacuoles of triglyceride
collect in liver cells via the process of Steatosis. Normal liver may cover as much as
5% of its weight as fat. Lipiotic liver may contain as much as 50% of its weight as fat,
most of being triglycerides.
Severe fatty liver is sometimes accompanied by inflammation, a situation that
is mentioned to as Steatohepatitis. The progression to cirrhosis may be influenced by
the amount of fat and degree of Steatohepatitis and by a variety of other informing
factors.
Cirrhosis:
Cirrhosis can be defined as a chronic disease condition giving morphological
alteration of the lobular structure characterized by destruction and regeneration of the
parenchyma cells and increased connective tissue. Major morphological changes
induce granular or nodular appearance and are characterized by the presence of
septate or collagen throughout the liver[45].
Infective Agents:
These are mainly viruses like, Type A and Type B, Non – A, Non – B, Delta
agent, virus of yellow fever, Epstin – Barr virus, cytomegalovirus, virus of Herpes
simplex, Rubella, Marburg agent and others like Leptospira icterohaemorrhagiae,
Leptospira canicola, Taxoplasma gondii, Borrelia recurrentis, etc
Toxic Agents:
Chlorpromazine and other Phenothiazine derivatives, Monoamine oxidase
inhibitors (MAO-inhibitors), Erythromycin, Tetracycline, INH, Rifampicin, Methyl
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dopa, Chlorpropamide, Phenylbu-tazone, Indomethacin, Paracetamol, Thiouracil,
Acetaminophen, Halothen, Alcohol, Carbon tetrachloride, etc[46].
Table: 1. List of Hepatotoxic therapeutic agents and chemicals:
Therapeutic agents Chemicals
Allopurinol Methotrexate Alcohol
Amiodarone Nicotinic acid Arsenic
Azathioprine Nitrofurantoin Carbon tetrachloride
Carbamazepine Paracetamol Chloroform
Chlorpromazine Phenelzine Copper
Chloroform Phenytoin
Ciglitazone Pravastation
Cimetidine Quinidine
Dantrolene Rifampicin
Erythromycin Salicylates
Galactosamine Simvastatin
Halothane Sodium valproate
Iproniazid Sulphonamides
Isoniazid Tetracyclines
Ketoconazole Ethanol
Liver Cancer:
The liver is inclined to cancer induction by a variety of human made and
naturally occurring chemicals. Chemical substances include, aflatoxin B, cycasin, and
safrole etc among human made substance are DDT, carbon tetrachloride, chloroform,
thioacetamide. Studies in experimental animals designate quite clearly that
development of cancer of the liver is associated with the number of obvious non-
malignant lesions appearing prior to the occurrence of neoplastic malignancy.
Diagnosis:
Many further tests may also be used to support the diagnosis. These include blood test
such as,
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1) Liver function tests, which are blood tests that check a wide variety of liver
enzymes and byproducts.
2) A complete blood count (CBC), which looks at the type and number of blood
cells in the body.
3) Abdominal X-rays.
4) Ultrasounds, to show size of abdominal organs and the presence of masses.
5) An upper GI study, which can detect abnormalities in the esophagus caused by
liver disease.
6) Liver scans with radio tagged substances to show changes in the liver structure.
7) ERCP, or endoscopic retrograde cholangiopancreatography. A thin tube called an
endoscope is used to view various structures in and around the liver.
8) Abdominal CT scan or abdominal MRI, which provide more information about
the liver structure and function.
Diagnosis of Drug-Related Hepatotoxicity:
There is no single test, including liver biopsy that can be used to diagnose drug-
related Hepatotoxicity. Other causes of liver injury must first be considered with the
use of a combination of serologic tests, imaging studies, and clues from the patient‟s
history. CT denotes computed tomography, MRI magnetic resonance imaging, MRCP
magnetic resonance cholangiopancreatography, ERCP endoscopic retro grade
cholangiopancreatography, AST aspartate aminotransferase, ALT alanine
aminotransferase, TIBC totaliron-binding capacity, and A1AT alpha1-antitrypsin[7g].
Hepatotoxicity:
Hepatotoxicity implies chemical-driven liver damage. The liver plays a
Central role in transforming and clearing chemicals and is disposed to the toxicity
from these agents. Certain medicinal agents when taken in overdoses and sometimes
even when introduced within therapeutic ranges may injure the organ. Other chemical
agents such as those used in laboratories and industries, and natural chemicals (e.g.
microcystins) can also induce hepatotoxicity.
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Chemicals that cause liver injury are called hepatotoxins. The human body
identifies almost all drugs as foreign substances (i.e. Xenobiotics) and subjects them
to various chemical processes, (i.e. metabolism) to make them suitable for elimination.
This involves chemical transformations like reduction in fat solubility and alteration
in biological activity.
Although almost all tissue in the body have some ability to metabolize
chemicals, smooth endoplasmic reticulum in liver is the principal "metabolic clearing
house" for both endogenous chemicals (e.g., cholesterol, steroid hormones, fatty acids,
and proteins), and exogenous substances (e.g. drugs). The central role played by liver
in the clearance and transformation of chemicals also kinds it susceptible to drug
induced injury.
The mechanism of hepatotoxicity in liver can be labelled by two methods:-
1) Direct: - This group comprises the products (or their metabolic products)
that produce direct injury to the plasma membrane, endoplasmic reticulum and other
organelles of the hepatocytes. Direct hepatotoxicity may be exemplified as non-
selective destruction of the structural basis of hepatocyte metabolism.
Some of the direct hepatotoxins comprise carbon tetra chloride, chloroform,
tetrachloroethane, iodoform and elemental phosphorus.
2) Indirect: -These are more selective, and are antimetabolic and related
compounds that produce hepatic hurt by interference with specific metabolic pathway.
The hepatic damage produced by indirect hepatotoxins may be mainly
cytotoxicity expressed as necrosis or mainly cholestatic expressed as arrested bile
flow with or without bile duct injury.
A group of enzymes located in the endoplasmic reticulum, recognized as
cytochrome P-450, is the most important family of metabolizing enzymes in the liver.
Cytochrome P-450 is the terminal oxidase component of an electron transport chain.
It is not a single enzyme, but rather covers of a family of closely related 50
isoforms, six of them metabolize 90% of drugs[47]. There is a remarkable diversity of
individual P-450 gene products and this heterogeneity allows the liver to perform
oxidation on a vast array of chemicals (including almost all drugs).
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Due to its unique metabolism and close relationship with the gastrointestinal
tract, the liver is subject to injury from drugs and other substances. About 75% of
blood coming to the liver arrives directly from gastrointestinal organs and then spleen
via portal veins which carry drugs and xenobiotics in concentrated form. Several
mechanisms are accountable for either inducing hepatic injury or worsening the
damage process.
Many chemicals damage mitochondria, an intracellular organelle that
produces energy. Its dysfunction releases extreme amount of oxidants which in turn
injures hepatic cells. Activation of some enzymes in the cytochrome P-450 system
such as CYP2E1 also chief to oxidative stress injury to hepatocyte and bile duct cells
lead to accumulation of bile acid inside liver[48].
This promotes further liver damage. Non-parenchymal cells such as Kupffer
cells, fat storing stellate cells and leukocytes (i.e. neutrophil and monocyte) also have
role in the mechanism[49].
More than 900 drugs have been concerned in causing liver injury, and it is the
most common reason for a drug to be withdrawn from the market. Drug persuaded
liver injury is responsible for 5% of hospital admissions and 50% of all acute liver
failures[50].
The liver produces large quantities of oxygen free radicals in the course of
detoxifying xenobiotic and toxic substances.
Reactive oxygen species (ROS) has been exposed to be linked to liver diseases,
such as hepatitis, cirrhosis, portal hypertension, viral contagions and other liver
pathological conditions[51]. They play an important role in the inflammation process
after intoxication by ethanol, carbon tetrachloride or carrageenan.
These radicals and the reactive species resultant from them react with cell
membrane, induce lipid peroxidation and are responsible for various deleterious
belongings in cells and tissues where they are generated. ROS induce alterations and
loss of structural/functional architecture in the cell, leading directly to cytotoxicity
and/or indirectly to genotoxicity, with numerous serious anomalies favouring
disharmony and diseases[52].
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Hepatic injury caused by chemicals, drugs, and virus is a well-known
toxicological problem to be occupied care of by various therapeutic measures.
CCl4 induced toxicity:
Carbon tetrachloride has been widely used to study liver damage used by free
radicals. CCl4 toxicity is initiated by the bioactivation of CCl4 to CCl3 (tricloromethyl
free radicals) by the enzymes CYP2E1, CYP2B1, CYP2B2, CYP3A chiefly by
CYP2E1. The formed CCl3 rapidly reacts with molecular oxygen to form CCl3O2
(peroxytricloromethyl free radicals). Both CCl3 and CCl3O2 are highly reactive, they
covalently bind to macromolecules such as proteins, lipids and nucleic acids and react
with polyunsaturated fatty acids and form a series of self-propagating chain reactions
known as “propagation of lipid peroxidation” which may lead to damage of
endoplasmic reticulum and cell membrene which may lead to necrosis.
Paracetamol induced liver toxicity:
Paracetamol is a non-steroidal anti-inflammatory drug which is available as
OTC(over the counter) drug. The caution of this acetaminophen (Paracetamol) is its
active metabolite is injury to liver (i.e) leads to liver damage. Normal dose of the
drug- 4000mg per day (Maximum) (Franciscus A;2012) 2000-3000mg per day is
mostly recommended. The active metabolite of acetaminophen is N-acetyl p-
benzoquinoneimine(NAPQI)This NAPQI is toxic to the liver cells. Mostly the 90% of
acetaminophen is metabolized by glucuronide and sulfate conjucation and then
excreted in the urine. 5-10% is metabolized by cytochrome P450, mainly by CYP2E1
which produces NAPQI.
Alcohol induced toxicity:
Alcohol is metabolized by liver. This process produces a number of potentially
dangerous byproduct. Alcohol is converted to acetaldehyde by the enzyme Alcohol
dehydrogenase (ADH).The formed acetaldehyde is highly toxic. Normally the
enzyme Aldehyde dehydrogenase (ALDH) rapidly oxidizes acetaldehyde to acetate.
Both these enzymes ADH and ALDH are also involved in metabolism of vitamin A.
Apart from ADH, the enzyme CYP2E1 ( microsomal ethanol oxidizing system;
MEOS) is also involved in metabolizing alcohol. MEOS plays a major role when
blood ethanol levels are high. CYP2E1 produces a toxic byproduct N-acetyl-p-
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benzo-quinone imine (NAPQI) which is responsible for damaging the hepatic
protein[7h].
3.5.PHARMACOLOGICAL REVIEW
Models of Liver Fibrosis:
Several approaches to induce fibrosis in animals are designated and these
models can be divided according to their stimulus from inciting injury. Liver fibrosis
models are connected with
(1) Toxic damage (hepatocytes: CCl4 dimethylnitrosamine (DMN),
galactosamine; bile duct epithehal cells: thioacetamide (TAA),
(2) Immunological-induced damage (heterogonous serum and experimental
schistosomiasis),
(3) Biliary damage (common bile duct ligation (BDL) or occlusion),
(4) Alcohol-induced damage (baboon ethanol diet or Tsukamoto / French
model in rats). Nowadays, fibrosis-related models are established that have their
origin in fatty liver disease ,
(5) Fatty liver disease, in particular the 'malignant' inflammatory form non-
alcoholic steatohepatitis (NASH), can increase to liver fibrosis and cirrhosis.
It is strongly associated with obesity and diabetes, two modern health
problems in Western countries. Of the existing animal models for fatty liver disease,
as reviewed by the genetic lepton-deficient (ob/ob) or lepton- resistant (db/db) mice[53].
The dietary methionine/ choline-deficient models are cast-off in the majority
of published research. Progressive fibrosis was reported only in
themethionine/choline-deficient models in 100% of the mice.
BDL and CCl4 are the most widely used rodent models[54] in liver fibrosis
research to assess the effectively of experimental drugs on the pathogenesis, since
these models represent features of human pathogenesis. Therefore, these models are
the best categorized with respect to histological, biochemical, cell and molecular
changes connected with the development of fibrosis.
In the past years, there is a tendency in fibrosis - related research to shift from
rat to mice models, and most of the models originally described ferrates are now
applied in mice. Moreover, new testing models arise due to the development of
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transgenic or knock-out mice models, which were developed to elucidate the
pathogenesis and common pathways in liver fibrosis. Examples of knockouts with
spontaneous formation of liver fibrosis are mdr2-/- mice 1hx2-/- mice, and the mice
models for NASH mentioned above[55].
Acute and Chronic Models with Carbon Tetrachloride (CCl4)
CCl4 intoxication results in hepatocyte necrosis and apoptosis with damage
predominantly in zone III (around central vein) of the liver. The mechanism behind
this hepatocyte damage is the activation of CCl4 by cytochrome P450, which results in
the formation of trichioromethyl radical in these cells and this free radical initiates
lipid peroxidation[56] .
The damage to hepatocytes by CCl4 is replicated by high plasma alanine
transaminase (ALT) and aspartate transminase (AST) levels after CCl4 administration,
CCl4causes also fatty changes in the hepatocytes. This initial damage is followed by
hepatic stellate cell activation and tissue fibrosis.
The CCl4 model is related with tremendous inflammation, a feature that is also
often seen in livers of patients with liver fibrosis. Disadvantages of this model are the
variations obtained in disease induction in the animals and the relatively high rate of
mortality alter CCl4 administration > 20%.
In animal models CCl4 treatment is used to get different stages of the fibrotic
process, ranging from early damage and HSC activation until advanced cirrhosis. The
fibrotic stage obtained in the rodents depends on the number of injections of CCl4 that
are administered.
The models for CCI4 that are used in liver fibrosis research, are
(1) Acute damage (72 hours after a single injection of CCI4) with HSC activation
(2) Early and establish fibrosis (4-6 week of twice weekly CCl4 dosing),
(3) Early cirrhosis (8 week of twice weekly CCl4 dosing)
(4) Advanced micronodular cirrhosis (12 week of twice weekly CCl4 dosing). In
addition for each of these models,
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(5) Spontaneous recovery from fibrosis can be studied after cessation of dosing of
CCl4.This latter model is a valuable model to determine drug induced acceleration of
recovery from established fibrosis after removal of the inciting stimulus.
This is similar to treatment situations in patients with liver fibrosis in case
their inciting stimulus can be eradicated for instance after alcohol abstinence or after
antiviral therapy beside hepatitis virus infections.
CCl4 is administered to the animals via intraperitoneal, subcutaneous or oral
administration or by inhalation. For intraperitoneal injections, CCl4 is diluted in olive
oil and given indosages of 0.5 - 1.0 ml / kg to rats and mice. Often supplementation
of phenobarbital in drinking water (resulting in induction of hepatocyte cytochrome
P450) is used to get more reproducible fibrosis improvement and to accelerate the
speed of fibrosis development. Usually, phenobarbital concentrations of 0.3 - 0.4 g/I
in drinking water are used and started I week before the initial exposure to CCl4.
In case of inhalation of CCl4 the animals are placed in an inhalation chamber
twice a week with a progressively increasing exposure time (1.5 min). Also with this
procedure, supplementary phenobarbital in drinking water is added. To reduce early
toxicity and mortality, some research groups vary with the dose of CCL4 in time. In
these cases, gradually growing dosages in the first weeks are administered to the rats.
Bile Duct Ligation (BDL) :
The second well-studied experimental animal model of liver fibrosis is the bile
duct ligation model. This model corresponds with the human pathology of
biliarycirrhosis, such as extrahepatic biliary atresia and primary sclersoing cholangitis.
Ligation of the bile duct causes acute epithelial impairment and the detergent action
of the subsequently released bile salts in the liver is likely associated with the
solubilization of plasma membranes and hepatocyte cell death.
This latter is envisaged by elevated ALT and AST levels in plasma, in
particular proximately after ligation (first week). Characteristics of obstruction of the
bile are the appearance of bile products, such as bilirubin into the blood circulation,
which causes jaundice in these animals[57].
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The initial damage is followed by a massive expansion of the bile duct
epithelial cells and periductal my fibroblasts, which can be referred to as portal
expansion (stage 1) in total this results in marked liver enlargement, which can be up
to twice the weight as compared to normal.
Then, bile duct epithelial cells and my fibroblasts in the portal tract are
increasingly expanding which results in a gradual remodelling of the liver architecture
by linking adjacent portal tracts (biliary cirrhosis stage IV).
To ligate the bile duct, the abdomen of the rat is opened under general
anesthesia (preferably N2O/O2/halothane inhalation to agree quick recovery from
narcosis) to identify the common bile duct. The bile duct turns from the helium of the
liver, where the hepatic ducts meet, through the pancreas, into the lower end of the
duodenum. Of note, threat has no gall bladder in contrast to other rodents.
Three ligatures are located and tied around the bile duct; two close to the liver
and one close to the duodenum. The first ligatures will prevent formation of a
reservoir of bile outside the liver. After tight closure, the bile duct is cut between the
second and third ligation in order to prevent restoration of the bile flow by bile duct
formation around the ligature. Subsequently, the abdomen is closed over and
analgesics can be given to the rats.
We use a local anaesthetic compound (Marcaine which contains bupivacaine),
but also systemic acting analgesics are sometimes administered (e.g. Temgesic
(containing buprenorphine). For mice, the procedure is a little bit more complicated
because a mouse possesses a gall bladder, and consideration should be [paid to tightly
ligate the whole duct, in general more than three ligatures are needed, to prevent
rupture of the bladder and subsequent problems.
Already in the first days after ligation, proliferation of bile duct epithelial cells,
activation and proliferation of HSC and my fibroblasts, and deposition of extra
cellular matrix can be detected microscopically starting in the portal areas of the liver
(zone 3). After one week, a fibrous expansion of the portal areas is visible and after
about 10-14 days, portal- portal bridging is visible.
Three to four weeks after ligation, these rates develop advanced cirrhosis
characterized by extensive proliferation of the bile ducts, around which the activated
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and transformed HSC are detectable (Markers: a - smooth muscle action and PDGF
beta receptor) and around which the interstitial collagens (types I and III) are
deposited.
A major advantage of the BDL model is the relatively fast development of
fibrosis (within 3 weeks) in rats. Furthermore, the model is quite reproducible, and
the mortality due to the ligation procedure in rats is low (<10%). Disadvantages of
the BDL models are the limited inflammation associated with this type of fibrosis
development and the excessive expansion of bile duct epithelial cells.
Another drawback with regard to drug screening is that the BDL-induced
disease is difficult to reverse with experimental drugs, and a reason for this may be
because the initiating stimulus (ligation of the bile duct) remains present during
treatment periods and causes continuous damage as subsequent fibrosis that troubles
the potential treatment effects.
Dimethylnitrosamine (DMN):
DMN induces liver damage leading to fibrosis and cirrhosis. Characteristic
for this model is that ongoing administration of this toxic compound finally leads to
the development of hepatocellular carcinoma in rodents.
DMN induces liver injury by starting damage to the hepatocyte. It is
metabolized primarily in hepatocytes by Cytochrome P450 (isotype 2E1) to more
toxic compounds with formation of reactive oxygen species in hepatocytes and sub-
sequent this will lead to lipid peroxidation. In difference to the hepatotoxin CC14,
DMN administration does not cause fatty changes, steatosis in the hepatocytes[53]. To
induce the fibrosis, DMN (10 microliter/kg body wt., i.p) is given 3 days a week for 3
weeks to rats.
After administration of DMN, hemorrhagic necrosis is evident in centrolobular
part (zone III) of the liver. Incomplete septa appear after 7 days and micronodular
cirrhosis is developed after 3 weeks of treatment with DMN. Increased numbers of
HSC and my fibroblasts are found in the formed septa. Influx of inflammatory cells,
mainly lymphocytes, is noted early in DMN - induced liver injury.
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Advantages of this model are that the disease induction is quite reproducible in
the animals, and this model is associated with a prominent inflammatory reaction.
Furthermore, this model can be used to study the transition from cirrhosis to
hepatocellular carcinoma, and the effect of drugs on this process.
HSC in Culture (In Vitro System):
HSC are key players in fibrosis and these cells predominantly orchestrate the
development of the disease. To evaluate the ant fibrotic efficacy of experimental
drugs, these primary cultured cells are useful in assessing specific effects on HSC
activities. In particular, the primary isolated HSC are valuable in drug research,
because in vitro they spontaneously transform into my fibroblasts, and this
transformation process is related with cellular activation proliferation and matrix
production resembling cellular activities that also happen in vivo.
This transformation does not occur in the various HSC cell lines that are also
used in literature. Proximately after isolation they signify a inactive stage, e.g. as
present in the normal healthy liver, with vitamin A droplets as their main
characteristic. During culture on plastic for about 10-14 days a cell with fibroblast -
like features is attained. This transformed cell displays different cellular activities as
compared to the original isolated one.
The procedure to isolate HSC is well described by various fibrosis research
groups Briefly, HSC are isolated from livers of normal rats weighing at least 500g in
order to achieve a good separation from the other hepatic cells.
The liver is digested with pronase, collagenase and DNase by in situ perfusion.
Pronase is essential in the isolation, yet it affects the viability of other hepatic cells
(i.e. hepatocytes) and therefore this procedure can only be used isolate HSC from the
liver.
After several centrifuge steps, the cells suspension is subjected to a Nycodenz
gradient to gather the HSC on top of the Nycodenz layer. The separation is based on
the low density of the HSC as compared to other liver cells, as a consequence of their
high cellular lipid content. Instead of Nycodenz, also other compounds are used e.g
Stractan, Metrizamide, or Percoll, to separate the HSC from the other cells by density
gradients.
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The yield of HSC after collagenase / pronase digestion and Nycodenz
separation is about 20-40 x 10E6 cells per rat liver.
The yield of HSC attained from a mouse liver is much smaller and to isolate
and purify proper amounts of HSC, about 5 mice have to be used at the same time in
one total isolation (Geerts, personal communication)
The purity after isolation can be established by phase contrast microscopy or
by staining of the cells with markers for hepatic cell types. The isolated cells are
cultured in DMEM containing 10% FCS 100 U/ml penicillin, and 100 ug/ml
streptomycin. After 10-14 days in culture, the cells exhibition an activated phenotype
as assessed by light microscopy and acquires the presence of alpha-smooth muscle
action.
Additionally, it is also conceivable to isolate HSC from human livers. Often
(parts of) human livers are used that are unbecoming for transplantation are derived
from tumor-free parts of the human liver and separated after partial hepatectomy.
Roughly, two methods are used to isolate human stellate cells.
(i) out-growth of the cells by culturing small pieces of the livers in medium and
(ii) a combined digestion with collagenase / pronase, after which HSC were separated
from other liver non - parenchymal cells by centrifugation over density gradients
similar to threat procedure.
Of note, the first method will yield a combination of various (myo) fibroblastic cells
including HSC and myofibroblasts.
These cells are afterward cultured in DMEM< supplemented with 5% Fetal
Calf Serum and 5% G Human Serum. The fibroblastic nature of the cells can be
microscopically evaluated, and tested for the expression of a smooth muscle action.
Liver Slice System:
A second in vitro test system which was recently developed to assess effects
of anti fibrotic drugs is the liver slice preparation. Drug studies with tissue slices
(8mm diameter, 250 un thickness that is about 10-12 cell-layers thick) comprising
stellate cells in their natural environment that uphold there in vivo cellular functional
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and anatomic relationships, may provide additional information about the
hepatocellular specificity of the experimental drug and their effects on all hepatic cells.
Hepatoprotective and antioxidant effects of tender coconut water (TCW) were
examined in carbon tetrachloride (CCl4)-intoxicated female rats.
Liver damage was showed by the increased levels of serum glutamate
oxaloacetate transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT)
and decreased levels of serum proteins and by histopathological studies in CCl4
intoxicated rats.
Augmented lipid peroxidation was presented by elevated levels of
thiobarbituric acid reactive substance (TBARS) viz, malondialdehyde (MDA),
hydroperoxides (HP) and conjugated dienes (CD), and also by significant reduction in
antioxidant enzymes activities, such as superoxide dismutase (SOD), catalase (CAT)
and also reduced glutathione (GSH) content in liver.
Darkening of urine On the other hand, CCl4 intoxicated rats treated with TCW
retained almost normal levels of these constituents. Decreased activities of antioxidant
enzymes in CCl4 intoxicated rats and their reversal of antioxidant enzyme activities in
TCW treated rats, shows the effectiveness of TCW in combating CCl4 induced
oxidative stress.
Hepatoprotective outcome of TCW is also evidenced from the
histopathological studies of liver, which did not show any fatty infiltration or necrosis,
as observed in CCl4 intoxicated rats[58].
Exams and Tests Physical Examination:
 Nutritional assessment
 Yellowing of the sclera is usually the first detectable sign of jaundice.
 Darkening of urine
 Skin examination for icterus
 Stigmata of chronic liver disease
 Abdominal examination
 Inflammed and tender liver
 Fluid in the abdomen (ascites) that can become infested
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 Blood tests
 These may initially include
 Complete blood count – TC ,DC, ESR, Cholesterol
 Liver function test
 In women, a pregnancy test may be obtained.
 Urine analysis: Urine analysis for bile salts and bile pigments
Laboratory Tests:
 Abdominal ultrasound
 Autoimmune blood markers
 Hepatitis virus serologists
 Liver function tests
 Liver biopsy to check for liver destruction
 Paracentesis if fluid is in abdomen
 Tests for Liver Function
Bilirubin:
Bilirubin is one of the most important factors indicative of hepatitis. It is a red-
yellow pigment that is normally metabolized in the liver and then defecated in the
urine.
In patients with hepatitis, the liver cannot process bilirubin, and blood levels
of this substance rise. High levels of bilirubin cause the yellowish skin tone known as
jaundice.
Liver Enzymes (Aminotransferases):
Enzymes known as aminotransferases, including aspartate (AST) and alanine
(ALT), are free when the liver is damaged. Measurements of these enzymes,
particularly ALT, are the least expensive and most non-invasive tests for determining
sternness of the underlying liver disease and monitoring treatment effectiveness.
Enzyme levels vary, however, and are not always an accurate indicator of disease
activity.
Alkaline Phosphatase (ALP):
High ALP levels can indicate bile duct blockage.
REVIEW OF LITERATURE
HEPATOPROTECTIVE ACTIVITY OFMAAVILINGAPATTAI CHOORANAM 82
GGT (gamma glut amyl transpeptidase):
GGT is often elevated in those who use alcohol or other liver-toxic substances
to excess.
Serum Albumin:
Serum albumin measures protein in the blood (low levels indicate poor liver
function). Total protein, Serum total protein, protein in the blood (low levels indicate
poor liver function).
Prothrombin Time (PT):
The PT test measures in seconds the time it takes for blood clots to form (the
longer it takes the greater the risk for bleeding[59].
3.6.LATERAL RESEARCH
Vetiveria zizanioides:
 Anti tuberculosis activity:
Vetiveria zizanioides (Family: poaceae) root extracts and fractions were
evaluated for antimycobacterial activity against Mycobacterium tuberculosis H37Rv
and H37Ra strains using radiometric BACTEC 460 TB system.
The ethanolic extrat of intact as well as spent root were showed potent
antituberculosis activity at a minium concentration of 500μg/mL. The hexane fraction
also showed antibacterial action by recording continuous decline in growth index (GI)
of M.tuberculosis at 50μg/mL[60].
Plectranthus vettiveroides:
 In vitro Anti cancer and Anti oxidant activity:
The efficacy of Plectranthus vetiveroides against various cancer cell lines
showed that the incubation of cancer cells reduced the viability of all cancer cell lines
and dead cells were significantly increased with high extract concentration. Hence
hydro alcoholic extract of Plectrathus vettiveroides exhibited high cytotoxicity. Also
the extract showed potent antioxidant activity against all the three tested methods.
REVIEW OF LITERATURE
HEPATOPROTECTIVE ACTIVITY OFMAAVILINGAPATTAI CHOORANAM 83
Even at very low concentration Plectranthus vettiveroides showed high efficacy. In
conclusion Plectranthus vettiveroides posses significant anti oxidant and anticancer
activity[61].
Gymnema sylvestre:
 Antidiabetic and Hypolipiemic activity:
The aqueous leaf extract of gymnema sylvestre at the dose of 400, 600 and
800mg kg-1 body weight was administered orally once a day to the groups for 30days.
Teh fasting blood glucose, cholesterol, HDL-cholesterol and serum triglyceride
content were estimated in both normal and alloxan induced diabetic rats. All the
content were found to be significantly reduced (P<0.05) (except HDL) in treated rats
whereas the extract also showed the potent elevation in the level of serum HDL-
cholesterol. The study reveals that Gymnema sylvestre has significant antidiabetic
activity and a hypolipidemic activity in alloxan induced and normal fasting rats[62].
Acalypha indica:
 Anelgesic activity and Anti inflammatory activity:
The methanolic extract of Acalypha indica showed statistically significant
(p,0.001) analgesic activity in mice in a dose dependent manner. A sustained and
significant (p,0.001) inhibition of carrageenan induced inflammation of rat paw was
observed with 125mg/kg and 250mg/kg body weight.
The methanolic extract of A.indica also demonstrated anti inflammatory effect
in a dose dependent manner. Maximum inhibition by the extract was observed at
250mg/kg body weight after three hours of injestion, which was comparable to that
of the standard drug phenylbutazone at a dose of 100mg/kg body weight[63].
Tephrosia purpurea:
 Anti ulcer activity:
Antiulcer activity of aqueous extract of Tephrosia purpurea(AETP) was
studied in rats in which gastric ulcers were induced by oral administration of ethanol
or 0.6M HCL or by pyloric ligation or indomethacin and duodenal ulcers were
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induced by oral administration of cysteamine HCL. AETP administered in the dose of
1 to 20mg/kg orally 30min peror of to ulcer induction. The result suggest that AETP
possesses significant antiulcer property which could be either due to cytoprotecting
action of the drug or by strenthening of gastric and duodenal mucosa and thus
enhancing mucosal defence[64].
Aegle marmelos:
 Antidiarrhoeal activity:
The decoction of the unripe fruit of Aegle marmelos showed cidal activity
against Giardia and rotavirus whereas viability of none of the six bacterial strains
tested was affected. It significally reduced bacterial adherence to and invasion of
HEp-2 cells. The extract affected production of cholera toxin and binding of both
E.coli heat labile toxin cholera toxin and their binding to gangliosside monosialic
receptor. The decoction of the unripe fruit of Aegle marmelos has limited
antimicrobial activity, affected th bacterial colonisation to gut epithelium and
production of certain enterotoxins. These obsevation suggest the mode of action of
A.marmelos in infectious of diarrhoea[65].
Stereospermum colais:
 Anticancer activity:
The anticancer activity was evaluated using standard methods like MTT and
No assay methods. S. colais ethyl acetate and methanol extracts and B. acutangula
ethyl acetate extract showed free radical scavenging and anti-cancer effect 54 against
Colon cancer cell lines Colo320. Also plant extracts cause apoptosis analyzed by
DNA fragmentation assay. Plant extracts when treated with cells causes apoptosis
when assayed with CASPASE.
 In-vitro antioxidant activity:
Methanol extracts of Stereospermum colais showed concentration dependent
antibacterial activity ranging from 62.5 µg /ml to 2000 µg /ml when compared with
standard curcumin in different in vitro models[66].
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Ocimum sanctum:
 Antibacterial activity:
Ocimum sanctum fixed oil showed good antibacterial activity against
Staphylococcus aureus, Bacillus pumilus and psedomonas aereginosa. Antibacterial
activity was evaluated by paper disc deffusion method[67].
Mukia maderaspatana:
 Antidiabetic activity:
Methanol extract of the dried whole plant (0.25 and 0.5mg/ml) were studies
for teh inhibition of gluconeogenesis in rat liver slices. Mukia inhibited
gluconeogenesis by 45% and with with insulin inhibition increased by 50%[68].
Rivea ornata:
 anti inflammatory activity:
The anti inflammatory activity of the methanolic extract of R.ornata at the
doseof 400mg/kg has a significant reduction in the Carageenan induced paw oedema
in rats. So 400mg/kg dose of methanolic extract exhibiting anti inflammatory effect
against acute inflammation[69].
Limonia acidissima:
 Wound healing and anti oxidant activity:
In incision wound healing model, the methanolic extract of L.acidissima has
significant wound healing activity and antioxidant activity in animals treated with
400mg/kg of the extract[70].
Hemidesmus indicus:
 in vitro antioxidant and antithrombotic activity:
The methanolic extract of H.indicus roots was found to inhibit lipid
peroxidation and and scavenge hydroxyl and superoxide radicals in vitro. The amount
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rquired for 50% inhibition of lipid peroxide formation was 217.5μg/ml. The extract
also inhibited ADP-induced platelet aggregation in vitro[71].
Sida rhombifolia:
 Anti inflammatory, anticholinergic and cytotoxic activity:
The ethyl acetate of plant extract exhibited the most significant antioxidant
activities by scavening DPPH radicals and ferrous ions with EC50 of 380.5 and
263.4μg/mL, respectively. In contrast the n-hexane extract showed the strongest anti
inflammatory activity with IC50 of 52.16 and 146.03μg/mL for no and protein
denaturation inhibition assays. The same extract also revealed the strongest effects in
anti cholesterase and cytotoxic tests at the concentration of 100μg/mL. AChE enzyme
inhibition was 58.55% and human cancer cells. SNU-1 and Hep G2 inhibition was
68.52% and 47.82% respectively[72].
Withania somnifera:
 Immunomodulatory activity:
Administration of an extract from the powdered root of the plant W.somnifera
was found to stimulate immunological activity in Bab1/c mice. The extract along with
the antigen produced an enhancement in the circulatory antibody titre and the number
of plaque forming cells(PFC) in the spleen. It also showed the enhancement in
phagocytic activity of peritonial macrophages (76.5pigmented cells/200) when
compared to control(31.5/200 cells) in mice[73].
Smilax china:
 Anti inflammatory activity and anti nociceptive activity:
The aqueous exract of the tuber Smilax china tested for its anti inflammatory
activity in rats by egg-albumin induced oedema and nociceptive effects in mice using
hot plate test and acetic acid induced abdominal consrticton test, at the dose of
1000mg/kg had a significant anti inflammatory and nociceptive effect compared to
physilogical saline[74].
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Crataeva magna:
 Antiurolithiatic avtivity:
The ethanol extract(400mg/kg) had significant urolithiasis activity in
lactose(30%)+ethylene glycol(1%) and ammonium chloride(2%)+ethylene
glycol(0.75%) methods induced urolithiasis in rats respectively. Both models resulted
in serum creatinine and calcium, urine oxalate and kidney weight significantly
increased in final body weight and urine volume output when compared to toxic
group[75].
3.7.PHARMACEUTICAL REVIEW
CHOORANAM:
Definition:
Chooranam is a fine powder of drugs. The “Chooranam” may be applied to the
powders of a single drug or a mixture of two or more drugs, which are powdered
separately prior to their being mixed to homogeneity.
Method of preparation:
Equipment required:
1. The drug enumerated in the recipe in clean and well dried state.
2. A mortar and pestle.
3. A fine sieve or fine cloth of close mesh.
Process of preparation:
The drugs which are to be used in the preparations should be taken from
recently collected material. Drugs which are aged by prolonged storage or changed in
colour, taste and scent and those that are insects infected or attacked by fungi should
be positively rejected.
However, drugs like Emboli fruits, Senna, Long pepper, Jaggery and cow’s
ghee are preferred from fairly aged stock, provided they are not infested with pests,
deteriorated or spoiled or developed rancidity.
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In general, the aromatic drugs are slightly fried in order to enhance their aroma
and milling properties. Any extraneous material, organic or inorganic, should be
removed from the drugs by close inspection.
The Chooranam should be as fine as to be called amorphous and should be
never damp. The fineness of the sieve should be 100 mesh or still finer.
Purification of the prepared Chooranam:
    t̀̀   Y  㐠̀ ⸳  㐠    
            yȀ     Y   
   t̀̀     ̀  Ȁ i   ை 곀 
 Ȁ  t  凘~  Ȁ   ைȀ  凘 
   t̀̀ ⸳   Ȁ     㐠  凘 
       i RைȀ       凘 
   t̀̀   Y ை     凘    y ை  
  ̀      곀     ޏ  㐠  㐠~   ”
-    㐠~凘 ை   㐠~     㐠tޏ⸳G    
The prepared Chooranam is mixed with the milk,in a pot with half a quantity
of milk and half a quantity of water is taken. The mouth of the pot is covered with a
thin cloth material. Above this cloth the mixed Chooranam is placed. The pot is
placed over the stove and heated.
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Then the Chooranam is placed in the sunlight and powdered. Equal amount of
sugar is added and taken internally to cure all diseases. If the drug is taken without
purification the disease does not cure. If taken after purification the disease cures
easily.
Storage:
The prepared Chooranam should be allowed to cool by spreading and mixing,
prior to packing. They should be stored in tightly stopper glass, polythene or tin
containers, or in polythene or cellophane bags and sealed. These bags should in turn
be enclosed in cardboard boxes.
The Chooranam to facilitate easy handling and to assure exact dosage
administration, could be pressed into tablets, could be packed in bottles or tubes made
either of glass or plastic or packed in strip of metal foil or plastic sheets.
In industry the tablets are made, counted & packed by electronic devices.
Then Chooranam is said to retain its potency for three months and then
gradually deteriorate. However if properly packed & stored they keep good for a
year[77].
According to AYUSH guidelines shelf life of Chooranam is one year[78].
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Table: 2. ANALYTICAL SPECIFICATIONS OF CHURNA/CHOORANAM
Sl. No TESTS
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13
Description
Macroscopic, Microscopic
Loss on drying at 1050 C
Total – ash
Acid – insoluble ash
Water-soluble extractive
Alcohol – soluble extractive
Particle size (80-100 mesh for Churna; 40-60
mesh for churna)
Identifications, TLC/HPTLC-with marker (wherever
possible)
Test for heavy/Toxic metals
Lead
Cadmium
Mercury
Arsenic
Microbial contamination
Total bacterial count
Total fungal count
Test for specific Pathogen
E. coli
Salmonella spp.
S.aureus
Pseudomonas aeruginosa
Pesticide residue
Organochlorine pesticides
Organophosphorus pesticides
Pyrethroids
Test for Aflatoxins (B1,B2,G1,G2)
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4. MATERIALS AND METHODS
DRUG SELECTION:
For this present study, the Herbal formulation “Maavilingapattai
Chooranam” was taken as the compound drug preparation for Hepatoprotective
activity mentioned in the classical Siddha literature “Sirorathina Vaidhiya
Booshanam” written by Angamuthu Mudhaliyar, published by Thamarai Noolagam,
Chennai-26, pg.no:148-149.
Table 3: Ingredients ofMaavilingapattai Chooranam:
INGREDIENTS:
S.no NAME OF DRUGS BOTANICAL NAME QUANTITY
1. Iruveli Vetiveria zizanioides 35gms (1 palam)
2. Vilamichu Plectranthus vettiveroides 35gms (1 palam)
3. Chiru kurinchan Gymnema sylvestre 35gms (1 palam)
4. Poonai vanangi Acalypha indica 35gms (1 palam)
5. Kozhunji Tephrosia purpurea 35 gms (1 palam)
6. Koovilam Aegle marmelos 35gms (1 palam)
7. Pathiri Stereospermum colais 35gms (1 palam)
8. Thulasi Ocimum sanctum 35gms (1 palam)
9. Musumusukkai Mukia maderaspatana 35gms (1 palam)
10. Musuttai Rivea ornata 35gms (1 palam)
11. Vila Limonia acidissima 35gms (1 palam)
12. Nannari Hemidesmus indicus 35gms (1 palam)
13. Kurundhotti Sida rhombifolia 35gms (1 palam)
14. Ashwagandhi Withania somnifera 35gms (1 palam)
15. Parangichakkai Smilax china 70gms (2 palam)
16. Maavilingapattai Crataeva magna 280gms (8 palam)
17. Seenisarkarai Saccharum officinarum -
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Collection of the Plant materials:
All the raw materials were bought from the Ramasamy Mudhaliyar Store,
Parry’s corner, Chennai.
Identification and Authentication of the drug:
The raw materials were identified and authenticated by the experts of
Gunapadam, Government Siddha Medical College, Arumbakkam, Chennai- 106. The
specimen sample of each raw material has been kept in the PG Gunapadam
department individually for future reference.
Purification of the drugs:
Purification process was done as per classical Siddha literature[79].
Table 4: Purification of drugs:
S.no Raw Drug Method of Purification
1. Iruveli The root was cleaned with a white cloth. Finally washed and dried.
2. Vilamichu The root was cleaned with a white cloth. Finally washed and dried.
3. Chiru kurinchan The root was cleaned with a white cloth. Finally washed and dried.
4. Poonai vanangi The root was cleaned with a white cloth. Finally washed and dried.
5. Kozhunji The root was cleaned with a white cloth. Finally washed and dried.
6. Koovilam The root was cleaned with a white cloth. Finally washed and dried.
7. Pathiri The root was cleaned with a white cloth. Finally washed and dried.
8. Thulasi The root was cleaned with a white cloth. Finally washed and dried.
9. Musumusukkai The root was cleaned with a white cloth. Finally washed and dried.
10. Musuttai The root was cleaned with a white cloth. Finally washed and dried.
11. Vila The root was cleaned with a white cloth. Finally washed and dried.
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S.no Raw Drug Method of Purification
12. Nannari The root was cleaned with a white cloth. Finally washed and dried.
13. Kurundhotti The root was cleaned with a white cloth. Finally washed and dried.
14. Ashwagandhi Dried and powdered then it is steamed in milk.
15. Parangichakkai Dried and powdered then it is steamed in milk.
16. Maavilingapattai Outer skin of bark was peeled off.
4.1. PREPARATION OF THE DRUG:
 Procedure:
35grams of purified Iruveli, 35grams of purified Vilamichu, 35grams of
purified Chirukurinchan, 35grams of Poonaivanangi, 35grams of Kozhunji, 35grams
of Koovilam, 35grams of Pathiri, 35grams of Thulasi, 35grams of Musumusukkai,
35grams of Musutai, 35grams of Vila, 35grams of Nannari, 35grams of Kurundhotti,
35grams of Ashwagandhi, 70grams of Parangichakkai, 280grams of Maavilingapattai
were taken and powered separately. Then all the powder were mixed together.
Finally, the mixture was ground well which favours the homogenous
preparation .Then the mixture of the powder was sieved through the thin clean white
cloth. After that one third of the chooranam weight of sugar was added to the
mixture and again it was ground well.
Finally, the end product was obtained, which was kept in an air tight container
and labeled as “Maavilinga Pattai Chooranam” (MPC).
 Purification of the Chooranam- Steaming process (Pittaviyal murai):
The “Maavilinga Pattai Chooranam” was purified by pittaviyal method
(steam cooking in milk) as per Siddha classical literature. A mud pot was taken and it
was half filled by milk and mixed with equal quantity of pure water. The mouth of the
pot was sealed by a cloth. This chooranam was placed over a clean dry cloth and tied
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firmly around the mouth of mud pot. The gap between mud pots was tied with a wet
cloth to avoid evaporation. The mud pot was kept on fire and boiled until the cow’s
milk reduced in the lower pot.
The same drug was later dried and powdered then sieved again. It was used for
the further study[80].
 Storage of the drug:
The prepared test drug was stored in a clean, air tight glass container.
 Administration of the drug:
 Form of the medicine : Chooranam
 Route of Administration : Interal
 Dose : 2 gm twice a day depending on the severity
 Duration : 12- 24 Days.
 Indication:
Kamalai, Pun, Purai, Megavettai, Megapadai, Themal.
Fig 2: INGREDIENTS OFMAAVILINGAPATTAI CHOORANAM:
2.1.Vetiveria zizanioides 2.2Plectranthus vettiveroides
2.3.Gymnema sylvestre 2.4.Acalypha indica
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2.5.Tephrosia purpurea 2.6.Aegle marmelos
2.7.Stereospermum colais 2.8.Ocimum sanctum
2.9.Mukia maderaspatana 2.10.Rivea ornata
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2.11.Limonia acidissima 2.12.Hemidesmus indicus
2.13.Sida rhombifolia 2.14.Withania somnifera
2.15.Smilax china 2.16.Crataeva magna
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2.17.Saccharum officinarum
2.18.Final Product (Maavilingapattai Chooranam)
4.2. STANDARDIZATION OF THE DRUG:
Standardization of the drug brings the validation to be used as a medicine by
subjecting the drug to many analysis and determining its quality and effectiveness.
Standardization includes many studies such as its organoleptic properties, physical
characteristics and phytochemical properties and also to assess the active principles
and elements present in the drug.
Method of standardization:
Techniques Involved In Standardization of Compound Drugs:
 Macroscopic Methods
 Microscopic Methods
 Physical Methods
 Chemical Methods
 Biological Methods
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4.2.1. ORGANOLEPTIC CHARACTER:[81]
The organoleptic characters of the sample were evaluated which include evaluation of
the formulation by its colour, odor, taste, texture etc.
Colour:
A sample of Chooranam were taken in watch glasses and placed against white back
ground in white tube light. The Chooranam were observed for its color by naked eye.
Odour:
Chooranam were smelled, the time intermission between two smelling was kept 2
minutes to nullify the effect of previous smelling.
Taste:
A sample of about Chooranam was tasted and the taste was reported.
Size:
The chooranam was completely sieved through mesh size 88.
4.2.2 PHYSICOCHEMICAL ANALYSIS:[82]
Physicochemical studies of the trial drug have been done according to WHO
guidelines. Physico‐chemical studies like total ash, water soluble ash, acid Insoluble
ash, water and alcohol soluble extract, loss on drying at 105°C and pH were done at,
Dr. MGR University, Chennai.
1. Solubility Test:
A pinch of sample (MPC) was taken in a dry test tube and to it 2 ml of the
solvent was added and shaken well for about a minute and the results are observed.
The test was done for solvents like distilled water, Ethanol, Petroleum ether,
Propylene glycol, Toluene, Benzene, Chloroform, Ethyl alcohol, Xylene, Carbon tetra
chloride and the results are observed individually.
2. pH value:
Potentiometrically, pH value is determined by a glass electrode and a suitable
pH meter. The pH of the Maavilingapattai Chooranam was written in results column.
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3. Loss on Drying:
An accurately weighed 2gm of Maavilingapattai Chooranam formulation was
taken in a tarred glass bottle. The crude drug was heated 1050 c for 6 hours in an oven
till a constant weight. The percentage moisture content of the sample was calculated
with reference to the shade dried material.
4. Determination of total Ash:
Weighed accurately 2g of Maavilingapattai Chooranam formulation was
added in crucible at a temperature 6000c in a muffle furnace till carbon free ash was
obtained. It was calculated with reference to the air dried drug.
5. Determination of acid insoluble ash:
Ash above obtained was boiled 5min with 25ml of 1M hydrochloric acid and
filtered using an ash less filter paper. Insoluble matter retained on filter paper was
washed with hot water and filter paper was burnt to a constant weight in a muffle
furnace. The percentage of acid insoluble ash was calculated with reference to the air
dried drug.
6. Determination of water soluble ash:
Toal Ash 1g was boiled for 5min with 25ml water and insoluble matter
collected on an ash less filter paper was washed with water and ignited for 15 min at a
temperature not exceeding 4500c in a muffle furnace. The amount of soluble ash is
determined by drying the filtrate.
7. Determination of water soluble extractive:
5gm of air dried drug. Coarsely powered Maavilingapattai Chooranam was
macerated with 100ml of distilled water in a closed flask for twenty-four hours,
shaking frequently. The solution was filtered and 25 ml of filtered was evaporated in a
tarred flat bottom shallow dish, further dried at 10000c and weighted. The percentage
of water soluble extractive was calculated with reference to the air dried drugs.
8. Determination of alcohol soluble extractive:
2.5gm of air dried drugs coarsely powdered Maavilingapattai Chooranam
was macerated with 50ml. alcohol in closed flask for 24 hours. With frequent
shaking.it was filtered rapidly talking precaution against loss of alcohol. 10ml of
MATERIALS AND METHODS
HEPATOPROTECTIVE ACTIVITY OFMAAVILINGAPATTAI CHOORANAM 100
filtrate was the evaporated in a tarred flat bottom shallow dish, dried at 10000c and
weighed. The percentage of alchol soluble extractive was calculated with reference to
air dried drug.
4.2.3.PHYTOCHEMICAL ANALYSIS:
The Phytochemical screening of the extract gives general idea regarding the
nature of chemical constituents present in the crude drug. The phytochemical tests
were done as the method illustrated[83].
 Test for Alkaloids:
Extracts were dissolved in dilute hydrochloric acid and filtered.
1) Mayers’s test: Filtrates were treated with Mayer’s reagent (Potassium, Mercuric
iodide). Formation of a yellow coloured precipitate indicates the presence of
alkaloids.
2) Wagnor’s test: Filtrates were treated with Wagner’s reagent (Iodine in
potassium iodide). Formation of brown/ reddish precipitate indicates the
presence of the alkaloids.
3) Dragendroff’ test: Filtrates were treated with Dragendroff’s reagent (solution
of Potassium with Bismuth iodide). Formation of red precipitate indicates the
presence of alkaloids.
4) Hager’s test: Filtrates were treated with Hager’s reagent (saturated picric acid
solution) presence of alkaloids conformed by the formation of yellow precipitate.
 Test for Carbohydrates and Reducing Sugars:
Extracts were dissolved individually in 5ml distilled water and filtered. The
filtrates were used to test the presence of carbohydrates.
1) Molisch’s test: To 2ml of a plant sample extract, two drops of of alcoholic
solution of alpha naphthol are added. The mixture is shaken well few drops of
concentrated sulphuric acid slowly along the sides of the test tube. A violet ring
indicates the presence of carbohydrates.
2) Benedict’s test: Filtrates were treated with Benedict’s reagent and heated gently
orange red precipitate indicates the presence of reducing agents.
 Test for Glycosides:
Extracts were hydrolysed with dilute HCl and then subjected to the test of glycosides.
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1) Modified borntrager’ s test: Extracts were treated with ferric chloride solution
and immersed in boiling water for about 5 minutes. The mixture was cooled and
extracted with equal volumes of benzene. The benzene layer was separated and
treated with ammonia solution. Formation of rose pink colour in ammonical
layer indicates the presence of anthranol glycosides.
2) Cardiac glycoside (keller-killiani test ): Extracts was shaken with distilled
water (5ml). to this, glacial acetic acid (2ml) containing few drops of ferric
chloride was added followed by sulphuric acid (1ml) along the side of the test
tube. The formation of the brown ring at the interface gives positive indication
for cardiac glycoside and a violet ring may appear below the brown ring.
 Test for Saponins:
1) Froth test: Extracts were diluted with distilled water to 20ml and this was
shaken graduated cylinder for 15 minutes. Formation of 1cm layer of foam
indicates the presence of saponins.
2) Foam test: 0.5gm of extract was shaken with 2ml of water if foam produced
persists for ten minutes. It indicates the presences of saponins.
 Detection of phytosterols:
1) Salkowski’s test: Extracts were treated with chloroform and filtered. The
filtrates were treated with few drops of conc.sulphuric acid shaken and allowed
to stand. Appearance of golden yellow colour indicates the presence of
triterpenes.
 Detection of phenol ferric chloride test:
Extracts were treated with 3- 4 drops of ferric chloride solution. Formation of
bluish black colour indicates the presence of the phenols.
 Detection of tannins Gelatin test:
The extract is dissolved in 5ml distilled water and 2ml of 1% solution of
Gelatin containing 10% NaCl is added to it. White precipitate indicates the presence
of phenolic compounds.
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 Detection of flavonoids:
1) Alkaline Reagent Test: Extracts were treated with few drops of sodium
hydroxide solution. Formation of intense yellow colour, which becomes
colourless on addition of dilute acid, indicates the presence of flavonoids.
2) Lead acetate Test: Extracts were treated with few drops of lead acetate solution.
Formation of yellow colour precipitate indicates the presence of flavonoids.
 Detection of Proteins and Amino acids:
1) Xanthoproteic Test: The extracts were treated with few drops of concentrated
Nitric acid. Formation of yellow colour indicates the presence of proteins.
2) Ninhydrin Test: To the extract ,0.25% w/v Ninhydrin reagent was added and
boiled for few minutes. Formation of blue colour indicates the presence of
amino acid.
 Detection of Diterpenes:
1) Copper acetate test:Extracts were dissolved in water and treated with 3-4 drops
of copper acetate solution. Formation of emerald green colour indicates the
presence of diterpenes.
 Gum and Mucilage:
To 1ml of extract add 2.5 ml of absolute alcohol and stirring constantly. Then
the precipitate was dried in air and examine for its swelling properties. Swelling
was observed that will indicate presence of gum and mucilage.
 Test for Fixed oils and Fats:
1) Spot Test: A small quantity of extract is pressed between two filter papers. Oil
stain on the paper indicates the presence of fixed oils.
 Test for Quinones:
Extract was treated with sodium hydroxide blue or red precipitate indicates
the presence of Quinones.
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HPLC - High Performance Liquid Chromatography (HPLC)[84]:
HPLC is a technique in analytical chemistry which is used to separate the
components in a mixture, to identify each component, and to quantify each
component. It relies on pumps to pass a pressurized liquid solvent containing the
sample mixture through a column filled with a solid adsorbent material. Each
component in the sample interacts slightly differently with the adsorbent material,
causing different flow rates for the different components and leading to the separation
of the components as they flow out of the column. In this study, the detection and
quantitation were carried out using 515 HPLC pumps and 2489 UV/Visible detectors
of Waters Company while the software used was Empower.
Two methods using different mobile phases were used for chromatographic
separation of the research drugs – Method I (binary gradient method of Acetonitrile &
0.1% Phosphoric acid in Water) and Method II (binary gradient method of Methanol
& 1:25 Acetic acid in Water). Results obtained during Method I have been discussed
since better separation of compounds was observed during this analysis. The
chromatographic conditions for Method I are as given below:
 Column : Symmetry C18, 5 µm, 4.6x250 mm
 Run Time : 30 minutes
 Injection Volume : 20 µl
 Wavelength (Dual) : 272 nm & 360 nm
 Solvent A : Acetonitrile
 Solvent B : 0.1% Phosphoric acid in water
 Flow rate : 1.0 ml/min.
 Pump Mode : Gradient
4.2.4.BIO-CHEMICAL ANALYSIS[85]:
The bio-chemical analysis was done to identify the acid and basic radicals present in
the sample.
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Preparation of extract:
5g of MPC was taken in a 250 ml clean beaker and 50 ml of distilled water
was added, boiled well and allowed to cool and filtered in a 100 ml volumetric flask
and made up to 100 ml with distilled water.
Preliminary Basic and Acidic radical studies:
Test for basic radicals:
1. Test for Potassium:
To a pinch of the MPC 2 ml of sodium nitrate and 2 ml of cobalt nitrate solution in
30% glacial acetic acid was added and observed for the presence of yellow precipitate.
2. Test for Calcium:
To 2 ml of the MPC extract 2 ml of 4% ammonium oxide solution was added and
observed for the formation of white precipitate.
3. Test for Magnesium:
To 2ml of MPC extract, drops of sodium hydroxide solution was added and watched
for the appearance of white precipitate.
4. Test for Ammonium:
To 2ml of MPC extract few ml of Nessler's reagent and excess of sodium hydroxide
solution are added for the appearance of brown color.
5. Test for Sodium:
Hydrochloric acid was added with a pinch of the MPC sample and a paste was made
and introduced into the blue flame of Bunsen burner and observed for the appearance
of intense yellow color.
6. Test for Iron (Ferrous):
The MPC extract was treated with Conc. HNO3 and ammonium thiocyanate and
waited for the appearance of blood red color.
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7. Test for Zinc:
To 2 ml of the MPC extract drops of sodium hydroxide solution was added and
observed for white precipitate formation.
8. Test for Aluminium:
To the 2m1 of the MPC extract sodium hydroxide was added in drops and noted for
any characteristic changes.
9. Test for Lead:
To 2 ml of MPC extract 2ml of potassium iodide solution was added and noted for
yellow colored precipitate.
10. Test for Copper:
a. A pinch of MPC sample was made into a paste with concentrated Hcl in a watch
glass and introduced into the non-luminous part of the flame and noted for blue color
appearance.
b. To 2 ml of MPC extract excess of ammonia solution was added and observed for
the appearance of blue coloured precipitate.
11. Test for Mercury:
To 2m1 of the MPC extract sodium hydroxide solution was added and noted for
yellow precipitate formation.
12. Test for Arsenic:
To 2 ml of the MPC extract 2ml of Sodium hydroxide solution was added and brown
wash red precipitate if appeared was noted.
Test for acid radicals:
1. Test for Sulphate:
To 2 ml of the MPC extract 5% of barium chloride solution was added and observed
for the appearance of white precipitate.
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2. Test for Chloride:
The MPC extract was treated with silver nitrate solution and observed for the
appearance of white precipitate.
3. Test for Phosphate:
The MPC extract was treated with ammonium molybdate and concentrated HNO3
and observed for the appearance of yellow precipitate.
4. Test for Carbonate:
The MPC extract was treated with concentrated HCL and observed for the appearance
of effervescence.
5. Test for Fluoride & Oxalate:
To 2ml of MPC extract 2ml of dil. acetic acid and 2ml calcium chloride solution were
added and heated and watched for cloudy appearance.
6. Test for Nitrate:
To 1 gm of the MPC, copper turnings was added and again concentrated H2SO4 was
added, heated and the test tube was tilted vertically down and viewed for any
characteristic changes.
4.2.5.AVAILABILITY OFMICROBIAL LOAD:
Enumeration of bacteria by plate count – Agar plating technique[86]:
The plate count technique was one of the most routinely used procedure
because of the enumeration of viable cells by this method.
Principle:
This method is based on the principle that when material containing bacteria
are cultured, every viable bacterium develops into a visible colony on a nutrient agar
medium. The number of colonies, therefore are the same as the number of organisms
contained in the sample.
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Dilution:
A small measured volume is mixed with a large volume of sterile water or
saline called the diluent or dilution blank. Dilution is usually made in multiples of ten.
A single dilution was calculated as follows:
Volume of the sample
Dilution =
Total volume of the sample and the diluent
Requirements:
 Sample or Bacterial suspension
 9 ml dilution blanks (7)
 Sterile petri dishes (12)
 Sterile 1 ml pipettes(7)
 Nutrient agar medium (200 ml)
 Colony counter
Procedure:
1. Label the dilution blanks as 10-1, 10-2, 10-3, 10-4, 10-5, 10-6, 10-7.
2. Prepare the initial dilution by adding 1 ml of the MPC into a 9 ml dilution
blank labeled 10-1 thus diluting the original sample 10 times.
3. Mix the contents by rolling the tube back and forth between hands to
obtain uniform distribution of organisms.
4. From the first dilution transfer 1 ml of the suspension while in motion, to
the dilution blank 10-2 with a sterile and fresh 1 ml pipette diluting the
original specimen to 100 times.
5. From the 10-2 suspension, transfer 1 ml of suspension to 10-3 dilution blank
with a fresh sterile pipette, thus diluting the original sample to 1000 times.
6. Repeat this procedure till the original sample has been diluted 10,000,000
times using every time a fresh sterile pipette.
7. From the appropriate dilutions transfer 1ml of suspension while in motion,
with the respective pipettes, to sterile petri dishes. Three petri dishes are
used for each dilution.
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8. Add approximately 15 ml of the nutrient medium, melted and cooled to
450c, to each petri dish containing the diluted sample. Mix the contents of
each dish by rotating gently to distribute the cells throughout the medium.
9. Allow the plates to solidity.
10. Incubate these plates in an inverted position for 24-48 hours at 370c.
Observation:
Observe all the plates for the appearance of bacterial colonies. Count the
number of colonies in the plates.
Calculate the number of bacteria per ml of the original suspension as follows:
Number of colonies (average of 3 replates)
Organisms per millimeter =
Amount of plated × dilution
4.2.6.SOPHISTICATED INSTRUMENTAL ANALYSIS:
 FTIR - Fourier Transform Infra-red Spectroscopy[87]:
FTIR (Fourier Transform Infra-red Spectroscopy) is a sensitive technique
particularly for identifying organic chemicals in a whole range of applications
although it can also characterise some inorganics. Examples include paints,
adhesives, resins, polymers, coatings and drugs. FTIR is an effective analytical
instrument for detecting functional groups.
APPLICATIONS:
 Quatitative scans and Qualitative scan
 Solids, liquids, gases
 Organic samples, inorganic samples
 Unknown identification and Impurities
 Screening formulation
 Pharmaceuticals.
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Fig no.3.1: FTIR INSTRUMENT
Fig no.3.2: FTIR MECHANISM
Principle:
Spectrophotometric tests are commonly used in the Identification of chemical
substances and quantification of polymorphic forms. The test procedures are
applicable to substances that absorb IR radiation. The IR absorption spectrum of a
substance compared with that obtained concomitantly for the corresponding reference
standard / reference substance provide conclusive evidence of the identity of the
substance being tested.
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Recording Infrared spectrum of a solid as a disc (as per USP ‹197K›) :
 Triturate about 1 to 2 mg of the substance to be examined with 300 to 400 mg,
unless otherwise specified, of finely powdered and dried potassium bromide.
If the substance is a hydrochloride it is preferable to use potassium chloride.
 Carefully grind the mixture and spread it uniformly in a suitable die.
 Submit it to the pressure of about 800 mPa (8 tons/cm2 ).
 Examine the disc visually and if any lack of uniform transparency is observed,
reject the disc and prepare again.
 Record the spectrum between 4000 to 650 cm-1 unless otherwise specified in
individual standard test procedure.
 When sample and standard are measured for concordance, the transmittance
obtained at the start of the scan range, should not deviate by more than 10%
between them ( For eg. If the standard shows a transmittance of 75%, the
sample transmittance can be between 65% and 85%).
FT-IR was the most advanced and the major advantage was its
 Speed
 Sensitivity
 Mechanical Simplicity
 Internally Calibrated
 ICP-MS - Inductively Coupled Plasma Mass Spectrometry[88]:
Analysis of Trace Metal and Inorganic materials.
Inductively Coupled Plasma Mass Spectrometry is a technique routinely used
to analyse trace levels of a wide range of inorganic elements. The ICP-MS allows for
the detection and quantification of elements with atomic mass ranges 7 to 250. This
covers Lithium to Uranium. The typical detection limits are in the parts per billion
(ppb) range and even parts per trillion (ppt) in some cases. The ICP-MS analysis
methods available at LPD Lab Services allow the detection, identification and
quantification of a wide array of elements using a Perkin Elmer ELAN 6000 ICP-MS.
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Fig no:4.1.: ICPMS- INSTRUMENT
Fig no:4.2. ICP MS MECHANISM
Analysis: Analyze according to the manufacturer suggestions for program and m/z.
Calculate and report results based on the original sample size.
Applications of ICP-MS:
 Monitoring of trace metals in drinking water, ground water, rainwater,
wastewater or industrial effluent streams.
 Trace elements in product / raw materials or from washed or rinsed surfaces.
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 Analysis of additives and purity in metal alloys.
 Analysis of low level contaminants in chemical products, beverages, foods,
cosmetics, pharmaceuticals.
 Analysis of soluble / leachable material from solid samples such as medical
devices, polymers, PCB`s.
 Analysis can be performed on a diverse range of sample.
 SEM - Scanning Electron Microscope[89]:
DEFINITION:
Scanning Electron Microscopy (SEM), also known as SEM analysis or SEM
microscopy, is used very effectively in microanalysis and failure analysis of solid
inorganic materials. Scanning electron microscopy is performed at high
magnifications, generates high-resolution images and precisely measures very small
features and objects.
SEM ANALYSIS APPLICATIONS:
The signals generated during SEM analysis produce a two-dimensional image and
reveal information about the sample including:
External morphology (texture)
 Chemical composition (when used with EDS) Orientation of materials making
up the sample
The EDS component of the system is applied in conjunction with SEM analysis to:
 Determine elements in or on the surface of the sample for qualitative
information
 Measure elemental composition for semi-quantitative results
 Identify foreign substances that are not organic in nature and coatings on metal
SEM Analysis with EDS – qualitative and semi-quantitative results
Magnification – from 5x to 300,000x
Sample Size – up to 200 mm (7.87 in.) in diameter and 80 mm (3.14 in.) in height
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Materials analysed – solid inorganic materials including metals and minerals.
Fig no:5.1: SEM INSTRUMENT
Fig no:5.2: SEMMECHANISM
THE SEM ANALYSIS PROCESS:
Scanning Electron Microscopy uses a focused beam of high-energy electrons
to generate a variety of signals at the surface of solid specimens. In most SEM
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microscopy applications, data is collected over a selected area of the surface of the
sample and a two-dimensional image is generated that displays spatial variations in
properties including chemical characterization, texture and orientation of materials.
The SEM is also capable of performing analyses of selected point locations on the
sample. This approach is especially useful in qualitatively or semi-quantitatively
determining chemical compositions, crystalline structure and crystal orientations.
The EDS detector separates the characteristic X-rays of different elements into
an energy spectrum and EDS system software is used to analyse the energy spectrum
in order to determine the abundance of specific elements. A typical EDS spectrum is
portrayed as a plot of X-ray counts vs. energy (in keV). Energy peaks correspond to
the various elements in the sample. Energy Dispersive X-ray Spectroscopy can be
used to find the chemical composition of materials down to a spot size of a few
microns and to create element composition maps over a much broader raster area.
Together, these capabilities provide fundamental compositional information for a
wide variety of materials, including polymers. In scanning electron microscope high-
energy electron beam was focused through a probe towards MPC. Variety of signals
was produced on interaction with the surface of the sample. This results in the
emission of electrons or photons and it was collected by an appropriate detector.
The types of signal produced by a scanning electron microscope include:
 Secondary electrons
 back scattered electrons
 characteristic x-rays light
 specimen current
 Transmitted electrons.
This gives the information about the sample and it includes external morphology,
texture, its crystalline structure, chemical composition and it displays the shape of the
sample.
 XRD - X-ray Powder Diffraction (XRD)[90]:
X-ray powder diffraction (XRD) is a rapid analytical technique primarily used
for phase identification of a crystalline material and can provide information on unit
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cell dimensions. The analyzed material is finely ground, homogenized, and average
bulk composition is determined.
DEFINITION:
X-ray powder diffraction is most widely used for the identification of unknown
crystalline materials (e.g. minerals, inorganic compounds). Determination of
unknown solids is important to studies in geology, environmental science,
material science and biology.
Fig no:6.1: XRD - X-ray Powder Diffraction
Fig no:6.2: XRD Mechanism
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APPLICATIONS:
 Characterization of crystalline materials[88].
 Identification of fine-grained minerals such as clays and mixed layer clays that
are difficult to determine optically
 Determination of unit cell dimensions.
 With specialized techniques, XRD can be used to:
 Determine crystal structures using Rietveld refinement
 Determine of modal amounts of minerals (quantitative analysis)
 Characterize thin films samples by:
 determining lattice mismatch between film and substrate and to inferring
stress and strain.
 determining dislocation density and quality of the film by rocking curve
measurements
 measuring super lattices in multilayered epitaxial structures
 determining the thickness, roughness and density of the film using glancing
incidence X-ray reflectivity measurements
 Make textural measurements, such as the orientation of grains, in a
polycrystalline sample.
Strengths and Limitations of X-ray Powder Diffraction:
Strengths:
 Powerful and rapid (< 20 min) technique for identification of an unknown
mineral
 In most cases, it provides an unambiguous mineral determination
 Minimal sample preparation is required
 XRD units are widely available
 Data interpretation is relatively straight forward.
Limitations:
 Homogeneous and single phase material is best for identification of unknown
 Must have access to a standard reference file of inorganic compounds
 Requires tenths of a gram of material which must be ground into a powder
 For mixed materials, detection limit is ~ 2% of sample
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 For unit cell determinations, indexing of patterns for non-isometric crystal
systems is complicated.
Sample Collection and Preparation:
Determination of an unknown requires: the material, an instrument for grinding, and a
sample holder.
 Obtain a few tenths of a gram (or more) of the material, as pure as possible
 Grind the sample to a fine powder, typically in a fluid to minimize inducing
extra strain (surface energy) that can offset peak positions, and to randomize
orientation. Powder less than ~10 µm(or 200-mesh) in size is preferred
 Place into a sample holder or onto the sample surface.
4.3.TOXICOLOGICAL STUDIES:
Introduction:
The acute toxic class method is a stepwise procedure with the use of 3 animals
of a single sex per step. Depending on the mortality and/or the moribund status of the
animals, on average 2-4 steps may be necessary to allow judgment on the acute
toxicity of the test substance. Morbid animals or animals obviously in pain or showing
signs of severe and enduring distress shall be humanely killed, and are considered in
the interpretation of the test results in the same way as animals that died on test.
The method allows for the determination of an LD50 value only when at least two
doses result in mortality higher than 0% and lower than 100%.
4.3.1.ACUTE ORAL TOXICITY – OECD GUIDELINES - 423:
 Acute toxicity study was carried out as per OECD guideline (Organization for
Economic Co - operation and Development, Guideline-423[91].
 The experimental protocol was approved by the institutional ethical committee
(IAEC) under CPCSEA (IAEC approved Number:
IAEC/XLVIII/20/CLBMCP/2016)
 These studies were conducted in C.L. Baid Metha College of Pharmacy,
Dhuraipakkam, Chennai.
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Introduction:
 The acute toxic class method was stepwise procedure with the use of 3
animals of a single sex per step.
 Depending on the mortality and/or the moribund status of the animals, on
average 2-4 steps may be necessary to allow judgement on the acute toxicity
of the test substance.
 This procedure is reproducible, uses very few animals and is able to rank
substances in a similar manner to the other acute toxicity testing methods.
 The acute toxic class method is based on biometric evaluations with fixed
doses, adequately separated to enable a substance to be ranked for
classification purposes and hazard assessment.
 In principle, the method is not intended to allow the calculation of a precise
LD50, but does allow for the determination of defined exposure ranges where
lethality is expected since death of a proportion of the animals is still the major
endpoint of this test.
 The method allows for the determination of an LD50 value only when at least
two doses result in mortality higher than 0% and lower than 100%.
 The use of a selection of pre-defined doses, regardless of test substance, with
classification explicitly tied to number of animals observed in different states
improves the opportunity for laboratory to laboratory reporting consistency
and repeatability.
Principle of the Test:
It is the principle of the test that based on a stepwise procedure with the use of
a minimum number of animals per step, sufficient information is obtained on the
acute toxicity of the test substance to enable its classification. The substance is
administered orally to a group of experimental animals at one of the defined doses.
The substance is tested using a stepwise procedure, each step using three animals of a
single sex. Absence or presence of compound-related mortality of the animals dosed
at one step will determine the next step, i.e.
− no further testing is needed
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− dosing of three additional animals, with the same dose
− dosing of three additional animals at the next higher or the next lower dose
level. The method will enable a judgment with respect to classifying the test substance
to one of a series of toxicity classes.
Methodology:
Selection of Animal Species:
The preferred rodent species is the wistar albino rat, although other rodent
species may be used. Healthy young adult animals are commonly used laboratory
strains should be employed. Females should be nulliparous and non-pregnant. Each
animal, at the commencement of its dosing, should be between 8 to 12 weeks old and
the weight (200-220gm) should fall in an interval within ± 20 % of the mean weight
of the animals.
Housing and Feeding Conditions
The temperature in the experimental animal room should be 22ºC + 3ºC.
Although the relative humidity should be at least 30% and preferably not exceed 70%
other than during room cleaning the aim should be 50-60%. Lighting should be
artificial, the sequence being 12 hours light, 12 hours dark. For feeding, conventional
laboratory diets may be used with an unlimited supply of drinking water. Animals
may be group-caged by dose, but the number of animals per cage must not interfere
with clear observations of each animal.
Test Animals and Test Conditions:
Sexually mature Female Wistar albino rats (200-220gm) were obtained from
TANUVAS, Madhavaram, Chennai. All the animals were kept under standard
environmental condition (22 ± 3°C). The animals had free access to water and
standard pellet diet (Sai meera foods, Bangalore).
MATERIALS AND METHODS
HEPATOPROTECTIVE ACTIVITY OFMAAVILINGAPATTAI CHOORANAM 120
Preparation of animals:
The animals are randomly selected, marked to permit individual identification,
and kept in their cages for at least 7 days prior to dosing to allow for acclimatization
to the laboratory conditions.
Preparation for Acute Toxicity Studies
Rats were deprived of food overnight (but not water 16-18 h) prior to administration
of the,Maavilingapattai Chooranam.
The principles of laboratory animal care were followed and the Institutional Animal
Ethical Committee approved the use of the animals and the study design
Test Substance :MAAVILINGAPATTAI CHOORANAM
Animal Source : TANUVAS,Madhavaram, Chennai.
Animals : Wister Albino Rats (Female-3+3)
Age : 8-12 weeks
Body Weight on Day 0 : 200-220gm.
Acclimatization : Seven days prior to dosing.
Veterinary examination : Prior and at the end of the acclimatization period.
Identification of animals : By cage number, animal number and individual
marking by using Picric acid.
Number of animals : 3 Female/group,
Route of administration : Oral
Diet : Pellet feed supplied by Sai meera foods Pvt Ltd,
Bangalore.
Water : Aqua guard portable water in polypropylene bottles.
Housing & Environment : The animals were housed in Polypropylene cages
provided with bedding of husk.
Housing temperature : between 22ºC + 3ºC.
Relative humidity : between 30% and 70%,
Air changes : 10 to 15 per hour and
Dark and light cycle : 12:12 hours.
Duration of the study : 14 Days
Administration of Doses:
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Maavilingapattai Chooranam was suspended in water and administered to the
groups of wister albino rats in a single oral dose by gavage using a feeding needle.
The control group received an equal volume of the vehicle. Animals were fasted 12
hours prior to dosing. Following the period of fasting, the animals were weighed and
then the test substance was administered. Three Female animals are used for each
group. The dose level of 5,50,300 and 2000 mg/kg body weight was administered
stepwise. After the substance has been administered, food was withheld for a further
3-4 hours. The principle of laboratory animal care was followed. Observations were
made and recorded systematically and continuously as per the guideline after
substance administration.
The visual observations included skin changes, mobility, aggressively,
sensitivity to sound and pain, as well as respiratory movements. Finally, the number
of survivors was noted after 24 hrs and these animals were then monitored for a
further 14 days and observations made daily. The toxicological effect was assessed on
the basis of mortality.
Limit test:
The limit test is primarily used in situations where the experimenter has
information indicating that the test material is likely to be nontoxic, i.e., having
toxicity only above regulatory limit doses. A limit test at one dose level of 2000
mg/kg body weight was carried out with three animals per step. The test
substance-related mortality was not produced in animals, so further testing at the
next lower level need not to be carried out.
Observations:
Animals are observed individually after dosing at least once during the first 30
minutes, periodically during the first 24 hours, with special attention given during the
first 4 hours, and daily thereafter, for a total of 14 days, except where they need to be
removed from the study and humanely killed for animal welfare reasons or are found
dead.
It should be determined by the toxic reactions, time of onset and length of
recovery period, and may thus be extended when considered necessary. The times at
which signs of toxicity appear and disappear are important, especially if there is a
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tendency for toxic signs to be delayed. All observations are systematically recorded
with individual records being maintained for each animal.
a. Mortality:
Animals will be observed intensively at 0.5, 2.0, 4.0, 6.0, 12.0, 24.0 and
48.0 hours following drug administration on day 1 of the experiment and daily
twice thereafter for 14 days.
b. Body weight
Individual weight of animals was determined before the test substance was
administered and weights will be recorded at day 1, 7, and 14 of the study. Weight
changes were calculated and recorded. At the end of the test, surviving animals were
weighed and humanly killed.
C. Cage-side observation
These include changes in skin and fur, eyes and mucous membranes, and also
respiratory, circulatory, autonomic and central nervous systems, and somatomotor
activity and behavior pattern. Attention was directed to observations of tremors,
convulsions, salivation, diarrhoea, lethargy, sleep and coma.
d. Gross necropsy:
All animals (including those which die during the test period are removed
from the study) will be subjected to gross necropsy. Gross necropsy includes
examination of the external surface of the body, all orifices, cranial, thoracic and
abdominal cavities and their contents, brain, eye, thymus, lungs, heart, spleen, liver,
kidneys, adrenals, testes and uterus of all animals.
Histopathology:
Microscopic examination will be carried out in organs to show the evidence of
any toxicity in gross pathology.
Data and reporting:
All data were summarized in tabular form, (Table) showing for each test group
the number of animals used, the number of animals displaying signs of toxicity, the
number of animals found dead during the test, description of toxic symptoms, weight
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changes, food and water intake.
Test substance and Vehicle:
In order to ensure the uniformity in drug distribution in the medium the
suspension was made by mixing Maavilingapattai Chooranam with 2% CMC
solution and it was found suitable for dose accuracy.
Justification for choice of vehicle:
The vehicle selected as per the standard guideline was pharmacologically inert
and easy to employ for new drug development and evaluation technique[92].
4.3.2.REPEATED DOSE 28-DAY ORAL TOXICITY (407) STUDY OF
MAAVILINGAPATTAI CHOORANAM:[93]
Test Substance :Maavilingapattai Chooranam
Animal Source : TANUVAS,Madhavaram, Chennai.
Animals : Wister Albino Rats (Male -40, and Female-40)
Age : 6-8 weeks
Body Weight : 150-220gm.
Acclimatization : Seven days prior to dose.
Veterinary examination : Prior and at the end of the acclimatization period.
Identification of animals : By cage number, animal number and individual
marking by using Picric acid
Diet : Pellet feed supplied by Sai meera foods Pvt Ltd,
Bangalore
Water : Aqua guard portable water in polypropylene bottles.
Housing & Environment : The animals were housed in Polypropylene cages
provided with bedding of husk.
Housing temperature : between 22ºC + 3ºC.
Relative humidity : between 30% and 70%,
Air changes : 10 to 15 per hour
Dark and light cycle : 12:12 hours.
Duration of the study : 28 Days.
Justification for Dose Selection:
The results of acute toxicity studies in Wistar albino rats indicated that
Maavilingapattai Chooranam (MPC)was non-toxic and no behavioural changes was
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observed up to the dose level of 2000 mg/kg body weight. On the basis of body
surface area ratio between rat and human, the doses selected as per OECD guideline
three dose levels were selected for the study. They are low dose (X), mid dose (2X),
high dose (4X). X is calculated by multiplying the therapeutic dose (195 mg) and the
body surface area of the rat (0.018). i.e X dose is (100mg), 2X dose is 200mg/animal,
4X dose is 400mg/animal.
Preparation and Administration of Dose:
Maavilingapattai Chooranam suspended, It was administered to animals at
the dose levels of X, 2X. The test substance suspensions were freshly prepared every
two days once for 28 days. The control animals were administered vehicle only. The
drug was administered orally by using oral gavage once daily for 28 consecutive days.
Methodology:
Randomization, Numbering and Grouping of Animals:
80 Wistar Albino Rats (40M + 40F) were selected and divided into 4 groups.
Each group consist of 20 animals (Male -10, and Female-10). First group treated as a
control and other three group were treated with test drug (low, mid, high) for 28 days.
Animals were allowed acclimatization period of 7 days to laboratory conditions prior
to the initiation of treatment. Each animal was marked with picric acid. The females
were nulliparous and non-pregnant.
Table 5
MPC- MaavilingaPattai Chooranam
Groups No of Rats
Group I Vehicle control (Water) 20 (10 male,10 female)
Group II MPC- low dose X (100mg) 20 (10 male,10 female)
Group III MPC- Mid dose 2X(200mg) 20 (10 male,10 female)
Group IV MPC- High dose 4X (400mg) 20 (10 male,10female)
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Observations:
Experimental animals were kept under observation throughout the course of
study for the following:
Body Weight:
Weight of each rat was recorded on day 1,15,28, at biweekly intervals
throughout the course of study. From the data, group mean body weights and percent
body weight gain were calculated.
Food and water Consumption:
Food and water consumed per animal was calculated for control and the
treated dose groups.
Clinical signs:
All animals were observed daily for clinical signs. The time of onset, intensity
and duration of these symptoms, if any, were recorded.
Mortality:
All animals were observed twice daily for mortality during entire course of
study.
Functional Observations:
At the end of the 4th week exposure, ‘sensory reactivity’ to graded stimuli of
different types (auditory, visual and proprioceptive stimuli), ‘motor reactivity’ and
‘grip strength’ were assessed.
Laboratory Investigations:
Following laboratory investigations were carried out on day 29 in animals
fasted over-night. Blood samples were collected from orbital sinus using sodium
heparin (200IU/ml) for Bio chemistry and potassium EDTA (1.5 mg/ml) for
Hematology as anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10
minutes.
Haematological Investigations:
 Haematological parameters were determined using Haematology analyzer.
 Blood samples of control and experimental rats was analyzed for hemoglobin
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content, total red blood corpuscles (RBC), white blood corpuscles (WBC)
count and packed cell volume (PCV).
Biochemical Investigations:
 Biochemical parameters were determined using auto-analyzer.
 Serum was used for the estimation of biochemical parameters. Samples of
control and experimental rats were analyzed for protein, bilirubin, urea,
BUN, creatinine, triglyceride, cholesterol and glucose levels was carried
using standard methods. Activities of glutamate oxaloacetate
transaminase/Aspartate aminotransferase (GOT/AST), glutamate pyruvate
transaminase/ Alanine amino transferase (GPT/ALT) and alkaline
phosphatase were estimated as per the colorimetric procedure.
Necropsy:
All the animals were sacrificed by excessive anaesthesia on day 29. Necropsy
of all animals was carried out.
Histopathology:
Histopathological investigation of the vital organs was done.Control and
highest dose group animals will be initially subjected to histopathological
investigations. If any abnormality found in the highest dose group than the low, then
the mid dose group will also be examined. Organs will be collected from all animals
and preserved in 10% buffered neutral formalin for 24 h and washed in running water
for 24 h. The organ sliced 5 or 6µm sections and were dehydrated in an auto
technicon and then cleared in benzene to remove absolute alcohol. Embedding was
done by passing the cleared samples through three cups containing molten paraffin at
50°C and then in a cubical block of paraffin made by the “L” moulds. It was followed
by microtome and the slides were stained with Haematoxylin-eosin red.
Statistical analysis:
Findings such as intoxication, body weight changes, water and food consumption,
hematology and blood chemistry were subjected to One-way ANOVA followed by
dunnet test using a statistics software Graph pad version 7.
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4.4.PHARMACOLOGICAL STUDIES:
4.4.1.HEPATO PROTECTIVE ACTIVITY OF “MAAVILINGA PATTAI
CHOORANAM” (MPC) IN CCL4 INDUCED HEPATOTOXICITY RATS
MODEL:
Experimental design:
Animals were divided into 5 groups of 6 rats each.
Group I animals served as control and received liquid paraffin (LP) subcutaneously at
the dose of 3 ml/kg body weight of each animal.
Group II animals received CCl4+ LP (for 14 days) at the dose 1 ml CCl4/kg body
weight, in a suspension of double the volume of LP (which served as vehicle)
subcutaneously at lower abdomen on every 14 days of the treatment.
Group III and IV animals received subcutaneous administration of CCl4+ LP. They
also received test drug Maavilingapattai Chooranam orally at the dose of 100, 200
mg/kg body weight respectively as a suspension of water.
Group V received in addition to CCl4 suspension, silymarin (100 mg/kg body weight)
daily. Silymarin was used as a standard reference drug.
The animals were kept starved overnight on 14th day of experiment. On the
next day the animals were sacrificed by decapitation, and the blood was collected by
cutting the jugular vein. The liver and kidney in each case were dissected out, blotted
of blood, washed in saline and stored in a freezer. Liver were used for various
biochemical estimations.
Biochemical parameters studied:
The activities of serum glutamate pyruvate transaminase, and serum glutamate
oxaloacetate transaminase were estimated using standard methods. Estimation of
serum ALP, serum bilirubin and electrolytes were also carried out to assess the acute
hepatic damage caused by CCL4.
Statistical analysis:
The data obtained from the study were subjected to statistical analysis by one
way ANOVA followed by Dunnett t-test, and results were expressed in terms of
Mean±SEM values. Statistical analysis was performed using INSTAT- V3 Software
programme[94].
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4.4.2.HEPATOPROTECTIVE ACTIVITY OF “MAAVILINGA PATTAI
CHOORANAM” (MPC) AGAINST PARACETAMOL INDUCED
HEPATOTOXICITY IN RATS MODEL:
Experimental design:
The animals were randomly divided into five groups each consisting of six rats (n=6).
Group I animals were treated with vehicle for 8 days and served as normal control.
Group II animals were first treated with vehicle for 7 days and then, hepatotoxicity
was tried to induce on 8th day by oral administration of Paracetamol 3 g/kg b. wt. in a
single dose.
Group III, IV and V animals were first treated with MPC 100, MPC 200 and
silymarin 100 mg/kg/day
respectively for 7 days and then, hepatotoxicity was tried to induce on 8th day by oral
administration of Paracetamol 3 g/kg b. wt. in a single dose. 24 h after the last dosing
by Paracetamol, the blood was obtained through the retro-orbital plexus under light
anesthesia and the rats were sacrificed. Serum for the analysis of various biochemical
parameters was separated by centrifugation at 3000 rpm at 4 C for 20 min. A small
portion of tissue was fixed in formalin for histopathological examination.
Biochemical parameters studied:
The activities of serum glutamate pyruvate transaminase, and serum glutamate
oxaloacetate transaminase were estimated using standard methods. Estimation of
serum ALP, serum bilirubin and electrolytes were also carried out to assess the acute
hepatic damage caused by Paracetamol.
Statistical analysis:
The data obtained from the study were subjected to statistical analysis by one
way ANOVA followed by Dunnett t-test, and results were expressed in terms of
Mean±SEM values. Statistical analysis was performed using INSTAT- V3 Software
programme[95].
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4.4.3.HEPATOPROTECTIVE ACTIVITY OF “MAAVILINGA PATTAI
CHOORANAM” (MPC) AGAINST ETHANOL INDUCED HEPATOTOXICITY
IN RATS MODEL:
Experimental design:
The animals were divided into five groups, six animals in each group.
Animals in Group 1 were treated with Vehicle only twice a day P.O for 25 days
served as Normal Control Group.
Group 2 animals were treated with 40% ethanol 3.76 gm/kg twice a day P.O for 25
days which served as Positive Control Group.
Others animals were pretreated twice daily with MPC 100 and MPC 200 mg &
Silymarin 100 mg/kg P.O for 25 days, 1 hour before Ethanol administration. At the
termination day, animals were anaesthetized using anesthetic ether and blood
collected from retro orbital puncture. The level of AST, ALT, TP and ALP and BN
were estimated as per the standard procedures described by manufacturer using serum
kit.
Biochemical parameters studied:
The activities of serum glutamate pyruvate transaminase, and serum glutamate
oxaloacetate transaminase were estimated using standard methods. Estimation of
serum ALP, serum bilirubin and electrolytes were also carried out to assess the acute
hepatic damage caused by Ethanol.
Statistical analysis:
The data obtained from the study were subjected to statistical analysis by one
way ANOVA followed by Dunnett t-test, and results were expressed in terms of
Mean±SEM values. Statistical analysis was performed using INSTAT- V3 Software
programme[96].
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5. RESULTS AND DISCUSSION
The well known Traditional medicine Maavilingapattai Chooranam had been
subjected to various studies and standardization to establish the works of Siddhars to
be true. The study includes literary collections, organoleptic character,
physicochemical and phytochemical analysis, instrumental analysis, toxicological
study and pharmacological study. The drug Maavilingapattai Chooranam has been
selected for Hepatoprotective activity in reference with the text “Sirorathina
Vaidhiya Booshanam”.
Discussion on review of literature:
 Literary collections about the drug from various text books were done. Siddha
literatures related to the drug bring the evidence and importance of its utility in
treating Jaundice.
 Botanical aspect explains the identification, description, active principle and
medicinal uses of the plants.
 Gunapadam review brings the effectiveness of the drug in treating jaundice
(Kaamaalai).
 Pharmaceutical review describes about the Chooranam and its properties.
 The pharmacological review explains about the methodology of Hepatoprotective
Activity and the drugs used for this study..
 Modern and Siddha aspect of the disease was also reviewed.
Standardization of the test drug:
Standardisation of the drug is more essential to derive the efficacy and the
potency of the drug by analysing it by various studies. Following are the results of
physicochemical and phytochemical analysis. Physical characterisation and estimation
of basic and acidic radicals have been done and tabulated.
Toxicological results of the drug and pharmacological activity of the drug was
derived. Its result has been tabulated and the interpretation was made below. Thus it
give a complete justification to bring the effectiveness of the trial drug
Maavilingapattai Chooranam.
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The extensive review on botanical aspect gave information about the
microscopical characters, macroscopical characters, medicinal uses, constituents and
the importance of the herbs in detail. Most of the herbs included in the formulation are
hepatoprotective in activity. The studies strongly supported the fact through these
results. They are discussed below.
 Iruveli is indicated for curing Jaundice (Kaamaalai).
 Vilamichu is used in the treatment of biliousness.
 Kozhunji is indicated for the treatment of Liver diseases. It also known to
improving the fuctions of liver.
 Vilvam is indicated for curing Jaundice (Kaamaalai).
 Thulasi has an action of tonic to Liver.
 Musumusukkai is used in the treatment of jaundice (Kaamaalai).
 Vila is indicated for curing Jaundice (Kaamaalai).
 Ashuwagandhi has an action of tonic to Liver.
 Mavilingapattai is indicated for the treatment of Liver diseases.
Discussion on pharmacological aspect:
 The pharmacological aspect of the drug says about their mode of action and the
side effects which were used worldwide since ancient times.
 The current pharmacological methods available for carrying out the
Hepatoprotective studies were explained clearly and the suitable In-vivo models
carry out the activities were discussed.
 Result from the pharmacological study denotes the effects of Maavilingapattai
Chooranam(MPC) showed the promising effects in treating liver damage.
Moreover, the increased levels of the serum enzymes were significantly
decreased by the treatment with Maavilingapattai Chooranam implying that the
drug prevents the liver damage.
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Discussion on Pharmaceutical review:
 This review explained the preparation of Chooranam in detail including the
purification of raw drugs, methods of manufacturing of Chooranam and the
Siddha parameters for the standardization of analyzing Chooranam.
 The powdered drugs were filtered through the white cloth so as to reduce the size
of the particle in turn which enhances the bio-availability.
 The shelf life of the drug is improved by proper purification methods and
preservation.
Discussion on Materials and Methods:
 The preparation of the drug was done carefully so as to achieve the highest
potency. Chooranam are fine, dry powders of drugs. The term Chooranam
may be applied to the powder of single drug or a mixture of two or more drugs.
 On purification (pittaviyal), the weight of the Chooranam is different from the
exact value but not from the mean value when calculated.
 The Chooranam were also subjected to Siddha parameters of the testing like,
 Chooranam tends to be amorphous,
 It should be never damp,
 The fitness of the sieve should be 100 mesh or still finer.
 The standardization of the drugs was achieved through various procedures like
analyzing the organoleptic characters, physico-chemical characters, elements
present in the drug and the results and discussion of standardization
parameters is described below.
Organoleptic characters:
Table: 6. Organoleptic characters ofMaavilingapattai Chooranam:
Colour Brown
Odour Pleasant
Taste Bitter
Texture Fine powder
Particle size Completely pass through sieve no 88
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Physicochemical Analysis:
Table: 7. Physicochemical Analysis:
S.NO Parameter Result
1 pH 6.2
2 Loss on drying(at 1050 C) 5.66
3 Total ash value (%) 7.21
3 Acid Insoluble ash (%) 1.37
4 Water soluble ash (%) 3.03
5 Solubility
1.Distilled water Soluble
2.Benzene Soluble
3.Chloroform Soluble
The physicochemical analysis of the drug (MPC) result reveals pH, Loss on drying,
Total ash value, Acid insoluble ash and Water soluble ash. The interpretation of the
result were given below.
Interpretation:
1. pH:
It is a measure of hydrogen ion concentration. It is the measure of the acidic or
alkaline nature. 7.0 is neutral, above 7.0 is alkaline and below is acidic.
The pH of the drug Maavilingapattai Chooranam is 6.2 which is weak acidic
in nature. Acidic drug is essential for its bioavailability and effectiveness. Acidic
drugs are better absorbed in stomach.[97]
2. Moisture ( Loss on drying):
The total of volatile content and moisture present in the drug was established
in loss on drying. Moisture content of the drug reveals the stability and its shelf-life.
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High moisture content can adversely affect the active ingredient of the drug. Thus low
moisture content could get maximum stability and better shelf life. Loss on drying of
Maavilingapattai Chooranam is 5.66.[98]
3. Total Ash:
Ash constitutes are the inorganic residues obtained after complete combustion
of a drug. Thus Ash value is a validity parameter to describe and to assess the degree
of purity of a given drug. Total ash value of plant material indicated the amount of
minerals and earthy materials present in the drug. The total ash value of
Maavilingapattai Chooranam is 7.21 which determine the absence of inorganic
content.
5. Acid insoluble ash:
The acid insoluble ash value of the drug denotes the amount of siliceous
matter present in the plant. The quality of the drug is better if the acid insoluble value
is low. Acid insoluable ash value of Maavilingapattai Chooranam is 1.37.
6. Water soluble ash:
Water-soluble ash is the part of the total ash content, which is soluble in water.
Decreased water soluble ash value indicates easy facilitation of diffusion and osmosis
mechanism. Water soluble ash value of Maavilingapattai Chooranam is 3.03.
7. Solubility:
Solubility is the major factor that controls the bioavailability of a drug
substance. It is useful to determine the form of drug and processing of its dosage form.
The most frequent causes of low oral bioavailability are attributed to poor
solubility and low permeability .[99]
MPC is soluble in major solvents and sparingly soluble in some solvents
proves that its efficiency of solubility in the stomach indirectly, increasing the bio
availability.
Phytochemical analysis:
The phytochemical analysis of Maavilingapattai Chooranam result were given
below:
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Table: 8. Phytochemicals screening test:
SNO Phytochemicals Test Result
1. Carbohydrates Molisch’s test Present
Benedict’s test Present
2. Glycosides Modified Borntrager’s test Present
3. Saponins Froth test Present
4. Phenols Ferric chloride test Present
5. Flavanoids Alkaline reagent test Present
Lead acetate test Present
6. Diterpenes Copper acetate test Present
7. Gum & Mucilage Extract + Alcohol Present
The phytochemical analysis of the drug (MPC) result reveals Carbohydrats,
Glycosides, Saponins, Phenols, Flavanoids, Diterpenes and Gum & Mucilage. The
interpretation of the result were given below.
Interpretation:
 Carbohydrate:
 Carbohydrate contains plenty of antioxidants, vitamins and fiber that are
necessary for our health.
 Carbohydrate diet can improve the liver function in people with fatty liver
diseases.
 Carbohydrates plays an important role in storage of glucose. It regulates the
blood glucose level and provides energy to the body.
 Carbohydrates helps in fat metabolism. It plays an important role in homeostasis.
 Carbohydrates help us to fight inflammation and cancer, improve our digestive
system, heart and bone health.[100]
 Glycosides:
 In the liver, glycosides helps in the process of detoxification.
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 Glycosides have antibacterial activity, so they protect our body from bacteria and
infectious diseases.
 Glycosides increased the intestinal motility. So it produces laxation.[101]
 Saponins:
 Saponins include, supporting kuffer cells in the liver and encouraging normal
detoxification.
 In the digestive tract, saponins produce an emulsification of fat soluble molecules.
Saponins bind with bile acids and helps to eliminate them from the body,
preventing cholesterol from being reabsorbed.
 Saponins can boost the immune system, have an antioxidant effect and may even
support bone strength.[102]
 Phenols:
 Phenols possess rich anti-oxidant property and protect the body from oxidative
stress.
 Phenols inhibit the LDL cholesterol levels.
 Phenols reduces cell death and it regulate glucose metabolism.
 Phenols increase the vasodilation of blood vessels to promote circulation. It is a
Effective anti-hyperglycaemic agent. [103]
 Flavanoides:
 It is the most important group of polyphenolic compounds in plants.
 Flavonoids can exert their anti-oxidant activity by scavenging the free radicals,
by chelating metal ions or by inhibiting enzymatic systems responsible for free
radical generation.
 Flavanoids are immunomodulator. It also possesses anti-microbial activity which
is confirmed by the various anti-microbial assays.[104]
 Diterpenes:
 Diterpene has an anti-oxidant effect.
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 Diterpenes helps to cure hypertension. It also have tumour inhibitory properties
as well as a stimulating effect on the immune system.
 It is used widely as a stomachic.[105]
 Gum &Mucilage:
 It is used as a bulk laxatives.
 Gum and mucilage are used for their demulcent properties for cough
suppression.[106]
High Performance Liquid Chromatography (HPLC):
HPLC analysis were done. HPLC analysis performed with Maavilingapattai
Chooranam revealed the pressence of following compounds:
Table:9.
S.
NO
PARAMETERS METHOD UNITS RESULTS
1. Total Polyphenol as gallic
acid Equivalent
Indian Pharmacopoeia 2014 mg/100g 0.09
2. Total Flavonoids as
Quercetin Equivalent
TNTH/STP/FOOD/110 mg/100g 18.15
3. Total Alkaloids TNTH/STP/FOOD /426 mg/100g 1.93
4. Total Tannin as Tannic
Acid Equivalent
AOAC 20th Edn.2012,
955.35
mg/100g 0.98
HPLC analysis reveals the pressence of polyphenols, Flavanoids, Alkaloids and
Tannins.
RESULTS AND DISCUSSION
HEPATOPROTECTIVE ACTIVITY OFMAAVILINGAPATTAI CHOORANAM 138
Graph 1
Interpretation:
 Polyphenols are the member of very large family of plant derived compounds
which had the anti lipidogenic effect. This is mainly due to reduced fatty acid and
triglycerol synthesis, increased in fatty acid oxidation and reduction of oxidative
stress and inflammation.
 Beneficial effects of polyphenols in the prevention and treatment of liver steatosis
have been reported.
 Polyphenols are biomolecules which produce hepatoprotective effects which
reduce the liver fat accumulation, mainly by reducing lipogenesis and by
increasing fatty acid oxidation and decrease oxidative stress and inflammation are
the main factors responsible for liver damage[107].
 Flavanoids a group of plant compounds which have the beneficial effects against
Non Alcoholic Fatty Liver Disease.
 Flavanoids prevent Hepatosteatosis by increasing fatty acid oxidation in liver.
They can also reduce caloric intake and decrease body weight and fat deposition
in viseral tissues.
 Flavanoids are the unique antioxidant. It also correct dislipidemia and blood
pressure[108].
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 Tannins and alkaloids contains anti oxidant effect which produce many essential
effects in protecting the body.
Table: 10. Results of basic radicals studies:
S.NO Parameter Observation Result
1 Test for Potassium Yellow colour
precipitate
Positive
2 Test For Magnesium
.
White colour precipitate Positive
3 Test for Iron (Ferrous) Blood red colour Positive
4 Test For Zinc Formation of white
precipitate
Positive
The basic radical test reveals the presence of Potassium, Magnesium, Iron, Zinc. The
interpretation of the result were given below.
Interpretation:
Presence of these traces of minerals play an important role in the functioning
of various enzymes in biological system and also have immunomodulatory function
and hence the susceptibility to the course and the variety of viral infections.
Potassium:
 Potassium levels may be an indicator of impending liver problems.
 Potassium is absorbed through the small intestine. Severe lack of
potassium can disturb the liver function and if potassium level falls below
30% to 40% causes Non Alcoholic Fatty Liver Diseases.
 Potassium is important for maintaining the integrity of cell membranes and
functions as a vital electrolyte.[109]
Magnesium:
 Magnesium is essential for liver to prevent liver diseases. It enhances
immune system.
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 Depletion of magnesium levels leads to Cirrhosis and Fatty liver syndrome.
 It also helps to regulate blood glucose levels and aid in the production of
energy and protein[110].
Iron:
 Iron is an essential micronutrient that is an critical component of oxygen
transport proteins (Haemoglobin & Myoglobin).
 Chronic iron deficiency results in decreased haemoglobin production and
anaemia which may result chronic liver diseases.
 Iron is essential for oxygen transport, energy production, other cellular
growth and proliferation.
 Iron is an essential element for blood production and also needed for
energy metabolism.[111]
Zinc:
 The liver plays a central role in zinc homeostasis. Zinc is a trace mineral
that is essential to the normal functioning of the immune system.
 Zinc is essential for many metabolic and enzymatic functions. In Liver it
act as a powerful antioxidant.
 Deficiency of zinc leads to malabsorption syndrome and Cirrhosis of
liver[112].
Table: 11. Test for acid radical studies:
S.NO Parameter Observation Result
1 Test for Sulphate Formation of white precipitate Positive
Interpretation:
The acidic radicals test reveals the presence of Sulphate. Presence of Sulphate
is essential for liver protection by reducing increased serum enzymes of liver.
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Availability of bacterial and fungal load inMaavilingapattai Chooranam:
Table: 12. Bacterial and fungal dilutions:
MICROBES DILUTION RESULT
BACTERIA 10-4 5
BACTERIA 10-6 4
FUNGI 10-2 2
FUNGI 10-3 3
Interpretation:
 The availability of bacterial load in the Maavilingapattai Chooranam has
been performed by Agar plate techniques..
 As Maavilingapattai Chooranam is made from plant material it is more
prone to contamination. The contamination of herbal drugs by
microorganism not only cause bio deterioration but also reduces the
efficacy of drugs.
 The toxin produced by microbes makes herbal drugs unfit for human
consumption because the contaminated drug may develop various disease
instead of disease being cured.
 The contamination of Maavilingapattai Chooranam has been examined by
bacterial and fungal load.
 Total bacterial load in 10-4 dilution is 5 and 10-6 dilution 4.
 Total fungal load in 10-2 dilution is 2 and 10-3 dilution is 3.
This result shows the presence of bacterial and fungal load in the trial drug of
Maavilingapattai Chooranam . They are within the normal limits.[113]
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INSTRUMENTAL ANALYSIS:
FTIR Spectrum Analysis:
Fig 7: FTIR Spectrum analysis
Table 13: FT-IR INTERPRETATION:
Absorption peak cm-1 Stretch Functional group
3909 O-H stretch,
Free hydroxyl
Alcohols
Phenols
3452 N-H stretch 1,2 Amines
Amides
3008 C-H stretch
=C-H Stretch
Aromatics
alkines
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Absorption peak cm-1 Stretch Functional group
2104 -C=N Stretch Alkynes
1665 C=O stretch ɑ,β unsaturated
aldehydes,
ketones
1325 C-N stretch Aromatic amines
1196 C-H wag(-CH2 x) Alkylhalides
946 O-H bend Carboxylic acids
1764 C=O stretch Esters, saturated
aliphatic
1710 C=O stretch ɑ,β unsaturated
aldehydes,
ketones
1641 -C=C- stretch Alkenes
1630 N-H bend 1o amines
1390 C-H bend Alkanes
1344 N-O symmetric stretch Nitro compounds
1582 C-C stretching (ring) Aromatics
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The above table shows the presence of alcohol, phenols, alkane, acid, alkynes,
amide, aromatic, alkylhalide, ether, alkene, nitro compounds, ɑ,β unsaturated
aldehydes, ketones which represents the peak value. The interpretation of the result
were given below.
Interpretation:
FTIR instrumental analysis was done. The test drug (MPC) was identified to
have 35 peaks. They are the functional groups present in the trial drug
Maavilingapattai Chooranam.
 Phenols possess high anti-oxidant property which enhances the drug effect
against the liver disease.
 Phenolic compounds are also present in a number of biological systems and
natural products such as neurotransmitters, flavouring agents.[114]
 Aromatic amines has anti-oxidant property. In liver aromatic amines invovles
metabolic activation and also involved in detoxification. [115]
 OH group has higher potential towards inhibitory activity against
microorganisms.
 Amines enhance the drug effect against the hepatic disease. It also act on the
neurotransmitters, it is involved in the protein synthesis.[116]
 Alkanes have little biological activity, it protect against Microorganism.
 ɑ, β unsaturated aldehydes involved in free radical scavenging activity and also
used in the treatment of cancer.
 Phenols and flavanoids possess diverse biological activities, for example,
hepatoprotective activity, antioxidant and antidepressant activities[117].
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SEM (SCANNING ELECTRONMICROSCOPE):
Fig: 8. SEM (SCANNING ELECTRONMICROSCOPE)
The SEM image is done by 500X magnification via 20µm aperture shows maximum
depth focused.
Interpretation:
Biodegradable microparticles have been used frequently as drug delivery vehicles due
to its grand bioavailability, better encapsulation, control release and less toxic
properties. The advantages of microparticles are
 Increased therapeutic effect of the drug
 Decreased toxicity/ side effects
 Protection from physical and chemical degradation
 Improves stability and Increased bioavailability[118]
The test drug Maavilingapattai Chooranam contains micro particles.
 Micro particles present in the drug results in a better bioavailability and
facilitates absorption.
 The particles of micro size show that the drug may easily enter the cells at the
molecular level to treat the disease rapidly and increase the therapeutic effect.
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XRD (X-Ray Diffraction studies):
Fig 9: XRD
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Interpretation:
The structure, the size and shape of the particles are highly dependent on the
route of synthesis and high lights the efficacy of the drug. The nano particles may
enhance bio absorption of the drug.
The major diffraction peaks are identified after XRD analysis MPC
concluded the range 16-34nm in association with organic molecules propably plays an
important role in making it biocompatible and nontoxic at therapeutic doses. Other
elements present in MPC act as additional supplement and possibly helps in increase
the efficacy of the formulation.[119]
Table 14: ICP-MS results ofMaavilingapattai Choornam:
S. no Elements units Detected levels
1. Arsenic mg/kg BQL (LOQ 0.1)
2. Mercury mg/kg BQL (LOQ 0.1)
3. Lead mg/kg BQL (LOQ 0.1)
4. Cadmium mg/kg BQL (LOQ 0.1)
Discussion:
From the above results the heavy metals Cadmium, Lead, Mercury, Arsenic
are observed with in permissible limits. Hence the safety of the drug is ensured.
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TOXICITY STUDY RESULTS:
Acute oral toxicity study ofMaavilingapattai Chooranam – OECD 423
Dose finding experiment and its behavioural Signs of acute oral Toxicity:
Table: 15. Observation done:
Group Day
Body weight Normal
Assessments of posture Normal
Signs of Convulsion
Limb paralysis
Absence (-)
Body tone Normal
Lacrimation Normal
Salivation Normal
Change in skin color No significant colour change
Piloerection Normal
Defecation Normal
Sensitivity response Normal
Locomotion Normal
Muscle gripness Normal
Rearing Mild
Urination Normal
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Table: 16. (Observational study Results):
N
o
Dose
mg/kg
1 2 3 4 5 6 7 8 9 1
0
1
1
1
2
1
3
1
4
1
5
1
6
1
7
1
8
1
9
2
0
1. Control + - - + - + - - - - - - - - - - - - + -
2. 2000mg + - - + - + - - - - - - - - - - - - + -
1.Alertness 2.Aggressiveness 3. Piloerection 4. Grooming 5.Gripping 6. Touch
Response 7. Decreased Motor Activity 8.Tremors 9.Convulsions 10.Muscle Spasm
11.Catatonia 12.Musclerelaxant 13.Hypnosis 14.Analgesia 15.Lacrimation
16. Exophthalmos 17. Diarrhea 18. Writhing 19 Respiration 20. Mortality
(+ Present, - Absent).
Table: 17. Body weight of wistar albino rats group exposed to Maavilingapattai
Chooranam:
N.S- Not Significant,**(p < 0.01), *(p <0.05), n = 10 values are mean ± S.D (One-
way ANOVA followed by Dunnett’s test)
DOSE DAYS
1 7 14
CONTROL 220.6±31.474 221.4 ± 34.324 224.2 ± 27.623
HIGH DOSE 220.5± 27.75 221.7 ± 3.64 223.4 ± 3.22
P value (p)* NS NS NS
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Table: 18. Water intake (ml/day) of Wistar albino rats group exposed to
Maavilingapattai Chooranam:
N.S- Not Significant,**(p < 0.01), *(p <0.05), n = 10 values are mean ± S.D (One-
way ANOVA followed by Dunnett’s test)
Table: 19. Food intake (gm/day) of Wistar albino rats group exposed to
Maavilingapattai Chooranam:
DOSE DAYS
1 7 14
CONTROL 40.56±9.36 42.6±4.42 41.6±7.46
HIGH DOSE 43.4±1.14 44.3±1.12 46.2±2.20
P value (p)* NS NS NS
N.S- Not Significant,**(p < 0.01), *(p <0.05), n = 10 values are mean ± S.D (One-
way ANOVA followed by Dunnett’s test)
Interpretation of Acute toxicity studies:
In the acute toxicity study, the rats were treated with different concentration of
Maavilingapattai Chooranam from the range of 5mg/kg to 2000mg/kg.
 This dose level did not produce signs of toxicity, behavioral changes, and
mortality in the test groups as compared to the controls when observed during
14 days of the acute toxicity experimental period.
 However the behavior changes, Body weight, Water intake, food intake does
not produce much significant, Thus the results are non-significant.
DOSE DAYS
1 7 14
CONTROL 58.5 ± 6.74 60±9.13 60.4±4.13
HIGH DOSE 66.4±2.12 67.6.2±1.10 67.9±6.12
P value (p)* NS NS NS
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 These results showed that a single oral dose of the extract showed no mortality
of these rats even under higher dosage levels indicating the high margin of
safety of this extract.
 In acute toxicity test the Maavilingapattai Chooranam was found to be
nontoxic at the dose level of 2000mg/ kg body weight.
Repeated dose 28-day oral toxicity ofMaavilingapattai Chooranam OECD – 407
Repeated dose 28 day oral toxicity study was done and the results were
tabulated below.
Table: 20. Body weight of wistar albino rats group exposed to Maavilingapattai
Chooranam:
N.S- Not Significant,**(p < 0.01), *(p <0.05), n = 20 values are mean ± S.D (One-
way ANOVA followed by Dunnett’s test)
Table: 21. Water intake (ml/day) of Wistar albino rats group exposed to
Maavilingapattai Chooranam:
N.S- Not Significant,**(p < 0.01), *(p <0.05), n = 20 values are mean ± S.D (One-
way ANOVA followed by Dunnett’s test)
DOSE Days
1 15 28
CONTROL 302.1±1.14 302.2 ± 1.20 302.3± 0.22
LOW DOSE 297.1 ± 10.3 297.4 ± 1.11 298.4± 1.4
MID DOSE 298.6 ± 2.20 299.5 ± 2.1 299.4 ± 2.7
High DOSE 299.3± 1.20 299.5 ± 2.24 299.7 ± 2.20
P value (p)* NS NS NS
DOSE DAYS
1 15 28
CONTROL 84.2 ± 1.14 84±1.26 84.6±1.30
LOW DOSE 90.2±1.18 90.2±2.40 91.4±1.24
MID DOSE 90.8±2.20 92.1±1.60 93.1±1.20
HIGH DOSE 93.3±1.12 93.4±1.22 95.3±1.26
P value (p)* NS NS NS
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Table: 22. Food intake (gm/day) of Wistar albino rats group exposed to
Maavilingapattai Chooranam:
N.S- Not Significant,**(p < 0.01), *(p <0.05), n = 20 values are mean ± S.D (One-
way ANOVA followed by Dunnett’s test)
Interpretation of weight, water and food intake:
There is no significant change in weight, water intake and food intake by the
animals during the period of study.
Table: 23. Haematological parameters of Wistar albino rats group exposed to
Maavilingapattai Chooranam:
Category Control Low dose Mid dose High dose
P
value
(p)*
Haemoglobin
(g/dl)
13.4±0.06 15.2±0.23 15.6±0.5 16.6±0.60 N.S
Total WBC
(×103µL)
11.5±0.04 12.4±0.03 12.2±1.1 12.6±1.46 N.S
Neutrophils
(%)
25.2±0.02 27.3±0.08 27.5±0.6 28.6±2.12 N.S
Lymphocyte
(%)
70.1±1.21 69.2±1.10 69.7±0.8 70.3±1.28 N.S
Monocyte (%) 0.01±0.02 0.02±0.04 0.02±0.05 0.02±0.07 N.S
Eosinohil(%) .04±0.23 .03±0.25 .03±0.35 .03±0.42 N.S
DOSE DAYS
1 15 28
CONTROL 378.6± 1.20 378±1.32 378.8±2.30
LOW DOSE 382.1±3.24 381.2±3.20 381.4±3.40
MID DOSE 380.1±1.12 380.1±1.20 380.4±1.40
HIGH DOSE 382.1±1.10 382.2±2.20 383.6±1.20
P value (p)* NS NS NS
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Category Control Low dose Mid dose High dose
P
value
(p)*
Platelets
cells103/µl
233.13±2.16 244.14±4.30 245.3±3.5 246.4±3.14 N.S
Total RBC
106/ µl
6.64±0.01 6.68±0.40 6.68±1 6.69±1.04 N.S
PCV% 44.1±0.2 46.10±1.2 46.2±1.7 47.1±2.14 N.S
MCHC g/dL 35.8±1.10 38.8±0.12 38.5±0.6 38.3±1.10 N.S
MCV fL(µm3) 56.1±1.01 57.1±3.10 57.2±1.6 57.9±1.22 N.S
N.S- Not Significant,**(p < 0.01), *(p <0.05), n = 20 values are mean ± S.D (One-
way ANOVA followed by Dunnett’s test)
Interpretation:
 The haematological parameters of animals were done. The results of
repeated dose 28 days oral toxicity study was tabulated above.
 The Blood investigations of RBC, WBC, Hb, Platelets and ESR are
normal that is within the limits.
 The differential count, PCV, MCV showed no significant changes.
 Thus the trial drug Maavilingapattai Chooranam was good and safe drug
for oral administration.
Table: 24. Biochemical Parameters of Wistar albino rats group exposed to
Maavilingapattai Chooranam:
BIOCHEMICAL
PARAMETERS
CONTROL LOW
DOSE
MID DOSE HIGH
DOSE
GLUCOSE (R) (mg/dl) 189.02±01.15 187.10±
01.12
187±0.9 186.10±1.21
T.CHOLESTEROL
(mg/dl)
74.98±1.04 73.08±1.28 73.7±1.2 72.18±1.84
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BIOCHEMICAL
PARAMETERS
CONTROL LOW
DOSE
MID DOSE HIGH
DOSE
TRIGLYCERIDES
(mg/dl)
48.21±2.32 46.22±1.18 44.14±1.7 43.12±2.22
LDL 78.6±2.13 78.7±2.05 77.04±0.22 77.40±01.32
VLDL 14.2±1.52 14.20±2.41 14.1±1.6 14.04±2.15
HDL 28.12±4.32 28.32±2.50 28.7±2.1 29.51±1.23
Ratio 1(T.CHO/HDL) 3.73±1.16 3.72±1.80 3.71±1.9 3.74±2.33
Ratio 2(LDL/HDL) 1.92±1.22 1.92±1.20 1.93±4.2 1.94±06.02
Albumin(g/dL) 4.84±0.04 4.24±0.42 4.55±1.2 4.74±0.60
N.S- Not Significant,**(p < 0.01), *(p <0.05), n = 20 values are mean ± S.D (One-
way ANOVA followed by Dunnett’s test)
Interpretation
The biochemical parameters are within the normal range. This shows that the
trial drug Maavilingapattai Chooranam shows safe and non toxic effects on general
body metabolism.
Table: 25. Liver Function Test of Wistar albino rats group exposed to
Maavilingapattai Chooranam:
PARAMETERS CONTROL LOW
DOSE
MID DOSE HIGH DOSE
T BILIRUBIN
(mg/dl).
0.20±0.04 0.17±0.08 0.17±0.03 0.14±0.03
SGOT/AST(U/L) 21.13±1.42 19.11±0.2 18.1±0.06 17.1±1.1
SGPT/ALT(U/L) 34.12±1.24 31.12±1.82 31.1±0.9 30.12±1.52
ALP(U/L) 162.02±2.18 144.24±1.18 140.15±1.4 132.24±2.24
T.PROTEIN(g/dL) 6.94±0.10 6.32±0.54 6.48±0.30 6.78±0.12
N.S- Not Significant,**(p < 0.01), *(p <0.05), n = 20 values are mean ± S.D (One-
way ANOVA followed by Dunnett’s test)
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Interpretation
The above Liver function test showed that all the enzymes are normal in range.
Thus the liver function test of Maavilingapattai Chooranam shows normal in this 28
day repeated oral toxicity study.
Table: 26. Renal function test of Wistar albino rats group exposed to
Maavilingapattai Chooranam:
PARAMETERS CONTROL LOW
DOSE
MID DOSE HIGH
DOSE
UREA (mg/dl) 14.50±0.29 14.50±0.29 14.45±1.1 14.40±1.22
CREATININE
(mg/dl)
0.6±0.08 0.5±0.09 0.5±0.07 0.5±0.04
BUN(mg/dL) 23.06±0.82 21.13±2.20 22.31±0.03 22.10±1.14
URIC
ACID(mg/dl)
4.02±0.04 4.02±0.21 4.01±0.9 4±0.10
N.S- Not Significant,**(p < 0.01), *(p <0.05), n = 20 values are mean ± S.D (One-
way ANOVA followed by Dunnett’s test)
Interpretation
The renal function test of the animals shows the normal limits and not produce
any nephro toxicity, thus it suggests that the trial drug Maavilingapattai Chooranam
was safe for long term administration.
DISCUSSION:
Observations:
Overall observations were similar in both sex rats.
Clinical signs of toxicity
No clinical signs of toxicity were observed.
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Mortality
No mortality was observed after 28 days repeated dose administration of MPC.
All animals survived to study termination period.
Body weight
No significant alterations were observed in body weight.
Food and water consumption
No significant alterations were observed.
Physiological activities
No changes in the general behaviour.
Blood analysis
a. Hematology
No treatment related effects were observed.
b. Biological parameters
No treatment related effects were observed.
c. Histological examination
Histological examination of organs did not show any pathological changes.
Discussion
 The acute and repeated 28 days oral toxicity studies of MPC did not produce
any toxicity signs in wistar albino rats. Daily administration of MPC at
different doses 100mg/kg, 200mg/kg for 28 days was tolerated by the rats
without any mortality and morbidity, indicates the drug tolerance.
 Hence the polyherbal formulation of MPC can be considered to be safe drug
for prolonged duration use as revealed by toxicological studies.
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HISTOPATHOLOGY STUDIES:
Fig: 10.
CONTROL: HIGH DOSE:
LIVER
KIDNEY
SPLEEN
Interpretation:
From the histopathological examination, the slides of animal organs did not
reveal abnormalities.
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From the acute and repeated oral toxicity studies the drug produced some
significant changes. But the values were found within normal limits. So the drug MPC
was non toxic and safe.
Thus the safety of the drug is revealed so that it can be administered for long
time without side effects.
PHARMACOLOGY ACTIVITY:
Pharmacological activity study result CCl4 induced hepatotoxicity
Table: 27. Level of Serum Enzymes value (AST, ALT, ALP, GGT) withMPC:
Groups Treatment AST U/liter ALT U/liter ALP U/liter GGT U/liter
Group 1 Normal 35.14±0.09 28.20±1.25 88.11±2.18 4.24±1.24
Group 2 CCL4+ LP 145.11 ±
1.54
186.56±1.00 184.72±1.8 9.22±1.20
Group 3 CCL4+Low
dose (MPC)
100mg/kg
102.62±0.93 110.15±1.24 124.26±2.28 5.21±2.12*
Group 4 CCL4+High
dose (MPC)
200mg/kg
74.24±0.62* 62.10±2.16* 98.64±2.14* 5.16±1.22*
Group 5 CCL4+
Silymarin
100mg/kg
47.28±1.14 32.16±0.24 89.42±1.42 4.04±1.21
Statistical analysis ANOVA followed by Dunnett t-test.
* P< 0.05; ** P ˂ 0.01; *** P < 0.001 as compared with group I, a group II
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Table: 28. Effect of Total Protein and Bilirubin withMPC:
Groups Treatment Total Protein
g/dl
Bilirubin mg/dl
Group 1 Normal 5.06±0.20 0.24±0.03
Group 2 CCL4+ LP 1.90±0.46 1.3±0.09
Group 3 CCL4+Low dose (MPC)
100mg/kg
3.97±0.48 0.71±0.07
Group 4 CCL4+High dose (MPC)
200mg/kg
4.92±0.64* 0.62±0.03*
Group 5 CCL4+Silymarin100mg/kg 6.24 ±0.44 0.43±0.04
Statistical analysis ANOVA followed by Dunnett t-test.
* P< 0.05; ** P˂ 0.01; *** P < 0.001 as compared with group I, a group II
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Graph 3
Graph 4
HISTOPATHOLOGY SLIDES OF MPC ON CCL4 INDUCED
HEPATOTOXICITY:
Group I: Control rat showing normal central vein and normal hepatocytes.
Group II: Showing dilated central vein and hepatocytes with degeneration.
Group III: Liver tissue of rats treated with MPC at 100 mg /kg showing mild degree
of necrosis (N) with normal cells (C).
Group IV: Central vein showing normal hepatocytes with regenerating hepatocytes
and mild inflammation in the portal area.
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Group V: Photo micrograph of liver tissue treated with silymarin showing normal
hepatocytes , portal vein (V), portal Artery.
Fig:11.
Group 1 Group 2
Group 3 Group 4
Group 5
Interpretation:
 The present studies were performed to assess the hepatoprotective activity in rats
against Carbon tetrachloride as hepatotoxins.
 The serum marker enzymes, AST, ALT, ALP, GGT and Bilirubin and Total Proteins
were exceedingly susceptible to hepatotoxins. They assist as markers of inflammation
RESULTS AND DISCUSSION
HEPATOPROTECTIVE ACTIVITY OFMAAVILINGAPATTAI CHOORANAM 162
of liver cells or death of some cells due to liver damage and oxidative stress, which
stimulate the release of amino transferases from hepatocytes into the blood.
 The serum enzymes like AST, ALT, ALP, Bilirubin, GGT treated animals were
significantly reduced by seven days pretreatment of MPC at two dose levels
100mg/kg and 200mg/kg, when compared with CCl4 treated control. No significant
clinical abnormalities in other groups.
 The changes associated with Carbon tetrachloride induced liver damage of the present
study appeared similar to the acute viral hepatitis. In CCl4 induced hepatotoxicity, the
administration of the toxicant CCl4 showed a distinct rise in the levels of serum
marker enzymes namely AST, ALT, ALP, Bilirubin and as shown above Table no 27.
 A number of reports indicates that overdose of carbon tetrachloride can produce
centrizonal hemorrhagic hepatic necrosis in humans and experimental animals.
 Carbon tetrachloride is biotransformed by the cytochrome P-450 system to produce
the trichloromethyl free radical, which in turn covalently binds to cell membranes and
organelles to elicit lipid peroxidation, disturb Ca 2+ homeostasis and finally result in
cell death.
 The drug (MPC) treatment was carried out at two dose levels 100 and 200mg/kg, both
of which along with the standard treated group showed a significant reduction in the
elevated enzyme levels.
 The MPC treatments significantly reversed the levels of ALP. Reduction in ALP
levels with concurrent depletion of raised bilirubin levels suggests the stability of the
biliary function during injury with Carbon tetrachloride. Therefore the reduction in
the activity of these enzymes may result in a number of deleterious effects.
 Administration of MPC increased the activities against CCL4-induced liver damage
in rats to prevent the accumulation of excessive fats and protected the liver[115].
 These data suggests a dose dependent hepatoprotective activity of MPC. Reduction in
the levels of AST, ALT, and ALP towards the normal value is an indication of
regeneration process. The protective effect exhibited by MPC at dose level of 200
mg/kg was comparable with the standard drug.
 These findings also suggested that the MPC administered has significantly neutralized
the toxic effects of Carbon tetrachloride and helped in regeneration of hepatocytes.[120]
 This was further confirmed by histopathological slides in Fig 11.
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Pharmacological activity study result Paracetamol induced hepatotoxicity
Table: 29. Level of Serum Enzymes value (AST, ALT, ALP) withMPC:
Groups Treatment AST U/liter ALT U/liter ALP U/liter
Group 1 Normal 88.67 ±1.085 64.83±0.600 70.50±0.763
Group 2 Toxicant
Control(Paracet
amol-
1.25ml/kg)
242.5 ± 2.349 290.5±0.763 209.5±0.831
Group 3 Low dose
(MPC)
100mg/kg
186 ± 0.577 204.8±0.600 184.50±0.563
Group 4 High dose
(MPC)
200mg/kg
165.5 ± 0.763* 159±0.577* 130.5±0.436*
Group 5 Silymarin
100mg/kg
144.8 ± 0.600 120.8±0.945 104.5±0.672
Statistical analysis ANOVA followed by Dunnett t-test.
* P< 0.05; ** P˂ 0.01; *** P < 0.001 as compared with group I, a group II
Graph 5
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Table: 30. Effect of Total protein and Bilirubin withMPC:
Groups Treatment Total protein g/dl Bilirubin mg/dl
Group 1 Normal 6.04±0.31 0.24±0.6
Group 2 Toxicant
Control(Paracetamol-
1.25ml/kg)
3.39±0.39 1.6±0.09
Group 3 Low dose (MPC)
100mg/kg
4.18±0.21 0.88±0.03
Group 4 High dose (MPC)
200mg/kg
5.24±0.23* 0.79±0.07*
Group 5 Silymarin 100mg/kg 6.14±0.31 0.42±0.04
Statistical analysis ANOVA followed by Dunnett t-test.
* P< 0.05; ** P˂ 0.01; *** P < 0.001 as compared with group I, a group II
Graph 6
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Table: 31. Effect of Cholesterol withMPC:
Groups Treatment Cholesterol (mg/dl)
Group 1 Normal 149.8±6.52
Group 2 Toxicant
Control(Paracetamol-
1.25ml/kg)
337.9±10.14
Group 3 Low dose (MPC) 100mg/kg 271±6.28
Group 4 High dose (MPC) 200mg/kg 194.6±6.38*
Group 5 Silymarin 100mg/kg 166±5.82
Statistical analysis ANOVA followed by Dunnett t-test.
* P< 0.05; ** P˂ 0.01; *** P < 0.001 as compared with group I, a group II
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Table: 32. Effect of Triglycerides withMPC:
Groups Treatment Triglycerides (mg/dl)
Group 1 Normal 0.63±0.049
Group 2 Toxicant
Control(Paracetamol-
1.25ml/kg)
2.674±0.086
Group 3 Low dose (MPC) 100mg/kg 1.65±0.045
Group 4 High dose (MPC) 200mg/kg 0.974±0.261**
Group 5 Silymarin 100mg/kg 0.858±0.024
Statistical analysis ANOVA followed by Dunnett t-test.
* P< 0.05; ** P˂ 0.01; *** P < 0.001 as compared with group I, a group II
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Table: 33. Effect of Liver Volume and Liver Weight withMPC
Groups Treatment Liver Volume(ml) Liver Weight(g)
Group 1 Normal 2.721±0.054 4.56±0.71
Group 2 Toxicant
Control(Paracetamol-
1.25ml/kg)
4.624±0.086 5.66±0.61
Group 3 Low dose (MPC)
100mg/kg
3.546±0.95* 4.17±0.58*
Group 4 High dose (MPC)
200mg/kg
3.526±0.302* 4.29±0.63*
Group 5 Silymarin 100mg/kg 3.156±0.138 4.4±0.29
Statistical analysis ANOVA followed by Dunnett t-test.
* P< 0.05; ** P˂ 0.01; *** P < 0.001 as compared with group I, a group II
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Table: 34. Effect of Direct Duration of Sleep and Onset of Time withMPC:
Groups Treatment Duration of Sleep
(sec)
Onset of Time (min)
Group 1 Normal 94±2.711 169.9±1.70
Group 2 Toxicant
Control(Paracetamol-
1.25ml/kg)
230.2±1.79 59.9±2.96
Group 3 Low dose (MPC)
100mg/kg
169.9±2.11* 99±0.216*
Group 4 High dose (MPC)
200mg/kg
128.1±0.91* 127.70±2.29*
Group 5 Silymarin 100mg/kg 118±1.19 149±3.30
Statistical analysis ANOVA followed by Dunnett t-test.
* P< 0.05; ** P˂ 0.01; *** P < 0.001 as compared with group I, a group II
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HISTOPATHOLOGY SLIDES OF MPC ON PARACETAMOL INDUCED
HEPATOTOXICITY:
Group I: Control rat showing normal histological architecture with central vein and
normal hepatocytes.
Group II: Showing extensive areas of confluent necrosis and also showing fatty
changes and hydropic degeneration.
Group III: Liver tissue of rats treated with MPC at 100 mg /kg showing partial
protection of hepatocytes and mild degree of necrosis.
Group IV: Liver tissue of rats treated with MPC at 200 mg /kg showing centrizonal
protection with regenerating hepatocytes and mild inflammation in the portal area.
Group V: Photo micrograph of liver tissue treated with silymarin showing normal
histological architecture with central vein , portal vein and portal Artery.
RESULTS AND DISCUSSION
HEPATOPROTECTIVE ACTIVITY OFMAAVILINGAPATTAI CHOORANAM 170
Fig: 12.
Group 1 Group 2
Group 3 Group 4
Group 5
Interpretation
 Paracetamol induced hepatotoxicity is the generally used screening method for
testing the hepato protective nature of drugs. The hepatic damage increases the
level of serum marker enzymes like ALT, AST, ALP. This indicates the cellular
damage as well as loss of functional integrity of cell membrane in liver.
 The test was also conducted to compare the Liver Volume and liver weight of
Paracetamol induced rat and the rat with effect of Maavilingapattai Chooranam.
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 In paracetamol treated Wister albino rat the levels of serum marker enzymes
(ALT, AST, and ALP) and triglyceride level elevated significantly. These
increased levels were depicted in Table.
 Owing to damage of hepatocytes the cell necrosis occurs. The increased
production of serum enzymes in blood was related with central/submissive
necrosis of liver which causes severe hepatic injury.
 The liver volume and liver weight significantly increased. Duration of sleep
significantly increased and onset of time siginificantly decreased by the treatment
withMaavilingapattai Chooranam at 100 mg/kg p.o and 200 mg/kg p.o.
 Moreover, the increased levels of the serum enzymes were significantly
decreased by the treatment with Maavilingapattai Chooranam at 100 mg/kg and
200 mg/kg, all the details implying that the drug prevent the liver damage[116].
 The Maavilingapattai Chooranam treatment confirmed dose dependent
activity, Maavilingapattai Chooranam at 200 mg/kg revealed good result than
100mg/kg which is given in Table 29 for the determined levels of various serum
enzymes.[121] This was further confirmed by histopathological slides in Fig 12.
Pharmacological activity study result Ethanol induced hepatotoxicity
Table: 35. Level of Serum Enzymes value (AST, ALT, ALP) withMPC:
Groups Treatment AST U/liter ALT U/liter ALP
KA units/100ml
Group
1
Normal 22.14±0.39 38.20±3.66 106.10±1.18
Group
2
Ethanol 85.11 ±1.44 103.24±1.00 144.32±1.43
Group
3
Ethanol+
(MCM)
100mg/kg
67.02±0.46* 64.38±1.04* 130.16±1.18
Group
4
Ethanol+
(MCM)
200mg/kg
59.14±0.42* 42.14±1.16* 106.44±1.14*
Group
5
Ethanol+
Silymarin
100mg/kg
47.28±1.14 32.16±0.24 89.42±1.42
Statistical analysis ANOVA followed by Dunnett t-test.
* P< 0.05; ** P˂ 0.01; *** P < 0.001 as compared with group I, a group II
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Graph 12
Table: 36. Effect of Total Protein and Bilirubin withMPC:
Groups Treatment Total Protein g/dl
(TP)
Bilirubin mg/dl
(BN)
Group 1 Normal 4.07±0.20 0.62 ± 0.32
Group 2 Ethanol 2.52±0.16 3.42±0.34
Group 3 Ethanol+
(MPC) 100mg/kg
3.56±0.18* 2.28±0.33
Group 4 Ethanol+ (MPC)
200mg/kg
3.92±0.64* 1.67±0.22*
Group 5 Ethanol+ Silymarin
100mg/kg
6.24 ±0.44 a 1.2±0.22
Statistical analysis ANOVA followed by Dunnett t-test.
* P< 0.05; ** P˂ 0.01; *** P < 0.001 as compared with group I, a group II
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Graph 13
Graph 14
HISTOPATHOLOGY SLIDES OF MPC ON ETHANOL INDUCED
HEPATOTOXICITY:
Group I: Control rat showing normal liver tissue.
Group II: liver tissue of rat administered alcohol showing periportal necrosis with the
presence of multinucleated hepatocytes and dilated central vein.
Group III: Liver tissue of rats treated with MPC at 100 mg/kg showing apparantly
normal liver with few scattered hepatocytes.
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Group IV: Liver tissue of rats treated with MPC at 200 mg/kg showing normal
hepatocytes with regenerating hepatocytes and mild inflammation.
Group V: Photo micrograph of liver tissue treated with silymarin showing normal
hepatocytes, portal vein (V), portal Artery.
Fig: 13.
Group 1 Group 2
Group 3 Group 4
Group 5
Interpretation:
 In the present study ethanol was used to induce Hepatotoxicity.
 Ethanol produces a constellation of dose related deleterious effects in the liver.
Both acute and chronic ethanol administration cause enhanced formation of
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cytokines, especially TNF-alpha by hepatic Kupffer cells, which have a
significant role in liver injury.
 Elevated levels of AST and ALT are indications of hepatocellular injury.
 On the other hand suppression of elevated ALP activities with concurrent
depletion of raised bilirubin level and an increase in the total plasma protein
content suggests the stability of biliary dysfunction in rat liver during hepatic
injuries with toxicants.
 In Ethanol treated rats the levels of serum marker enzymes (AST, ALT, ALP and
Bilirubin) elevated significantly. Moreover, the increased levels of the serum
enzymes were significantly decreased by the treatment with Maavilingapattai
chooranam at 100 mg/kg p.o and 200 mg/kg p.o, implying that the drug prevent
the liver damage[117].
 The Maavilingapattai chooranam treatment confirmed dose dependent activity, at
dose level 200 mg/kg p.o revealed good result than 100mg/kg p.o.[122]
 This was further confirmed by histopathological slides in Fig 13.
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6. CONCLUSION
Liver diseases are the one of the most common health problem in the world
wide. The Liver is quantitatively important site for drug metabolism. However many
drugs are known to cause hepatic injury. Conventional and synthetic drugs are used in
the treatment of liver diseases are sometimes inadequate and can have serious adverse
effect. In the absence of a reliable liver protective drug in modern medicine there are a
number of medicinal preparations from Siddha system of medicine recommended for
the treatment of liver disorders.
In order to overcome this difficulty a novel attempt has been made to
standardize the Siddha drug Maavilingapattai Chooranam for its Hepatoprotective
properties by using analytical, preclinical studies.
The drug Maavilingapattai Chooranam was selected from the Siddha
literature Sirorathina Vaidhiya Booshanam to validate the safety and its efficacy of
CCL4, Paracetamol and Ethanol induced hepatotoxicity.
The ingredients of the test drug was identified and authenticated by Siddha
experts. The drug was prepared as per the procedure and subjected to various studies
to reveal its potency and effectiveness against the disease.
Various analysis such as physicochemical, phytochemical, biochemical
analysis, instrumental analysis was made. From the above analysis we came to know
the presence of active ingredients responsible for its activity.
Physico-chemical analysis:
 The pH of Maavilingapattai Chooranam was 6.2. This is weak acidic in nature.
Acidic drug is essential for its bioavailability and effectiveness. Acidic drugs are
easily absorbed in upper part of stomach. Hence, the drug should not produce any
harmful effect to the mucus membrane of the GI tract.
 Chooranam is one of the basic medicines in Siddha system. The medicines on
this order have fine particle size and low moisture content. The fine particle size
enhances the pharmacokinetic actions and the low moisture content indicates the
longer shelf life period of the drug.
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 Maavilingapattai Chooranam is soluble in major solvents and sparingly soluble
in some solvents proves that its efficiency of solubility in the stomach indirectly,
increasing the bio availability.
Phytochemical analysis:
 Phytochemical analysis showed the presence of Carbohydrates, Glycosides,
Saponins, Phenols, Flavanoides, Diterpenes, Gum & Mucilage.
 Biochemical analysis showed the presence of Potassium, Magnesium, Iron, Zinc
and Sulphate. Thus from these results we come to know the effectiveness of the
drug is due to the presence of these constituents and it has a synergistic effect in
acting against the disease.
 Phytochemicals are natural bioactive compound, found in plants and fibres,
which act as a defense system against diseases and more accurately to protect
against diseases.
 HPLC analysis performed with Maavilingapattai Chooranam revealed the
pressence of Polyphenols, Flavanoides, Alkaloides and Tannins.
 Polyphenols are biomolecules which produce hepatoprotective effects. Mainly
because of they reduce liver fat accumulation, mainly by reducing lipogenesis
and by increasing fatty acid oxidation and decrease oxidative stress and
inflammation, the main factors responsible for liver damage. Flavanoides are the
unique antioxidant, which have the beneficial effects against Liver Disease.
Antimicrobial activity:
 The Maavilingapattai Chooranam showed a broad-spectrum antimicrobial
activity contrary to all the microorganisms. In the study reveals that the presence
of bacterial and fungal load in the trial drug (MPC). They present within the
normal limits.
Instrumental analysis:
 Based on the results, Maavilingapattai Chooranam is preferably non-toxic to
human in its therapeutic dose. The standardization of the drug was evaluated by
chemical characterization with heavy metal analysis, functional group analysis,
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elemental analysis and determination of particle size by ICP-MS, FTIR, and SEM
respectively.
 ICP-MS reveals that in Maavilingapattai Chooranam, the heavy metals like Hg,
As, Cd, Pb were below detectable level. This reveals the safety of the drug.
 The FTIR results showed the presence of O-H Stretching and bend, OH group has
higher potential towards inhibitory activity against microorganisms. Phenols and
flavanoides possess highly Anti-Oxidant property which enhances the drug effect
against the disease.
 The major diffraction peaks are identified after XRD analysis. XRD pattern of the
trail drug Maavilingapattai Chooranam shows some good crystanility.
 The SEM picture shown the presence of microparticle of size 100-1000 nm in the
drug Maavilingapattai Chooranam. Further, the study shows that
Maavilingapattai Chooranam is a kind of micromedicine which favours the
advantages of bio availability, better absorption and non toxic with minimal dose
level.
Pharmacokinetic aspect:
The acid medicines were absorbed in acid medium. That is the Maavilingapattai
Chooranam may be absorbed in the upper part of GI tract.
Toxicity studies:
From the acute toxicity study as per OECD guideline 423, it was concluded
that the test drug Maavilingapattai Chooranam is a safest drug. No mortality was
obtained.
Toxicological study of both acute and sub-acute toxicity study were carried
out in animal model Wistar albino rat according to the OECD guidelines. The test
drug showed no acute toxicity as there was no mortality seen. The sub-acute toxicity
after the repeated dose of 28 days was done. The mortality, functional observations,
haematological and biochemical investigations were made. There was no significant
change seen in the normal values. Thus the toxicological study of the test drug greatly
establishes the safety and gives the justification for long time administration.
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In Conclusion, no toxic effect was observed up to 200mg/kg of
Maavilingapattai Chooranam treated over a period of 28 days (OECD 407). So, it can
be concluded that the Maavilingapattai Chooranam can be prescribed for therapeutic
use in human with the dosage recommendations of up to 100mg/kg body weight p.o.
Pharmacological activities:
The pharmacological study was carried out in the animal model Wistar albino
rats. Three activities were seen in the drug Maavilingapattai Chooranam. The
Activities were,
 CCL4 induced Hepatotoxicity
 Paracetamol induced Hepatotoxicity
 Ethanol induced Hepatotoxicity
Hepatoprotective activity against CCL4, Paracetamol and Ethanol induced
Hepatotoxicity:
The present study showed that Maavilingapattai Chooranam produce
protective against the hepatotoxicity induced by CCL4, Paracetamol and Ethanol. The
Hepatoprotective role of Maavilingapattai Chooranam might be due to its chemical
constituent. Hence Maavilingapattai Chooranam may be act as prophylactic as well
as curative drug in treating hepato toxic conditions. Further studies needs to isolate
the active constituents and mechanism of action. Thus the author validates
Maavilingapattai Chooranam as a new Hepato-protective drug which is cost effective
and without any side effect.
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7. SUMMARY
The test drug Maavilingapattai Chooranam was selected from the Siddha
literature Sirorathina Vaidhiya Booshanam written by Angamuthu Mudhaliyar for
its hepatoprotective activity.
 The dissertation started with an introduction explaining about the Siddha
concept, prevalence of jaundice and role of the test drug in treating hepatic diseases.
 The review of literature strengthened the positive facts of possessing the
Hepatoprotective activity by each of the single drug included in the formulation.
 The pharmacological review possessed all the information regarding the
exertion of action of the drugs, available drugs in the market, their adverse effects.
 The test drug Maavilingapattai Chooranam was prepared properly by the
given procedure.
 All the ingredients were identified and authenticated by the experts.
 Review of literature in various categories was carried out. Siddha aspect,
botanical aspect and pharmaceutical review disclosed about the drug and the disease.
 Pharmacological review was done to establish the methodologies.
 The drug was subjected to analysis such as physicochemical, phytochemical,
biochemical and also instrumental analysis which provided the key ingredients
present in the drug thus it accounts the efficacy of the drug.
 Toxicological study was made according to OECD guidelines comprising both
acute and sub-acute toxicity study. It showed the safety of the drug which attributes
its utility in long time administration.
 Pharmacological study was done. It revealed the Hepatoprotective activity of
Maavilingapattai Chooranam in animal model Wistar albino rats.
 Results and discussion gives the necessary justifications to prove the potency
of the drug.
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 Conclusion gives a compiled form of the study and explains the synergistic
effect of all the key ingredients and activities that supports the study.
 This current analysis authenticates that Maavilingapattai Chooranam has
impressive Hepatoprotective activity, which exemplifies the intelligence of the Siddha
literature to reach globally for the welfare of mankind. Thus the herbal formulation
Maavilingapattai Chooranam is validated for its safety and efficacy for treating
jaundice and it would be a great drug of choice.
FUTURE SCOPE
HEPATOPROTECTIVE ACTIVITY OFMAAVILINGAPATTAI CHOORANAM 182
8. FUTURE SCOPE
The Herbal formulation “Maavilingapattai Chooranam” was taken as the
compound drug preparation for Hepatoprotective activity mentioned in the classical
Siddha literature “Sirorathina Vaidhiya Booshanam” written by Angamuthu
Mudhaliyar. The mechanism of action by which Maavilingapattai Chooranam
produced its effect on hepatoprotective activity in experimental animals need to be
validated in a scientific manner using specific experimental animal models and also
multi-center clinical trials are required to understand the exact molecular mechanisms
of action. So it could be used worldwide for hepatoprotective action.
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